fluorodeoxyglucose f18 has been researched along with Adenocarcinoma in 1111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (0.27) | 18.7374 |
| 1990's | 68 (6.12) | 18.2507 |
| 2000's | 339 (30.51) | 29.6817 |
| 2010's | 587 (52.84) | 24.3611 |
| 2020's | 114 (10.26) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, U; Baron, L; Barshack, I; Davidson, T; Nissan, E; Urban, D; Zabatani, A | 1 |
| Inoue, H; Ito, R; Izumi, N; Komatsu, H; Matsuda, Y; Nishiyama, N; Tsukioka, T | 1 |
| Calandriello, L; Cancellieri, A; Chiappetta, M; Cocciolillo, F; Lococo, F; Sassorossi, C | 1 |
| Park, YM; Seo, HI | 1 |
| Hu, XY; Li, L; Luo, NN; Peng, LH; Qiu, DS | 1 |
| Brouwers, AH; de Leijer, JF; Kruijff, S; Links, TP; Metman, MJH; van der Hoorn, A; van Hemel, BM; Westerlaan, HE | 1 |
| Ampollini, L; Arena, V; Bertoglio, P; Casadio, C; Filosso, PL; Guerrera, F; Lesca, A; Lococo, F; Lyberis, P; Marchese, V; Paci, M; Puma, F; Rena, O; Ruffini, E; Vannucci, J; Ventura, L; Viti, A | 1 |
| Clements, HA; Patil, P; Petty, R; Ramkumar, PG; Walsh, S | 1 |
| Du, B; Hao, W; Li, X; Li, Y | 1 |
| Dong, A; Li, Z; Yu, Z; Zhang, J; Zhu, Y | 1 |
| Adinehpour, Z; Aghdam, RA; Haghighi, S; Kaghazchi, F; Vali, R | 1 |
| Baudin, E; Chevalier, B; Deschamps, F; Djennaoui, M; Do Cao, C; Hadoux, J; Jannin, A; Lamartina, L; Leboulleux, S; Lion, G; Moutarde, C; Schlumberger, M; Vantyghem, MC | 1 |
| Burge, M; Cavallucci, D; Chikatamarla, V; McGahan, W; O'Rourke, N; Thomas, P | 1 |
| Murakami, T; Nogami, M; Ueno, YR; Yokoo, S; Zeng, F | 1 |
| Jia, X; Pan, L; Zhang, Y; Zhao, X; Zhou, L; Zhou, X | 1 |
| Dong, A; Qiu, S; Zhu, Y; Zuo, C | 1 |
| Gökçek, A; Ozmen, O; Tatci, E | 1 |
| Bezerra Pinheiro, RB; Buchpiguel, CA; Ceconello, I; Mester, M; Ribeiro, U; Sado, HN; Sallum, RAA; Simionato Perrotta, F; Sobroza de Mello, E; Tustumi, F; Zilberstein, B | 1 |
| Dong, K; Huang, Q; Qin, C; Wang, S; Wen, G | 1 |
| Borel Rinkes, IHM; Braat, AJAT; de Keizer, B; de Vries, LH; Lebbink, CA; Lodewijk, L; Valk, GD; van Leeuwaarde, RS; van Santen, HM; van Treijen, MJC; Vriens, MR | 1 |
| Allen, M; Anconina, R; Chen, EX; Darling, GE; Elimova, E; Jang, RW; Liu, ZA; Metser, U; Ortega, C; Swallow, CJ; Taylor, K; Veit-Haibach, P; Wong, R; Yeung, J | 1 |
| Goksel, S; Karaman, E; Tuluce, K | 1 |
| Adinehpour, Z; Akbarian Aghdam, R; Amini, H; Divband, G; Kaghazchi, F | 1 |
| Chen, H; Kong, L; Meng, T; Pang, Y; Xu, W | 1 |
| Atzinger, A; Förster, S; Hartmann, A; Hohenforst-Schmidt, W; Klink, T; Kuwert, T; Schmidkonz, C; Steppert, C; Sterlacci, W; Sziklavari, Z; Vieth, M; Zhang, R | 1 |
| Dong, A; Zhu, Y; Zuo, C | 1 |
| Guo, QX; Li, M; Liu, Y; Long, WB; Pu, X; She, Q; Tang, Y; Wang, YL | 1 |
| Hermans, JJ; Litjens, G; Prokop, M; van Geenen, EJM; van Laarhoven, CJHM | 1 |
| Alçın, G; Arslan, E; Beyhan, E; Çermik, TF; Erol, Ö; Güzelbey, B | 1 |
| Chen, W; Cui, Y; Du, B; Li, X; Li, Y; Ma, Y | 1 |
| Chamroonrat, W; Charoenphun, P; Sakulpisuti, C | 1 |
| Amin, AA; Elahmadawy, MA; Heikal, SY; Shalash, AM; Youssef, AA | 1 |
| Kabel, AM; Magdy, AA; Mokhtar, HM; Naguib, TM; Sabry, NM; Salama, SA; Youssef, A | 1 |
| Abdelrahman, AM; Alva-Ruiz, R; Cleary, SP; Goenka, AH; Graham, RP; Grotz, TE; Haddock, MG; Halfdanarson, TR; Hallemeier, CL; Kendrick, ML; Leiting, JL; Ma, WW; McWilliams, RR; Merrell, KW; Nagorney, DM; Smoot, RL; Thiels, CA; Tran, NH; Truty, MJ; Warner, SG; Yonkus, JA | 1 |
| Chen, Y; Liu, H | 1 |
| Albertsmeier, M; Angele, M; Bassermann, F; Blankenstein, C; Combs, SE; Feith, M; Friess, H; Haller, B; Kasper, S; Liffers, ST; Lorenzen, S; Quante, M; Rauscher, I; Schmid, RM; Schwaiger, M; Siveke, JT; Slotta-Huspenina, J; Weber, WA; Weichert, W | 1 |
| Agrawal, A; Bedmutha, AS; Choudhury, S; Goel, M; Patkar, S; Purandare, NC; Puranik, AD; Ramadwar, M; Rangarajan, V; Shah, S | 1 |
| Bradley, KM; Coles, B; Coomer, W; Foley, KG | 1 |
| Bang, S; Han, K; Hwang, HK; Hwang, SH; Kim, MJ; Kim, SS; Lee, HS; Park, MS; Yoon, JK; Yun, M | 1 |
| Ganesan, P; Goyal, H; Halanaik, D; Kishore, S | 1 |
| Bülbül, HM; Bülbül, O; Çapa Kaya, G; Gezer, NS; Gürel, D; Tertemiz, KC; Ulukuş, EÇ | 1 |
| Buck, AK; Hartrampf, PE; Higuchi, T; Kosmala, A; Lindner, T; Michalski, K; Schirbel, A; Schlötelburg, W; Serfling, SE; Weich, A; Werner, RA | 1 |
| Goto, H; Harada, H; Hasegawa, H; Kakeji, Y; Kanaji, S; Matsuda, T; Oshikiri, T; Sawada, R; Urakawa, N; Yamashita, K | 1 |
| Larcos, G; Power, J | 1 |
| Keyhanian, K; Sekhon, HS | 1 |
| Basu, S; Sonavane, SN | 1 |
| Chen, W; Li, Y; Lin, Z; Zhang, Y | 1 |
| Hayashi, N; Iwasa, H; Kato, M; Matsumoto, T; Miyatake, K; Nakaji, K; Nishimori, M; Nitta, N; Tamura, M; Toi, M; Yamagami, T; Yamanishi, T; Yoshimatsu, R | 1 |
| Huang, W; Li, L; Su, Y; Wang, J; Zhou, H | 1 |
| Ayaz, S; Ayaz, UY | 1 |
| Bulzico, DA; Cavalcante, LBCP; Corbo, R; de Andrade, FA; Fernandes, PIW; Garcis Alves-Junior, PA; Gonzalez, F; Treistman, N; Vaisman, F | 1 |
| Baker, CR; Chicklore, S; Davies, AR; Deere, H; Gossage, JA; Green, M; Kelly, M; Lagergren, J; Maisey, N; Moore, JL; Santaolalla, A; Subesinghe, M; Van Hemelrijck, M | 1 |
| Bai, Y; Dong, A; Lin, X; Xu, S; Yang, B | 1 |
| Fan, L; Liu, S; Lyu, D; Tu, W; Wang, Y; Zhou, T | 1 |
| Hassan, A; Mufty, S; Rana, MF | 1 |
| Baker, C; Davies, A; Dunn, J; Gimson, E; Gossage, J; Hill, M; Kelly, M; Lagergren, J; Maisey, N; Meenan, J; Reyhani, A; Subesinghe, M; Zeki, S | 1 |
| Cohen, D; Even-Sapir, E; Fahoum, I; Hazut Krauthammer, S; Kesler, M | 1 |
| Durma, AD; Kamiński, G; Saracyn, M; Zegadło, A | 1 |
| Beer, AJ; Eiber, M; Henninger, M; Rischpler, C; Scheidhauer, K; Thaiss, W; Westphal, K | 1 |
| Chen, Y; Ding, H; Guo, C; Liang, J; Liu, Y | 1 |
| Shi, H; Yin, H; Yu, H | 1 |
| Ishimura, M; Kanaji, N; Manabe, Y; Mitamura, K; Murao, M; Murota, M; Nishiyama, Y; Norikane, T; Yamamoto, Y | 1 |
| Ding, X; Hou, L; Ju, N; Li, C; Luo, Q; Nie, L; Shen, C; Wang, Y | 1 |
| Chen, Y; Deng, J; Li, K; Liu, H; Xiang, F | 1 |
| Cui, Z; Feng, J; Huang, L; Li, J; Luo, Y; Ma, W; Tian, X; Xie, Y; Yuping, H; Zhang, K; Zhou, J | 1 |
| Chen, Z; Huang, Y; Shi, L; Tang, J; Tang, X; Wang, F; Wang, J; Yang, R; Zhao, Z | 1 |
| Lin, D; Liu, B; Liu, Q; Zhang, K | 1 |
| Chen, Y; Lin, Y; Miao, W; Wu, Z; Zheng, S | 1 |
| Colbatzky, T; Giesel, FL; Glatting, FM; Gutjahr, E; Haberkorn, U; Hackert, T; Heger, U; Hielscher, T; Hoppner, J; Kratochwil, C; Lang, M; Liermann, J; Pausch, T; Röhrich, M; Spektor, AM; Sperling, L; van Genabith, L | 1 |
| Brennan, T; Chen, H; Goenka, AH; Herrmann, K; Jacobson, M; Karbhari, A; Kuo, PH; Mosessian, S; Patnam, NG; Simeone, DM; Trivedi, KH; Truty, MJ; Valla, F; Zan, E | 1 |
| Cho, YS; Chung, IK; Lee, JW; Lee, MS; Lee, SM; Son, MW | 2 |
| Guo, JQ; Jiang, C; Shao, CX; Zhu, JD; Zou, JJ | 1 |
| Cheng, C; Liu, Z; Pan, G; Sun, G; Yang, X; Zhang, Y; Zuo, C | 1 |
| Buxó, E; Casanueva, S; Colletti, PM; Fernández-Esparrach, G; Fuster, D; Ginés, A; Mayoral, M; Pagès, M; Perlaza, P; Rios, J; Rubello, D; Sánchez-Izquierdo, N | 1 |
| Bucella, D; Buxant, F; Charaf, G; Crener, K; De Cuypere, M; Duch, J; Fastrez, M; Gebhart, G; Gennigens, C; Goffin, F; Hustinx, R; Jouret, M; Kridelka, F; Lovinfosse, P; Luyckx, M; Rovira, R; Squifflet, JL | 1 |
| Baratto, L; Duan, H; Iagaru, A | 1 |
| Chen, Y; Fu, W; Xu, T; Zeng, C; Zhang, X | 1 |
| Ajani, JA; Lu, Y; Wang, L | 1 |
| Dong, A; Dong, H; Zhou, W | 1 |
| Date, H; Hamaji, M; Murakami, K; Yoshizawa, A | 1 |
| Dong, P; Hu, W; Li, M; Liu, X; Tian, B; Wang, L; Wang, W | 1 |
| Aoki, S; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Matsumoto, Y; Miyakawa, A; Miyawaki, D; Nishimura, Y; Nonaka, H; Onishi, H; Saito, M; Saito, R; Sano, N; Sasaki, R; Shibamoto, Y; Shioyama, Y; Suzuki, G; Tominaga, L; Yamada, S | 1 |
| Artigas, C; Ene, D; Flamen, P; Plouznikoff, N; Woff, E | 1 |
| Adinehpour, Z; Akbarian Aghdam, R; Amini, H; Dehghani, T; Divband, G; Kaviani, H; Montahaei, Z; Rezaee, A; Vali, R | 1 |
| Caroli, P; Colletti, PM; Maffione, AM; Matteucci, F; Rubello, D | 1 |
| Caroli, P; Colletti, PM; Maffione, AM; Matteucci, F; Montesi, G; Rubello, D | 1 |
| Beheshti, M; Heinzel, A; Mueller, M | 1 |
| Khalil, FK; Mohamed, AZ; Tanvetyanon, T; Toloza, EM | 1 |
| Dedeoglu, SE; Kubat, B; Sayman, H; Tetikkurt, C; Tetikkurt, S | 1 |
| Heo, HJ; Jun, S; Kang, J; Kim, BS; Kim, GH; Kim, H; Kim, YH; Pak, K | 1 |
| Dong, A; Dong, H; Ji, X | 1 |
| Handa, Y; Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Cen, B; Chen, Y; Liu, L; Wang, Y; Xu, T | 1 |
| Cheng, J; Qi, M; Ren, C; Song, S; Sun, Y; Zhang, J; Zhang, Y | 1 |
| Byun, Y; Choi, Y; Han, Y; Jang, JY; Kang, J; Kim, H; Kwon, W; Moon, D | 1 |
| Fabritius, MP; Holzgreve, A; Knösel, T; Rübenthaler, J; Tiling, R | 1 |
| Abecasis, N; Brandão, F; Cabral, F; Casaca, R; Cruz, A; Fonseca, R; Monteiro, C; Pedro, C; Pinto, I; Ramos, P; Ratão, P; Salgado, L | 1 |
| Bae, DS; Cho, WK; Cho, YS; Choi, CH; Kim, BG; Kim, N; Kim, TJ; Lee, JW; Lee, YY; Park, W | 1 |
| Blaszkowsky, LS; Cañamaque, LG; Catalano, OA; Clark, JW; Fernandez-Del Castillo, C; Ferrone, CR; Furtado, FS; Groshar, D; Hong, TS; Lee, SI; Qadan, M; Rosman, DA; Ryan, DP; Striar, R; Umutlu, L; Vangel, M; Weekes, C | 1 |
| Faltova, H; Fencl, P; Harustiak, T; Lischke, R; Pazdro, A; Snajdauf, M; Stolz, AJ; Zemanova, M | 1 |
| Liu, C; Song, Y; Wang, PY; Wang, XM; Zheng, Y | 1 |
| Chargari, C; Deandreis, D; Genestie, C; Gouy, S; Grimaldi, S; Ilenko, A; Leary, A; Maulard, A; Morice, P; Pautier, P; Seebacher, V; Terroir, M | 1 |
| Datta-Gupta, S; Garg, P; Kumar, R; Sharma, A; Sharma, R | 1 |
| Liu, G; Patel, M | 1 |
| Bjerring, OS; Fristrup, CW; Hess, S; Lundell, L; Mortensen, MB; Petersen, H | 1 |
| Chen, H; Meng, T; Pang, Y; Sun, L; Yu, X | 1 |
| Haruštiak, T; Obermannová, R; Zemanová, M | 1 |
| Harada, Y; Kawamura, R; Shimizu, T; Suzuki, Y | 1 |
| Bekaii-Saab, T; Boffa, DJ; Frankel, WL; Fruth, B; Goodman, KA; Hall, NC; Ilson, DH; Janjigian, YY; Meyerhardt, JA; Meyers, MO; Mitchell, K; Niedzwiecki, D; Noonan, A; O'Reilly, EM; Ou, FS; Thurmes, PJ; Twohy, E; Venook, AP | 1 |
| Dong, A; Wang, Y; Zhao, Q | 1 |
| Chen, W; Cheng, NC; Fang, G; Hu, CM; Huang, LL; Xie, WP | 1 |
| Johnson, A; Manners, D; Norman, R; Piccolo, F | 1 |
| Hamada, K; Hashimoto, K; Honda, M; Kawamura, H; Nakayama, Y; Saginoya, T; Takada, T; Takano, Y; Todate, Y; Yamaguchi, H | 1 |
| Cao, J; Chen, Y; Huang, Y; Liu, H; Peng, D | 1 |
| Bardet, S; Ciappuccini, R; Clarisse, B; Dorbeau, M; Giffard, F; Licaj, I; Poulain, L; Saguet-Rysanek, V | 1 |
| Akeboshi, M; Fukui, M; Hayashizaki, Y; Imashimizu, K; Itoh, M; Kawaji, H; Ko, W; Mogushi, K; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Hu, Y; Li, Y; Liu, G; Shi, H; Tan, H; Xiao, J; Zhang, Y; Zhou, J | 1 |
| Cherian, SV; Estrada-Y-Martin, RM; Irani, AD; Weissferdt, A; Zhou, J | 1 |
| Dong, Y; Hu, G; Huang, P; Xiao, W; Zhao, X | 1 |
| Bai, L; Duan, XY; Gao, JG; Guo, CH; Guo, YM; Li, M; Shen, C; Zhao, Y | 1 |
| Ho, L; Hofstetter, WL; Komaki, R; Liao, Z; Lin, SH; Xi, M | 1 |
| Alchawaf, A; Germetaki, T; Khoja, L; Kordatou, Z; Mansoor, W; Owen-Holt, V; Papaxoinis, G; Patrao, A; Stamatopoulou, S; Weaver, JMJ | 1 |
| Bol, A; Di Perri, D; Geets, X; Hanin, FX; Janssens, G; Labar, D; Lee, JA; Robert, A; Sterpin, E | 1 |
| Abe, H; Ahn, JM; Chen, M; Choe, JH; Choi, H; Endo, H; Goodwin, J; Helke, KL; Inoue, M; Jenkins, DMR; Jeong, JY; Kim, JW; Lee, SY; Minna, JD; Neugent, ML; Robinson, MW; Ruthenborg, RJ; Shackelford, DB; Singh, PK; Takeda, N; Wake, M; Xuan, Z; Yoo, H | 1 |
| Broski, SM; Goenka, AH; Johnson, GB | 1 |
| Gorospe, L; Muñoz-Molina, GM; Pacios-Blanco, RE; Rioja-Martín, ME; Santos-Carreño, AL | 1 |
| Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Castanheira, JC; Costa, DC; Oliveira, C; Silva, ÂF; Vaz, SC | 1 |
| Li, ZG | 1 |
| Higashi, K; Ishigaki, Y; Nakamura, Y; Oguchi, M; Shimasaki, M; Takegami, T; Ueda, Y; Watanabe, N | 1 |
| Bhasin, DK; Das, A; Gupta, R; Mittal, BR; Nada, R; Rana, SS; Santhosh, S | 1 |
| Eguchi, H; Hatazawa, J; Hori, M; Nakamoto, A; Onishi, H; Ota, T; Sakane, M; Tatsumi, M; Tomiyama, N; Tsuboyama, T; Wakasa, K | 1 |
| Baldassari, MP; Barbosa, EM; Connolly, C; Delikatny, EJ; Deshpande, C; Drebin, J; Dunbar, A; Keating, J; Kucharczuk, JC; Kularatne, SA; Low, P; Mizelle, J; Newton, AD; Okusanya, O; Predina, JD; Singhal, S; Xia, L | 1 |
| Chen, Y; Kong, Y; Wang, Z; Yu, M | 1 |
| Amaya, K; Kaji, M; Maeda, K; Matsui, K; Mochizuki, K; Saito, J; Shimizu, K; Takeshita, M; Terai, S; Tsukada, T; Uchiyama, A; Watanabe, T | 1 |
| Bulut, N; Yılmaz, B | 1 |
| Dwary, AD; Khan, EM; Sharma, P | 1 |
| Belderbos, JSA; Das, M; De Ruysscher, D; Even, AJG; Jochems, A; La Fontaine, MD; Lambin, P; Mottaghy, FM; Reymen, B; van Elmpt, W | 1 |
| Goel, R; Subramaniam, RM; Wachsmann, JW | 1 |
| Castelo, B; Coronado, M; Lecumberri, B; López, E; Rodado, S | 1 |
| Balachandran, A; Bhosale, P; Katz, M; Rayamajhi, S; Reddy, A; Rohren, E | 1 |
| Chaddha, U; English, R; Panchabhai, TS; Patil, PD | 1 |
| Aniskhin, M; Berezina, N; Cherkashin, M; Puchkov, D | 1 |
| Mahajan, S; Pandit-Taskar, N | 1 |
| Ou, X; Shen, Y; Su, M; Yao, Y | 1 |
| Qin, L; Zhang, C; Zhang, Y | 1 |
| Aleman, BMP; Grootscholten, C; Lalezari, F; Steinberg, JD; van Dieren, JM; van Sandick, JW; Vegt, E; Voncken, FEM | 1 |
| Miyoshi, Y; Satoh, H; Takayashiki, N | 1 |
| Cola, B; Cuicchi, D; De Raffele, E; Lecce, F; Mirarchi, M | 1 |
| Beattie, B; Blanc-Autran, E; Fine, SW; Fox, JJ; Gavane, SC; Gönen, M; Humm, JL; Larson, SM; Lewis, JS; Morris, MJ; Nehmeh, S; Osborne, JR; Sawyers, CL; Scher, HI; Schöder, H; Solomon, SB; Vargas, HA; Veach, D; Weber, WA | 1 |
| Betancourt Cuellar, SL; Carter, BW; Correa, AM; Hofstetter, WL; Marom, EM; Palacio, DP; Wu, CC | 1 |
| Cho, S; Jheon, S; Kim, K; Son, BY; Yum, SW | 1 |
| Dercle, L; Garg, I; Goenka, AH; Hough, DM; Wang, ZJ; Yeh, R | 1 |
| Gollub, MJ; Gonen, M; Hotker, AM; Mazaheri, Y; Woo, KM | 1 |
| Hata, K; Kawai, K; Nishikawa, T; Nozawa, H; Oba, K; Tanaka, T; Watanabe, T | 1 |
| Dong, P; Li, L; Su, M; Tian, R | 1 |
| Gormsen, LC; Jochumsen, MR; Nielsen, GL | 1 |
| Eshghi, N; Kuo, PH; Lundeen, TF | 1 |
| Ge, D; Gu, J; He, J; Huang, Y; Jin, X; Lu, C; Shi, S; Xu, F; Ye, L; Zeng, Z | 1 |
| Enzinger, PC; Gerbaudo, VH; Hornick, JL; Killoran, JH; Kim, CK; Mamon, HJ; Nowak, JA | 1 |
| Hyun, SH; Koh, YW; Lee, SJ; Park, SY | 1 |
| Liu, Y; Wang, XY; Wu, N; Yang, YK; Zhao, YF; Zhu, Z | 1 |
| Hatanaka, K; Iwazaki, M; Miyaoka, M; Nakamura, N | 1 |
| Fencl, P; Harustiak, T; Hornofova, L; Lischke, R; Pazdro, A; Salkova, E; Snajdauf, M; Stolz, A; Zemanova, M | 1 |
| Chan, J; Chew, C; Schultz, C; Verma, S | 1 |
| Bal, C; Datta Gupta, S; Kumar, R; Parida, GK; Shamim, SA; Singhal, A; Tripathy, S | 1 |
| Buxó, E; Colletti, PM; Fernández-Esparrach, G; Fuster, D; Ginés, A; Mayoral, M; Ortín, J; Pagès, M; Perlaza, P; Rubello, D; Ruiz, C; Sánchez, N | 1 |
| Bires, P; Lederleitner, D; Masarykova, A; Pobijakova, M; Povinec, P; Scepanovic, D | 1 |
| Ahmed, HS; Farwell, MD; Metz, JM; Pantel, AR; Plastaras, JP | 1 |
| Jiang, HJ; Li, M; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
| Ando, Y; Kamada, H; Kobara, H; Masaki, T; Nagao, M; Okano, K; Okita, Y; Okuyama, H; Oshima, M; Suto, H; Suzuki, Y; Tsuji, A | 1 |
| Doai, M; Funasaki, A; Matoba, M; Motono, N; Sekimura, A; Ueda, Y; Uramoto, H; Usuda, K; Yamada, S | 1 |
| Aguiar, PT; Castro, ACG; Fagundes, TC; Machado, AM; Mafra, A; Mamede, M; P Junior, E; Silva, JA; Silva, LC; Silva, RG | 1 |
| Bourhis, J; Castelli, J; Depeursinge, A; Herrera, FG; Ozsahin, M; Prior, JO; Scher, N | 1 |
| Cho, S; Jheon, S; Kang, YK; Kim, K; Kim, SE; Lee, WW; Song, YS | 1 |
| Bronsert, P; Reichel, K; Ruf, J | 1 |
| Ladrón de Guevara, D; Pardo, C; Pefaur, R; Quera, R; Reyes, JM; Rozas, S; Schacher, S | 1 |
| Minato, H; Sasagawa, T; Shibata, T; Takagi, H; Takahashi, T | 1 |
| Chung, JH; Kim, S; Lee, SH; Pahk, K | 1 |
| Chin, AL; Diehn, M; Gensheimer, MF; Guo, HH; Kumar, KA; Loo, BW; Maxim, PG; Neal, JW; Wakelee, H | 1 |
| Choi, JY; Franks, TJ; Han, J; Kim, HK; Kim, TJ; Lee, KS; Zo, J | 1 |
| Furumoto, H; Hagiwara, M; Ikeda, N; Imai, K; Kajiwara, N; Kakihana, M; Maeda, J; Maehara, S; Masuno, R; Ohira, T; Okano, T; Shimada, Y | 1 |
| Agrawal, R; Asopa, RV; Malhotra, G; Meshram, V; Sonavane, S; Verma, P | 1 |
| Cui, F; Su, M; Tian, R; Wang, H; Wu, X | 1 |
| Buckel, E; Ferrario, M; Guevara, DL; Pavez, G; Romero, C; Tapia, V; Zapata, J | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Wu, D | 1 |
| Inoue, S; Ito, K; Kasai, Y; Kume, S; Masuya, D; Monden, K; Okada, N; Suzuki, Y; Takata, N; Tanaka, Y; Yoshimatsu, H | 1 |
| Cui, C; Feng, W; Guo, X; Huang, J; Li, X; Liang, Z; Liu, M; Ma, Y; Wu, Z; Zhang, F | 1 |
| Chung, YA; Lee, JW; Lee, SM | 1 |
| Li, TC; Lin, J; Ouyang, ML; Tang, K; Xu, MM; Zheng, XW | 1 |
| Huynh, KN; Nguyen, BD; Wu, KJ | 1 |
| Basu, S; Parghane, R | 1 |
| Basher, RK; Mittal, BR; Parihar, AS; Singh, G; Sood, A | 1 |
| Brismar, TB; Herlin, G; Lundell, L; Nilsson, M; Rouvelas, I; Zhang, YH | 1 |
| Beer, DG; Brown, RKJ; Carrott, PW; Chang, AC; Heiden, BT; Hermann, M; Lin, J; Lynch, WR; Nancarrow, DJ; Orringer, MB; Patel, N; Reddy, RM; Zhao, L | 1 |
| de Haas, RJ; de Jong, KP; Dierckx, RAJO; Kwee, TC; Murshid, KJA; Pennings, JP | 1 |
| Adachi, T; Eguchi, S; Ideguchi, R; Kudo, T; Myssayev, A; Sumida, Y; Tobinaga, S; Uetani, M | 1 |
| Cheng, MF; Ho, BY; Hsin, LW; Huang, YY; Jeng, YM; Kuo, HC; Kuo, TC; Shiue, CY; Tien, YW; Yen, RF | 1 |
| Antonowicz, S; Bradley, KM; El Kafsi, J; Findlay, JM; Gillies, RS; Maynard, ND; Middleton, MR; Segaran, A; Zhang, A | 1 |
| Doroudinia, A; Dorudinia, A; Kaghazchi, F; Mehrian, P | 1 |
| Belfiore, MP; Brunese, L; Capasso, R; Cappabianca, S; Carrafiello, G; De Filippo, M; Faella, P; Fiorello, A; Grassi, R; Muto, M; Muto, P; Nizzoli, R; Petrillo, M; Reginelli, A; Rossi, C; Rossi, G; Rotondo, A; Serra, N | 1 |
| Chen, P; Chen, W; Jia, C; Jiang, W; Li, X; Lu, D; Xu, W; Yin, G; Yu, L; Yu, X; Zhang, Y; Zhu, L; Zhu, X | 1 |
| Ålgars, A; Kemppainen, J; Ristamäki, R; Salminen, P; Sundström, J; Vihervaara, H | 1 |
| Ejima, M; Fujie, T; Fujii, S; Furusawa, H; Katayanagi, S; Kawahara, T; Majima, H; Masuo, M; Miyazak, Y; Nukui, Y; Sakashita, H; Shimada, S; Shirai, T; Suzuki, T; Taguchi, T; Tamaoka, M; Tasaka, Y; Tateishi, T; Tomii, S; Watanabe, Y | 1 |
| Christian, A; Foley, KG; Kynaston, H; Marshall, C; Peaker, J; Roberts, A; Spezi, E | 1 |
| Hu, Y; Luo, R; Shi, H; Xiu, Y; Yin, H | 1 |
| Fan, Q; Liu, H; Su, M; Wang, R | 1 |
| Bennink, RJ; Bijlsma, MF; Creemers, A; Ebbing, EA; Hulshof, MCCM; Jibodh, RA; Krishnadath, KK; Medema, JP; Meijer, SL; Punt, CJA; Steins, A; van Delden, OM; van der Zalm, AP; van Laarhoven, HWM; Waasdorp, C | 1 |
| Bekaii-Saab, TS; Collins, JM; Hopp, AC; Yang, M | 1 |
| Ito, R; Ito, S; Iwano, S; Kamiya, S; Kato, K; Naganawa, S | 1 |
| Giraudet, AL; Kryza, D; Mognetti, T; Moreau, A | 1 |
| Alison, MR; Chen, CW; Chen, TH; Chiang, JM; Chiu, CT; Hsieh, SY; Huang, SW; Lim, SN; Lin, WR; Lin, YH; Su, MY; Tsai, CL; Wu, RC; Yeh, CT; Yu, JS | 1 |
| Hou, B; Hu, Y; Huo, L; Xing, H; Zhao, Y | 1 |
| Anbai, A; Hashimoto, M; Hatakeyama, K; Kumagai, S; Okuyama, E; Takagi, N; Wada, Y | 1 |
| Eyck, BM; Lagarde, SM; Nieboer, D; Noordman, BJ; Onstenk, BD; Spaander, MCW; Valkema, R; van Lanschot, JJB; Wijnhoven, BPL | 1 |
| Hauser, T; Kreissl, MC; Li, X; Schaller, T; Widmann, T | 1 |
| Foley, K; Parkinson, C; Spezi, E; Staffurth, J; Whybra, P | 1 |
| Kapoor, R; Kumar, R; Mittal, BR; Parihar, AS; Singh, H; Vadi, SK | 1 |
| Ansari-Gilani, K; Ramaiya, NH; Yang, M | 1 |
| Axelsson, J; Båtsman, M; Blomqvist, L; Brännström, F; Brynolfsson, P; Ljuslinder, I; Palmqvist, R; Riklund, K; Rutegård, J; Rutegård, M; Rutegård, MK | 1 |
| Fatima, N; Tahseen, R; Zaman, A; Zaman, MU; Zaman, S; Zaman, U | 1 |
| An, YS; Byun, C; Han, SU; Hur, H; Jo, KS; Lee, D; Lee, KM; Lee, SJ; Lim, SK; Yoon, JK | 1 |
| Grosu, HB; Gutterman, DD; Lazzaro, R; Naidich, DP; Naik, SK; Patel, VK; Raoof, S; Travis, WD; Weingarten, JA; Wentowski, C | 1 |
| Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Adachi, S; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 4 |
| Büchler, MW; Strobel, O | 1 |
| Früh, M; Müller, J; Putora, PM | 1 |
| Amrami, KK; Babu, MA; Dyck, PJ; Howe, BM; Kawashima, A; Nathan, MA; Spinner, RJ | 1 |
| Bender, K; Grünberg, K; Haberkorn, U; Kauczor, HU; Ott, K; Stange, A; von Gall, CC; Weber, MA; Zechmann, C | 1 |
| Grigsby, PW; Mutch, DG; Powell, MA; Schwarz, JK; Zighelboim, I | 1 |
| Gotoh, M; Hasegawa, T; Higuchi, M; Osugi, J; Suzuki, H | 1 |
| Alafate, A; Fujiwara, T; Gobara, H; Hiraki, T; Ishii, H; Kaji, M; Kanazawa, S; Kato, K; Miyoshi, S; Okumura, Y; Sato, S; Shinya, T | 1 |
| Carozzi, FM; Carrozzi, L; Comin, C; Deliperi, A; Falaschi, F; Falchini, M; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maddau, C; Mascalchi, M; Paci, E; Picozzi, G; Pistelli, F; Vaggelli, L; Vella, A | 1 |
| Fujikawa, A; Kosuda, S; Kyoto, Y; Nakamori, T; Nakamori, Y; Naoi, Y | 1 |
| Cho, SB; Chung, CY; Joo, YE; Kim, JS; Lee, WS; Min, JJ; Myung, DS; Park, HC | 1 |
| Andreou, A; Fisher, C; MacVicar, D; Sohaib, A; Whitten, C | 1 |
| Chen, EC; Jiang, W; Li, MH; Liu, P; Ma, JB; Song, YP; Yu, JM | 1 |
| Corral, C; de Guevara, DL; Fariña, C; Fuentes, A; Pefaur, R | 1 |
| Amrami, KK; Garcia, JJ; Howe, BM; Nathan, MA; Spinner, RJ | 1 |
| Hartnett, GF; Lee, JC; Ravi Kumar, AS | 1 |
| Cheon, GJ; Chung, HH; Kim, HS; Kim, JW; Lee, I; Park, NH; Song, YS | 1 |
| Guler, OC; Onal, C; Oymak, E; Parlak, C; Reyhan, M | 1 |
| Alvarez, E; Calvo, FA; Carreras, JL; Ferrer, C; Garcia-Alfonso, P; Herranz, R; Ochoa, E; Peligros, I; Sole, CV | 1 |
| Chen, L; Chen, M; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Zhang, H; Zhang, L | 1 |
| Chu, Q; Hamidian Jahromi, A; Martin, B; Sangster, G; Shi, R; Shokouh-Amiri, H; Takalkar, A; Zibari, G | 1 |
| Ahn, SM; Bae, JY; Jung, JO; Kim, ES; Oh, YM; Sim, HH; Suh, SO; Yoo, JW; Yun, CY | 1 |
| Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
| Bashir, MR; Jaffe, TA; Neville, AM; Thacker, JM; Uronis, HE | 1 |
| Domen, H; Hatanaka, KC; Hatanaka, Y; Hida, Y; Hirano, S; Kaga, K; Matsuno, Y; Okamoto, S; Tamaki, N | 1 |
| Farjah, F; Lou, F; Rizk, NP; Rusch, VW; Sima, C | 1 |
| Adusumilli, PS; Bograd, AJ; Dunphy, MP; Morales, EA; Nitadori, J; Rizk, NP; Rusch, VW; Sima, CS | 1 |
| de Wet, C; Deonarine, P; Han, S; Poon, FW | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kim, CY; Kim, DH; Kim, HW; Lee, J; Lee, SW; Oh, JR; Son, SH; Song, BI | 1 |
| Bhethanabhotla, S; Durgapal, P; Gajendra, S; Gogia, A; Gupta, R; Sahoo, MK; Tanwar, P | 1 |
| Choi, JY; Huh, SJ; Kim, BT; Lee, JE; Nam, H; Oh, D; Park, W | 1 |
| Awasthi, V; Sahoo, K; Yadav, VR | 1 |
| Ishigatsubo, Y; Kaneko, T; Nagai, K; Shinkai, M; Watanabe, K; Yamaguchi, N | 1 |
| Cui, Y; Dong, A; Gao, L; Wang, Y; Yang, J; Zuo, C | 1 |
| Cheon, GJ; Chung, JK; Go, H; Lee, DS; Seo, HJ | 1 |
| Gómez-Rio, M; Jiménez-Heffernan, A; Llamas-Elvira, JM; Ramos-Font, C; Rodríguez-Fernández, A; Sánchez Sánchez, R | 1 |
| Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Ohde, Y; Ono, A; Takahashi, T; Yamamoto, N | 1 |
| Chen, W; D'Souza, WD; Kim, G; Kligerman, S; Lu, W; Suntharalingam, M; Tan, S; Zhang, H | 1 |
| Bolton, D; Chan, JG; Chang, JH; Clouston, D; Davis, ID; Esler, S; Goh, YP; Gong, SJ; Hiew, CY; Khoo, V; Lee, ST; Lim Joon, D; O'Sullivan, R; Scott, AM; Tochon-Danguy, H; Wada, M | 1 |
| Chung, HW; Kim, HJ; Kim, WS; Lee, KY; So, Y | 1 |
| Albarello, L; Ambrosi, A; Canevari, C; Castiglioni, I; De Cobelli, F; Del Maschio, A; Esposito, A; Gallivanone, F; Gianolli, L; Giganti, F; Mazza, E; Orsenigo, E; Staudacher, C | 1 |
| Hida, Y; Hirano, S; Kaga, K; Matsui, Y; Muto, J; Nakada-Kubota, R; Ohtaka, K; Okamoto, S; Shiga, T; Tamaki, N | 1 |
| Geiger, GA; Grover, S; Kim, MB; Langer, CJ; Plastaras, JP; Pryma, DA; Rengan, R; Simone, CB; Xanthopoulos, EP | 1 |
| Kessing, R | 1 |
| Blanc, E; Calais, J; Cardot, V; Mabille, L | 1 |
| Fukui, M; Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K; Tsushima, Y | 1 |
| Aguiló, R; Arriola, E; Belda-Sanchis, J; Curull, V; Pijuan, L; Rodríguez de Dios, N; Rodríguez-Fuster, A; Sánchez-Font, A; Suárez-Piñera, M; Taus, Á; Vollmer, I; Zuccarino, F | 1 |
| Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, H; Zhang, WJ; Zhao, SJ; Zheng, R | 1 |
| Fukuchi, M; Higuchi, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Sakai, M; Sohda, M; Suzuki, S; Tanaka, N; Tsushima, Y; Yokobori, T | 1 |
| Fujita, S; Imai, Y; Katakami, N; Takeshita, J | 1 |
| Bifulco, M; Bocchino, M; de Rosa, I; Rea, G; Somma, F; Valente, T | 1 |
| Ino, K; Kobayashi, A; Mabuchi, Y; Minami, S; Ota, N; Shiro, M; Takano, R; Tanizaki, Y; Terada, M; Yagi, S | 1 |
| Darling, G; Guindi, M; Knox, J; Metser, U; Moshonov, H; Rashidi, F; Wong, R | 1 |
| Ball, DL; Binns, DS; Brennan, S; Campeau, MP; Fisher, RJ; Hicks, RJ; Lin, MY; MacManus, M; Solomon, B; Wu, M | 1 |
| Hong, YS; Kim, HO; Kim, JC; Kim, JS; Kim, TW; Lee, HS; Yu, CS | 1 |
| Aggarwal, C; Haas, AR; Shi, WY; Simone, CB; van Deerlin, VM; Watt, CD; Yu, GH | 1 |
| Bailly, M; Besse, H; Gauvain, S; Kerdraon, R; Metrard, G | 1 |
| Bitencourt, AG; Guimarães, MD; Lima, EN; Marchiori, E | 1 |
| Hirami, Y; Maeda, A; Nakata, M; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
| Accardo, M; Fiorelli, A; Orditura, M; Santini, M | 1 |
| Jambawaliker, S; Krishnamoorthy, SK; Saif, MW | 1 |
| Ahn, SJ; Kang, WJ; Lee, JD; Park, MS | 1 |
| Cui, X; Fang, N; Wang, Y; Zeng, L; Zhang, C; Zhang, H | 1 |
| Anzellotti, A; Awasthi, V; Bailey, J; Gali, H; Matlock, G; McFarland, A; Watson, J | 1 |
| Aebersold, DM; Cihoric, N; Klaeser, B; Krüger, K; Lössl, K; Tapia, C | 1 |
| Gyobu, T; Honda, O; Inoue, M; Johkoh, T; Kusumoto, M; Leung, AN; Morii, E; Okumura, M; Sumikawa, H; Tanaka, Y; Tomiyama, N; Ueda, K; Watanabe, H; Watanabe, S; Yanagawa, M | 1 |
| Castelli, P; Crippa, S; Falconi, M; Laiti, S; Partelli, S; Salgarello, M; Spinelli, AE; Tamburrino, D; Zamboni, G | 1 |
| Abbadi, RA; Cheow, HK; Ford, HE; Harper, SJ; Huguet, EL; Jah, A; Jamieson, NV; Praseedom, RK; Sadat, U; Whitley, S; Wilson, CB | 1 |
| Agrawal, A; Jiwnani, S; Karimundackal, G; Kulkarni, M; Laskar, SG; Pramesh, CS; Purandare, NC; Rangarajan, V; Shah, S | 1 |
| Berlangieri, S; Eek, R; Murphy, C; Schwalb, H | 1 |
| Ameshima, S; Anzai, M; Araya, T; Demura, Y; Ishizaki, T; Ishizuka, T; Kasahara, K; Matsuoka, H; Morikawa, M; Nishi, K; Nishitsuji, M; Sumida, Y; Tsuchida, T; Umeda, Y | 1 |
| Haro, A; Nagashima, A; Saitoh, G; Yasuda, M | 1 |
| Lu, P; Sun, Y; Yu, L | 1 |
| Öztürk, H | 1 |
| Herrmann, K; Lordick, F; Ott, K; Schmidt, T | 1 |
| Chang, H; Chang, TH; Chang, WC; Chu, CM; Gao, HW; Ho, CL; Hsu, HH; Hsu, YC; Huang, TW; Ko, KH; Shen, DH | 1 |
| Agrawal, K; Mohan, HK; Weaver, J | 1 |
| Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
| Altini, C; Caliandro, C; De Luca, R; Fanelli, M; Montemurro, S; Niccoli-Asabella, A; Rubini, D; Rubini, G | 1 |
| Baba, H; Baba, Y; Ida, S; Ishimoto, T; Iwagami, S; Iwatsuki, M; Miyamoto, Y; Nagai, Y; Sakamoto, Y; Watanabe, M; Yamao, T | 1 |
| Doran, MG; Fareedy, SB; Gavane, S; Osborne, JR; Spratt, DE; Tarlinton, L; Zelefsky, MJ | 1 |
| Allendorf, JD; Chabot, JA; Einersen, P; Epelboym, I; Leung, D; Winner, MD | 1 |
| Allegri, V; Ambrosini, V; Castellucci, P; Fanti, S; Ghedini, P; Grassi, I; Guidalotti, PL; Montini, GC; Nanni, C | 1 |
| Babacan, NA; Erselcan, T; Hasbek, Z; Kacan, T; Salk, I; Turgut, B; Yucel, B | 1 |
| Choi, BB; Lee, YJ; Suh, KS | 1 |
| Groen, H; Hollema, H; Pavlov, K; Plukker, JT; Pruim, J; Pultrum, BB; Schreurs, LM; Smit, JK | 1 |
| Beck, AP; Booth, CJ; Caporizzo, DJ; Carlson Scholz, JA; Chen, MK; Kwiatkowski, AE; Smith, PC; Wilson, SR; Zeiss, C | 1 |
| Cheng, W; Fu, H; Liang, S; Tang, Y; Wang, H; Wu, S; Wu, Z; Ye, Z | 1 |
| Mimae, T; Miyata, Y; Okada, M; Sasada, S; Tsubokawa, N; Yoshiya, T | 1 |
| Brunner, TB; Chu, KY; Hawkins, M; Mukherjee, S; Partridge, M; Wilson, JM | 1 |
| Jeon, TJ; Lee, M; Lee, YK; Ryu, YH; Sohn, SK | 1 |
| Cappelli, A; Castellucci, P; D'Errico, A; Di Fabio, F; Ercolani, G; Giampalma, E; Golfieri, R; Pinna, AD; Pinto, C; Rojas Llimpe, FL; Serra, C | 1 |
| Aung, W; Endo, H; Fujibayashi, Y; Furukawa, T; Hasegawa, S; Inoue, M; Jin, ZH; Saga, T; Yoshii, Y; Yuan, Q; Zhang, MR | 1 |
| Guo, R; Jin, Y; Li, B; Xu, H | 1 |
| Force, S | 1 |
| Bergquist, A; Karlson, BM; Rasmussen, I; Rorsman, F; Sangfelt, P; Sundin, A; Wanders, A | 1 |
| De Raedt, N; De Ruysscher, D; Deroose, CM; Dooms, C; Gheysens, O; Nackaerts, K | 1 |
| Ajani, JA; Carter, BW; Correa, AM; Cuellar, SL; Erasmus, JJ; Hofstetter, WL; Komaki, R; Lee, JH; Macapinlac, HA; Swisher, SG; Welsh, JW | 1 |
| Bussink, J; de Geus-Oei, LF; Kaanders, JH; Looijen-Salamon, MG; Meijer, TW; Oyen, WJ; Schuurbiers, OC; Span, PN; van der Drift, MA; van der Heijden, EH; Visser, EP | 1 |
| Huh, JW; Kim, HR; Kwon, SY; Lee, JH | 1 |
| Aramaki, T; Endo, M; Mizuno, T; Okamura, Y; Sugiura, T; Uesaka, K; Yamamoto, T | 1 |
| Brunotte, F; Cochet, A; Cormier, L; Créhange, G; Humbert, O; Kanoun, S; Walker, PM | 1 |
| Choi, HJ; Jo, K; Kang, CM; Lee, JD; Lee, JH; Lee, WJ; Ryu, YH | 1 |
| Berry, MF; D'Amico, TA; Englum, BR; Erhunmwunsee, L; Onaitis, MW | 1 |
| Cappetta, A; Evangelista, L; Opocher, G; Pastorelli, D; Spano, L; Zovato, S | 1 |
| Choi, JY; Choi, YL; Han, J; Jeong, CJ; Jeong, JY; Lee, HY; Lee, KS | 1 |
| García Vicente, AM; Honguero Martínez, AF; Jiménez Londoño, GA; León Atance, P; Soriano Castrejón, AM; Udias, JM; van Gómez López, O | 1 |
| Eguchi, H; Hatazawa, J; Hori, M; Kim, T; Nagano, H; Nakamoto, A; Onishi, H; Sakane, M; Tatsumi, M; Tomiyama, N; Wakasa, K | 1 |
| Dong, Y; Liu, Y; Qian, W; Wang, X; Wang, Y; Wu, S; Zhang, J | 1 |
| Akdemir, UO; Algin, E; Benekli, M; Buyukberber, S; Cetin, B; Coskun, U; Gumusay, O; Kapucu, O; Ozet, A; Uner, A | 1 |
| Dong, M; Li, W; Li, Y; Sun, X; Xing, L | 1 |
| Huang, ZQ; Li, J; Li, X; Liu, QW; Tan, HH; Tan, R; Yao, SZ | 1 |
| Chen, R; Huang, G; Liu, J; Ni, Y; Xie, W; Zhou, X | 1 |
| Cho, YL; Chong, GO; Hong, DG; Jeong, SY; Lee, DW; Lee, YH; Lee, YS; Park, JY | 1 |
| Fingerle, AA; Holzapfel, K; Maegerlein, C; Rummeny, EJ; Souvatzoglou, M | 1 |
| Elliott, JA; Halpenny, D; Johnston, C; King, S; Malik, V; Muldoon, C; O'Farrell, NJ; Reynolds, JV | 1 |
| Bourhis, J; Callaway, S; Elicin, O; Herrera, FG; Ozsahin, M; Prior, JO | 1 |
| Chen, X; Han, Y; Hu, X; Jiang, C; Tang, T; Yang, B; Zhao, H | 1 |
| Koizumi, H; Kurimoto, N; Nakamura, H; Saji, H; Shinmyo, T; Tagaya, R; Takagi, M | 1 |
| Alzayed, MF; Artho, G; Hickeson, M; Nahal, A | 1 |
| Colletti, PM; Fernández-Esparrach, G; Fuster, D; Mayoral, M; Pagès, M; Pineda, E; Pons, F; Rubello, D | 1 |
| Assante, R; Fonti, R; Klain, M; Nicolai, E; Pace, L; Pellegrino, T; Salvatore, B; Salvatore, M; Storto, G; Zampella, E | 1 |
| Chen, P; Huang, Q; Jiang, M; Sun, L; Wu, H | 1 |
| Chen, Y; Guo, L; Hu, X; Huang, J; Ji, C; Ling, C; Xu, H; Zhang, B; Zhu, W | 1 |
| Machida, Y; Motono, N; Sagawa, M; Sakuma, T; Tanaka, M; Ueno, M; Usuda, K | 1 |
| Choi, JY; Kim, JJ; Lee, JH; Min, BH; Rhee, PL; Tae, CH | 1 |
| Jeon, TJ; Kim, JK; Lee, JH; Oh, EJ; Park, JS; Ryu, YH; Yoo, JS; Yoon, DS; Yoon, SO | 1 |
| Khong, PL; Lee, EY; Lee, VH; Qian, W; Wong, MP; Yu, X | 1 |
| Li, X; Liu, S; Wang, M; Yao, S | 1 |
| Doğan, D; Karahatay, S; Karatas, O; Kavakli, K; Okuyucu, K; Ozaydın, S | 1 |
| Li, ZG; Qin, XJ | 1 |
| Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 1 |
| Abe, M; Cong, Y; Kato, Y; Nomori, H; Sugimura, H | 1 |
| Barbaro, B; Coco, C; Crucitti, A; de Waure, C; Gambacorta, MA; Giordano, A; Leccisotti, L; Persiani, R; Stefanelli, A; Tortorelli, AP; Valentini, V; Vecchio, FM | 1 |
| Abiko, M; Sato, T; Shiono, S; Yanagawa, N | 1 |
| Duong, C; Hicks, RJ; Kaneko, Y; Link, E; Murray, WK | 1 |
| Bentzen, SM; Bowen, SR; Bradshaw, TJ; Chappell, RJ; Deveau, MA; Forrest, LJ; Jeraj, R; Kubicek, L; White, P | 1 |
| Charette, N; Deleporte, A; Flamen, P; Garcia, C; Guiot, T; Hendlisz, A; Paesmans, M; Vandeputte, C | 1 |
| Karasawa, Y; Kitahara, H; Okumura, M; Orii, T; Yoshimura, M | 1 |
| Benveniste, AP; Benveniste, MF; Godoy, MC; Truong, MT; Viswanathan, C | 1 |
| Chou, PC; Ho, TY; Tsang, NM; Yang, CT; Yen, TC | 1 |
| Boland Froemming, JM; Brinjikji, W; Holland, WP; Johnson, GB; Peikert, T | 1 |
| Akhurst, T; Hicks, RJ; MacManus, M | 1 |
| Clavero R, JM; Furnaro L, F; Ladrón de Guevara H, D; Lazo P, D; Pardo B, C; Pefaur D, R; Piottante B, A; Rodríguez D, P; Yévenes A, S | 1 |
| Ahn, H; Hong, JH; Jeong, IG; Kim, CS; Kwon, T; You, D | 1 |
| Han, YJ; Li, HS; Tian, Y; Wang, L; Wang, QS; Wu, HB; Zhou, WL | 1 |
| Dong, M; Liu, K; Ma, S; Wang, Y; Yao, Y; Zhou, J | 1 |
| Barber, PV; Booton, R; Califano, R; Crosbie, PA; Evison, M; Martin, J; Summers, Y | 1 |
| Gao, K; Li, XY; Liang, Y; Wu, N; Zhang, LF; Zhou, LN | 1 |
| Beauregard, JM; Blouin, AC; Bouchard, F; Caron, A; Dujardin, T; Fradet, V; Fradet, Y; Lacombe, L; Lemay, C; Pouliot, F; Rimac, G; Tiguert, R | 1 |
| Andratschke, N; Bundschuh, RA; Essler, M; Mayer, B; Papp, L; Pyka, T; Specht, HM; Zsótér, N | 1 |
| Hoshikawa, M; Kimura, H; Kurimoto, N; Marushima, H; Nakamura, H; Saji, H; Tagaya, R; Takagi, M | 1 |
| Alnaji, RM; Attwood, K; Ben-David, K; Gannon, J; Hochwald, SN; Jabi, F; Kanehira, K; Kukar, M; Malhotra, U; Mattson, D; Nava, H; Platz, TA; Salerno, K | 1 |
| Fisichella, PM | 1 |
| Alluri, KC; Chaudhry, MA; Chirindel, A; Herman, JM; Pawlik, TM; Subramaniam, RM; Wahl, RL | 1 |
| Gong, LL; Li, XX; Liu, NB; Ren, P; Wang, P; Xu, WG; Yang, CW; Yuan, XK; Zhao, LJ; Zhu, L | 1 |
| Katano, A; Nakagawa, K; Okuma, K; Takenaka, R; Yamashita, H | 1 |
| Ito, H; Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
| Audollent, R; Dohan, A; Eveno, C; Jouvin, I; Pocard, M; Sarda, L; Soyer, P | 1 |
| Cosman, P; Das, A; Devadas, M; Lin, M; Merrett, N; Mittal, A; Wilson, R; Ziazaris, W | 1 |
| Ichimura, K; Kaji, M; Kanazawa, S; Mitsuhashi, T; Miyoshi, S; Sato, S; Shinya, T; Soh, J; Tanaka, T; Toyooka, S | 1 |
| Cho, H; Choi, JY; Kim, HK; Kim, J; Lee, HY; Lee, KS; Um, SW | 1 |
| Jain, AS; Muthukrishnan, I; Panneer, V; Simon, S; Srivastava, MK | 1 |
| Fisker, RV; Gade, M; Kubik, M; Petersen, LJ; Thorlacius-Ussing, O | 1 |
| Bosari, S; Castellani, M; Del Gobbo, A; Ferrero, S; Franco, R; Gaudioso, G; Nosotti, M; Palleschi, A; Pellegrinelli, A; Vaira, V; Zito Marino, F | 1 |
| Ibuki, Y; Mimae, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M; Yoshiya, T | 1 |
| Chen, Y; Huang, Z; Zhang, Y; Zhou, F | 1 |
| Claxton, Z; Fagan, AJ; Harmon, M; Johnston, C; Keogan, M; Malik, V; Meaney, JF; Muldoon, C; O'Toole, D; Ravi, N; Reynolds, JV | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Bae, KT; Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Noda, Y; Ono, H; Watanabe, H | 1 |
| Bao, M; Chen, Q; Han, Y; Li, J; Li, Z; Lin, Q; Lin, Z; Liu, S; Peng, M; Xiong, L; Xu, B; Ye, B; Zhu, W | 1 |
| Ito, R; Ito, S; Iwano, S; Kato, K; Kishimoto, M; Naganawa, S | 1 |
| Da, J; Di, J; Guo, Y; Liang, C; Liu, D; Liu, J; Qiang, G; Shi, B; Xu, R; Xu, Y; Yan, J | 1 |
| Makis, W | 1 |
| Furukawa, T; Kushitani, K; Mimae, T; Miyata, Y; Okada, M; Takeshima, Y; Tsutani, Y | 1 |
| Ajani, JA; Badgwell, BD; Bhutani, MS; Blum, MA; Charalampakis, N; Das, P; Elimova, E; Estrella, JS; Lee, JH; Matamoros, A; Planjery, V; Rogers, JE; Sagebiel, T; Shimodaira, Y; Shiozaki, H; Wadhwa, R; Weston, B; Xiao, L | 1 |
| Altorki, NK; Ameye, L; Berghmans, T; Borst, GR; de Jong, WK; Eschmann, S; Flamen, P; Garcia, C; Govindan, R; Higashi, K; Komaki, R; Lafitte, JJ; Meert, AP; Paesmans, M; Patz, EF; Rami-Porta, R; Sculier, JP; Van Baardwijk, A; Vansteenkiste, J; Wong, CY | 1 |
| Choi, WH; Kim, TJ; Kim, YK; Lee, KY; O, JH; Yoo, IeR | 1 |
| Ahn, JH; Choi, JY; Choi, YS; Han, J; Kang, J; Kim, EY; Kim, HK; Kim, J; Kwon, OJ; Lee, G; Lee, HY; Lee, KS; Shim, YM; Song, SH | 1 |
| Dahlman, A; Fröhlich, C; Horak, ID; Jacobsen, HJ; Jensen, MM; Kjaer, A; Kragh, M; Kristensen, LK; Lantto, J; Nielsen, CH; Poulsen, TT | 1 |
| Cho, JH; Choi, YL; Kim, H; Kim, J; Kim, JH; Lee, G; Lee, HY; Lee, KS; Sohn, I; Yoon, HJ | 1 |
| Chan, JKI; Tai, WM; Wen, JM | 1 |
| Fuccio, L; Giaccherini, L; Guido, A; Morganti, AG | 1 |
| Canpolat, T; Erhamamci, S; Nursal, GN; Reyhan, M; Yapar, AF | 1 |
| Mena, E; Rahmim, A; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R; Young, B | 1 |
| Álvarez, A; Calzado, MA; Caro, T; Lara-Chica, M; Medina, M; Moreno, P; Muñoz, E; Salvatierra, Á; Soler-Torronteras, R | 1 |
| Brentnall, TA; Chen, R; Jeffrey, RB; Laeseke, PF; Willmann, JK | 1 |
| Brandi, L; Carbonelli, C; Cavazza, A; Cesario, A; Di Paolo, ML; Gasparini, E; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Serra, S; Sgarbi, G; Sverzellati, N | 1 |
| Abe, H; Aikou, S; Fukayama, M; Jinbo, K; Koyama, K; Matsusaka, K; Momose, T; Mori, K; Nomura, S; Okumura, Y; Onoyama, H; Seto, Y; Takahashi, M; Ushiku, T; Yamagata, Y; Yamashita, H | 1 |
| Ashrafinia, S; Jackson, A; Marcus, C; Rahmim, A; Schmidtlein, CR; Sheikhbahaei, S; Soltani, M; Subramaniam, RM | 1 |
| Buvat, I; Chouahnia, K; Martinod, E; Orlhac, F; Soussan, M | 1 |
| Abbott, AM; Chen, DT; Davis-Yadley, AH; Malafa, MP; Pimiento, JM | 1 |
| Lee, SJ; Park, KJ; Park, SY; Yoon, JK | 1 |
| Capitain, O; Couturier, O; Gustin, P; Hatt, M; Lacombe, M; Marquis, A; Ménager, É; Paumier, A; Peyraga, G; Rio, E; Septans, AL; Trémolières, P; Vénara, A; Visvikis, D | 1 |
| Court, LE; Fried, DV; Hofstetter, WL; Lin, SH; Meijer, GJ; van Rossum, PS; van Vulpen, M; Zhang, L | 1 |
| Kanda, Y; Kanzaki, A; Kariya, T; Kato, Y; Ohara, T; Tsuboi, R | 1 |
| Cheong, JH; Cho, A; Chung, HC; Hyung, WJ; Jung, M; Kang, B; Kim, H; Kim, HI; Kim, HS; Lim, SM; Noh, SH; Rha, SY; Yun, M | 1 |
| Dong, A; Dong, H; Jing, W; Zuo, C | 1 |
| Choe, JG; Kim, S; Pahk, K; Rhee, S | 1 |
| Chang, S; Kim, SJ; Koo, PJ | 1 |
| Cai, Y; Cheng, Z; Lu, T; Nan, Y; Yin, C | 1 |
| Cheng, Z; Hu, N; Luo, J; Tan, Y; Wang, Y | 1 |
| Chand, M; Curtis, NJ; Rymer, B; Siddiqui, MR | 1 |
| Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
| Chen, R; Huang, G; Liu, J; Zhou, X | 1 |
| Hotta, K; Kaji, M; Kiura, K; Kubo, T; Minami, D; Ninomiya, T; Oda, N; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanimoto, M | 1 |
| Chen, G; Liao, JQ; Wang, SX; Wang, SY | 1 |
| Aras, G; Bahadır, A; Çermik, TF; Gündoğan, C; Kanmaz, ZD; Kocatürk, C; Öz, B; Özkurt, CÜ; Tuncay, E; Yaşar, ZA | 1 |
| Bi, GC; Fang, Y; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, DS; Zhang, WJ; Zheng, R | 1 |
| Koike, T; Nagasawa, A; Namura, O; Okamoto, T; Tsuchida, M | 1 |
| Abraham, T; Da Silva, R; Friedmann, P; Goldman, I; Huang, K; Kennedy, TJ; Libutti, SK; Love, C; Ng, N; Serrano, OK | 1 |
| Chen, H; Li, J; Li, M; Wang, S; Zeng, Q | 1 |
| Han, JK; Hur, BY; Joo, I; Kim, SH; Lee, DH | 1 |
| Asa, S; Gungor, S; Kupik, O | 1 |
| Anderson, TM; Lu, Y; Patel, D | 1 |
| Boellaard, R; Hoekstra, OS; Menke-van der Houven van Oordt, CW; Mulder, ER; Roth, C; van Helden, EJ; Verheul, HM | 1 |
| Chang, JW; Cheng, NM; Chung, HW; Fang, YD; Ho, KC; Hou, MM; Liu, YC; Su, TP; Yang, CT; Yen, TC | 1 |
| Alongi, F; Cirillo, M; Di Paola, G; Fersino, S; Fiorentino, A; Giaj-Levra, N; Gori, S; Mazzola, R; Ricchetti, F; Ruffo, G; Ruggieri, R; Salgarello, M; Zamboni, G | 1 |
| Bastos, D; Cerri, G; Etchebehere, E; Queiroz, MA; Santos, A; Viana, P | 1 |
| Chauhan, A; Chudgar, AV; Dubroff, JG; Mulugeta, PG | 1 |
| Chang, S; Kim, SJ; Koo, PJ; Kwak, JJ | 1 |
| Cease, K; Chen, G; Chopra, V; Gross, M; Raghunathan, R; Ramnath, N; Troeschel, S; Zhao, L | 1 |
| Gao, X; Wang, D; Yu, L; Zhang, M | 1 |
| Belohlavek, O; Fencl, P; Harustiak, T; Zemanova, M | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Furth, C; Genseke, P; Kalinski, T; Riedel, S; Rogasch, JM; Schreiber, J; Schultz, M; Steffen, IG; Steinkrüger, FL; Wertzel, H | 1 |
| Asakura, K; Kaseda, K; Kazama, A; Ozawa, Y | 1 |
| Kang, DY; Lee, JW; Lee, SM; Lee, SY; Na, JO | 1 |
| Carter, BW; Court, LE; Fried, DV; Ho, L; Hofstetter, WL; Lin, SH; Meijer, GJ; van Rossum, PSN; Zhang, L | 1 |
| Bang, JH; Bang, YJ; Cha, Y; Ha, H; Han, SW; Im, SA; Jin, MH; Kim, JW; Kim, TY; Lee, KH; Nam, AR; Oh, DY; Park, JE | 1 |
| Bui, C; Do, V; Hadjashrafi, A; Loh, H; Mansberg, R; Shetty, D | 1 |
| Arnett, ALH; Haddock, MG; Hallemeier, CL; James, SE; Macintosh, EM; Merrell, KW; Nathan, MA; Neben Wittich, MA; Ravi, K; Shen, KR | 1 |
| Fukuhara, M; Hasegawa, T; Higuchi, M; Inoue, T; Owada, Y; Suzuki, H; Watanabe, Y; Yamaura, T | 1 |
| Aide, N; Babin, E; Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Michels, JJ; Rame, JP | 1 |
| Fu, Z; Li, Q; Li, Z; Liu, M; Zhang, J | 1 |
| Guler, OC; Onal, C; Torun, N; Yildirim, BA | 1 |
| Alkasab, TK; Kunawudhi, A; Mahmood, U; Wong, AK | 1 |
| Law, SY; Lee, EY; Lo, AW; Vardhanabhuti, V | 1 |
| Higashi, K; Ishigaki, Y; Nakamura, Y; Oguchi, M; Sagawa, M; Shimasaki, M; Takegami, T; Tonami, H; Ueda, Y; Yamagishi, T | 1 |
| Abdul-Rahman, H; Bauerfeind, P; Eshmuminov, D; Fischer, M; Gubler, C; Lehmann, K; Reiner, C; Schneider, PM; Veit-Haibach, P; Weber, A | 1 |
| Claver Valderas, MA; de la Peña Moral, J; Frutos Esteban, L; Fuster Quiñonero, M; García-Pérez, R; Ortiz Ruiz, E; Parrilla Paricio, P; Sánchez-Bueno, F | 1 |
| Copin, D; D'Hulst, L; De Spiegeleer, B; Delcourt, A; Maes, A; Van de Wiele, C; Van Vlaenderen, M | 1 |
| Kudithipudi, V; Maheshwary, R; Nguyen, D; Rajput, A; Tran, C | 1 |
| Coolen, J; Coosemans, W; Demey, K; Deroose, CM; Haustermans, K; Nafteux, P; Van Cutsem, E; Van Veer, H; Vandecaveye, V | 1 |
| Choi, JY; Choi, YS; Han, J; Jeong, JY; Jung, SH; Kim, HK; Kim, J; Kim, W; Lee, HY; Lee, KS; Shim, YM; Woo, MA; Zo, JI | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Naswa, N; Soundararajan, R; Walia, R | 1 |
| Jha, AK; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Vicente, E; Xiao, J | 1 |
| Ding, LY; Jiang, ZL; Liu, KJ; Wu, HY; Wu, SX | 1 |
| Goto, T; Kurita, A; Matsuzaki, N; Nishimura, S; Nishimura, T; Okada, H; Terajima, H; Uchida, Y; Yazumi, S | 1 |
| Hadas, M; Halankar, J; Hussey, D; Langer, D; Metser, U; Mohan, R; Tamir, S | 1 |
| Bae, JM; Choi, JY; Jeong, JY; Kim, HS; Kwon, OJ; Lee, HY; Lee, KS; Shim, YM; Sohn, I; Son, JY | 1 |
| Albano, D; Bertagna, F; Bertoli, M; Bosio, G; Morassi, ML; Orlando, E | 1 |
| Hsu, YL; Lin, IC; Tung, CL | 1 |
| Annunziata, T; Bellafiore, S; Cesario, A; Filice, A; Fioroni, F; Formisano, D; Galeone, C; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T | 1 |
| Calcagni, ML; Castelluccia, A; Mantini, G; Massaccesi, M; Mattoli, MV; Scolozzi, V | 1 |
| Alnaji, R; Attwood, K; Du, W; Gabriel, E; Hochwald, S; Kukar, M | 1 |
| Bui, C; Hennessy, G; Le, K; Loh, H; Mansberg, R; Vamadevan, S | 1 |
| Baba, H; Chikamoto, A; Hashimoto, D; Inoue, R; Komohara, Y; Sakamaki, K; Shiraishi, S; Takamori, H; Yamanaka, T; Yamashita, Y; Yamashita, YI; Yoshida, N | 1 |
| Matsuoka, K; Miyamoto, Y; Ueda, M | 1 |
| Kong, L; Shi, F; Zhang, NS; Zhu, H | 1 |
| Koh, YW; Lee, SJ; Park, SY | 1 |
| Chong, S; Coupe, N; Lee, S; Lin, M; Manoharan, V; Merrett, N; Ng, W; Wilson, R; Yap, J | 1 |
| Lenglinger, J; Riegler, M; Ringhofer, C | 1 |
| Buchpiguel, CA; Ceconello, I; Gama-Rodrigues, J; Habr-Gama, A; Kiss, D; Kruglensky, D; Perez, RO; Proscurshim, I; São Julião, GP | 1 |
| Belinc, D; Chen, DT; Eikman, EA; Farma, JM; Malafa, M; Melis, M; Santillan, AA; Walters, J | 1 |
| Balan, A; Mirsadraee, S; Naik, K; Salahudeen, HM; Scarsbrook, AF | 1 |
| Bollschweiler, E; Hölscher, AH | 1 |
| Conrad, GR; Jackson, RT; Sinha, P | 1 |
| Inoue, Y; Nagata, T; Shimizu, M; Taguchi, Y; Takashima, S; Tanaka, K | 1 |
| Prabhakar, HB; Rabinowitz, CB; Sahani, DV | 1 |
| de la Morena, E; Gasent Blesa, JM; Laforga Canales, JB; Vázquez, C; Vilaseca Martínez, D | 1 |
| Decker, PA; Meyers, BF; Putnam, JB; Veeramachaneni, NK; Zoole, JB | 1 |
| Al Haddad, M; Aranda-Michel, J; Bonatti, H; Dougherty, M; Fitzpatrick, P; Hinder, R; Huguet, K; Kim, G; Martin, K; McLaughlin, S; Nguyen, JH; Stockland, A | 1 |
| Araya, T; Fujimura, M; Ishiguro, T; Kasahara, K; Katayama, N; Kimura, H; Minato, H; Yasui, M | 1 |
| Almeida, SA; Fonseca, LM; Franco, CA; Landesmann, MC; Martins, Rde C; Siciliano, AA; Silva, FB | 1 |
| Guan, YS; Luo, ZM; Pan, WM; Su, XH; Sun, L; Wei, JH; Wu, H | 1 |
| Blake, MA; Choi, NC; Colen, RR; Fischman, AJ; Holalkere, NS; Roedl, JB | 1 |
| Carrozzi, L; Comin, C; Falaschi, F; Grazzini, M; Innocenti, F; Lopes Pegna, A; Maria Carozzi, F; Mascalchi, M; Paci, E; Picozzi, G; Ronchi, C; Spinelli, C | 1 |
| Akashi, T; Chiba, T; Ito, H; Ito, K; Kubota, K; Mochizuki, M; Morita, T; Morooka, M; Murata, Y; Nomura, T; Shibuya, H | 1 |
| Jordan, CD; Salskov, A; Schmidt, R; Turcotte, E; Vallières, E; Vesselle, H; Wiens, L; Wood, DE | 1 |
| Ahn, MI; Cho, DG; Cho, KD; Kang, CU; Kim, CH; Oh, JK; Yoo, J | 1 |
| Juweid, M; Milhem, M; O'Dorisio, T | 1 |
| Bhargava, P; Stair, M; Verstovsek, G; Vollink, J | 1 |
| Goo, JM; Jeon, YK; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Park, CM; Park, EA | 1 |
| Binderup, T; Jensen, MM; Jørgensen, JT; Kjaer, A | 1 |
| Bouchiat, C; Carlioz, R; Cellarier, GR; Jego, C; Kerebel, S; Laurent, P; Pons, F; Poyet, R | 1 |
| Higashi, K; Ito, K; Kato, T; Kobayashi, T; Niho, S; Sakuma, T; Sekiguchi, R; Takahashi, T; Tonami, H; Ueda, Y | 1 |
| Obando, JA; Samii, JM; Yasrebi, M | 1 |
| Weber, W; Wieder, H | 1 |
| Haba, R; Hagiike, M; Izuishi, K; Kaji, M; Kameyama, R; Murota, M; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
| Cohen, SJ; Konski, A; Li, T; Meropol, NJ; Sigurdson, E; Small, W; Spies, S; Stryker, S; Wahl, A; Yu, JQ | 1 |
| Azar, RR; Chen, J; Early, DS; Edmundowicz, SA; Govindan, R; Keswani, RN; Kohlmeier, C; Meyers, BF; Sharma, A | 1 |
| Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Ogawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Kawabe, T; Mineura, K; Miyamoto, J; Owada, K; Sasajima, H; Tatsuzawa, K | 1 |
| Goya, T; Honda, Y; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Uno, K | 1 |
| Nakazawa, K; Ohtsuka, M; Satoh, H; Sekizawa, K | 1 |
| Bollschweiler, E; Dietlein, M; Eschner, W; Hölscher, A; Kobe, C; Mönig, SP; Schicha, H; Schmidt, M; Vallboehmer, D; Vallböhmer, D | 1 |
| Cheng, MF; Hsu, YC; Huang, CT; Shih, JY; Tsai, MF; Tsai, YJ; Wei, PF; Yang, CH; Yang, PC; Yen, RF | 1 |
| Ajani, JA; Bhutani, MS; Hofstetter, W; Javeri, H; Komaki, R; Lee, JH; Maru, D; Rohren, E; Swisher, SG; Wang, X; Xiao, L | 1 |
| Brix, WK; Jones, DR; Kozower, BD; Smith, PW; Swenson, BR; Taylor, MD; Theodosakis, N; Wick, MR | 1 |
| Endo, K; Endou, H; Higuchi, T; Hisada, T; Imai, H; Ishikita, T; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Nakajima, T; Oriuchi, N; Shimizu, K; Sunaga, N; Yanagitani, N | 1 |
| Brix, WK; Jones, DR; Kozower, BD; Lau, CL; Smith, PW; Swenson, BR; Taylor, MD; Theodosakis, N; Wick, MR | 1 |
| Chang, HR; Chung, D; Debruhl, N; Gornbein, JA; Minami, CA; Prati, R | 1 |
| Duan, Y; Lu, PO; Wang, WZ; Yu, LJ | 1 |
| Hu, M; Kong, L; Li, MH; Liu, NB; Yang, GR; Yu, JM | 1 |
| Cheng, Z; He, J; Lin, L; Liu, L; Mao, YS; Zheng, R | 1 |
| Bennewith, KL; Erler, JT; Feazell, J; Giaccia, AJ; Graves, EE; Ham, CM; Huang, X; Kambham, N; Koong, A; Yang, GP | 1 |
| Hwang, SC; Lee, KB; Park, KJ; Sheen, SS; Sun, JS; Yoon, JK; Yoon, SN | 1 |
| Jheon, S; Kim, DJ; Kim, HR; Lee, WW; Sung, SW | 1 |
| Reske, SN | 1 |
| Barbour, AP; Gotley, DC; Martin, I; Shenfine, J; Smithers, BM; Thomas, J; Wong, D | 1 |
| Grunkemeier, GL; Kernstine, KH | 1 |
| Kobayashi, H; Mori, T; Nakashima, R; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, S | 1 |
| Abood, G; Aranha, GV; Moreira, J; Nagda, S; Shoup, M; Smith, JW; Wagner, RH | 1 |
| Eslamy, HK; Krupitskaya, Y; Kumar, A; Nguyen, DD; Wakelee, HA | 1 |
| Absher, K; Conrad, GR; Lee, J; Sinha, P | 1 |
| Bisi, G; Castellano, G; Deandreis, D; Penna, D; Varetto, T | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Hinterthaner, B; Näke, K; Sabet, A | 1 |
| Harada, T; Isowa, N; Kawasaki, Y; Maeda, R; Miura, H; Onuma, H; Tokuyasu, H; Touge, H | 1 |
| Abiko, T; Koizumi, S; Takanami, I | 1 |
| Ford, JM; Humke, E; Kim, J; Koong, AC; Quon, A | 1 |
| Fujiwara, H; Kaneda, K; Kizaki, T; Nishimura, T; Sendo, H; Shirakawa, S; Wada, T | 1 |
| Dehdashti, F; Grigsby, PW; Huettner, PC; Kidd, EA; Rader, JS; Siegel, BA; Spencer, CR | 1 |
| Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
| Adusumilli, PS; Akhurst, TJ; Bains, MS; Goodman, K; Ilson, D; Rizk, NP; Rusch, VW; Tang, L | 1 |
| Casneuf, V; Dierckx, R; Fonteyne, P; Pauwels, P; Peeters, M; Van Damme, N; Van de Wiele, C | 1 |
| Addeo, P; Bucci, L; Camera, L; D'Antonio, D; Mainenti, PP; Mainolfi, C; Manchia, A; Mancini, M; Maurea, S; Pace, L; Persico, F; Persico, G; Salvatore, M; Speranza, A; Tanga, M | 1 |
| Goya, T; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Tomiyoshi, K; Uno, K | 1 |
| Coha, B; Daković, M; Gardasanić, J; Latić, A; Mitrecić, D; Radmilović, K; Stefanić, M | 1 |
| Gallagher, DJ; Kemeny, N; Libby, DM | 1 |
| Dooms, C; Stroobants, S; Vansteenkiste, J; Verbeken, E | 1 |
| Abikhzer, G; Makis, W; Rush, C | 1 |
| Aburano, T; Chen, Z; Tian, M; Ye, X; Zhan, H; Zhang, H; Zhang, Y; Zhao, C | 1 |
| Bauduceau, O; Bonardel, G; Chargari, C; Dechaud, C; Fayolle, M; Foehrenbach, H; Gontier, E; Soret, M | 1 |
| Lurain, JR; Nemcek, A; Rademaker, A; Schink, JC; Singh, DK; Small, W; Spies, S; Vern, TZ | 1 |
| Beukema, JC; Busz, DM; Langendijk, JA; Muijs, CT; Plukker, JT; Pruim, J; Schreurs, LM; van der Borden, AJ; Van der Jagt, EJ | 1 |
| Bissoli, S; Chierichetti, F; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Choi, M; Heilbrun, LK; Lawhorn-Crews, JM; Shields, AF; Venkatramanamoorthy, R; Zalupski, MM | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Kim, K; Lee, JY; Lee, KH; Lee, SJ; Shim, YM | 1 |
| Adachi, K; Fujimoto, H; Ibata, H; Kaneda, M; Omoto, Y; Sakai, T; Watanabe, F | 1 |
| Endo, K; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Oriuchi, N; Shimizu, K; Sunaga, N; Tominaga, H; Yanagitani, N | 1 |
| Hirata, T; Kitamura, H; Nakamura, H; Nishikawa, J | 1 |
| Feith, M; Siewert, JR; Stein, HJ | 1 |
| Demura, Y; Fujibayashi, Y; Kiyono, Y; Kudo, T; Lohith, TG; Okazawa, H; Umeda, Y | 1 |
| Cigarral, C; de la Torre, A; Montero, A; Rodríguez, G; Salas, C | 1 |
| Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C | 1 |
| Hata, Y; Homma, S; Isobe, K; Shibuya, K; Takagi, K; Takai, Y | 1 |
| Ishikawa, Y; Ito, H; Kameda, Y; Kondou, T; Mizutani, Y; Murakami, S; Nakayama, H; Noda, K; Oshita, F; Saito, H; Sakuma, Y; Suga, Y; Tsuboi, M; Yamada, K; Yokose, T | 1 |
| Grigsby, PW; Huettner, P; Miller, TR; Rader, J; Showalter, TN | 1 |
| Lupo, R; Merino, B; Monet, A | 1 |
| Chen, YK; Yeh, CL | 1 |
| Ananth, L; Barnett, PG; Gould, MK; Nair, VS | 1 |
| Chang, HP; Chang, TC; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; Wu, TI; Yen, TC | 1 |
| Hyun, IY; Yun, MY | 1 |
| Gong, H; Huang, W; Lu, Y; Xie, D; Yu, J | 1 |
| Hsiung, CY; Huang, ML; Hung, GU; Lin, ST | 1 |
| Delbeke, D; Martin, WH | 1 |
| Araki, N; Emori, M; Fujimoto, T; Hamada, K; Joyama, S; Naka, N; Nakanishi, K; Omori, S; Tomita, Y | 1 |
| Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T | 1 |
| Fan, W; Li, W | 1 |
| Chung, DH; Goo, JM; Jang, BG; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Lee, HY; Park, CM | 1 |
| Chen, YK; Huang, LW; Lee, SL; Pan, HS | 1 |
| Schauer, M; Theisen, J | 1 |
| Alavi, A; Chamroonrat, W; Gopal, R; Houseni, M; Zhuang, H; Zhuang, J | 1 |
| Khoo, JB; Lu, SJ; Ng, DC; Osmany, S | 1 |
| Karyagar, S; Karyagar, SS; Kece, C; Ozdil, B | 1 |
| Abikhzer, G; Makis, W; Stern, J | 1 |
| D'Souza, M; Garg, G; Jaimini, A; Jain, N; Khurana, A; Mondal, A; Sharma, R; Tripathi, M | 1 |
| Cho, YH; Chung, HW; Kim, JH; Kim, SY; Lee, EJ; Lee, KY; Lee, MH; Lee, SY; Park, HS; So, Y; Sung, IK; Yoo, MW; Yoon, SY | 1 |
| Liang, CY; Liu, X; Tian, XD; Zhang, JM; Zhang, T; Zhou, NK | 1 |
| Haerle, SK; Hälg, RA; Huber, GF; Schaefer, N; Schrepfer, T; Strobel, K | 1 |
| Higashi, T; Hiraoka, M; Matsuo, Y; Mizowaki, T; Nagata, Y; Nakamoto, Y; Narabayashi, M; Norihisa, Y; Saga, T; Shibuya, K; Takayama, K; Togashi, K | 1 |
| Bae, KT; Goshima, S; Hoshi, H; Kako, N; Kanematsu, M; Kondo, H; Watanabe, H; Yamada, T; Yamamoto, N | 1 |
| Becker, K; Herrmann, K; Keller, G; Langer, R; Lordick, F; Lorenzen, S; Ott, K; Panzram, B; Schwaiger, M; Siewert, JR | 1 |
| Campos, GC; de Carvalho Flamini, R; de Gusmão Funari, MB; Livorsi da Cunha, M; Mello, ME; Osawa, A; Wagner, J; Yamaga, L | 1 |
| Lin, M; London, K | 1 |
| Hong, L; Li, HB; Li, Y; Wang, JL; Wang, Q; Yue, MG | 1 |
| Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T | 1 |
| Hwang, SH; Kim, IJ; Kim, SJ; Lee, CH; Lee, EY; Lee, MK; Lee, SY | 1 |
| Mineura, K; Miyamoto, J; Owada, K; Sasajima, H | 1 |
| Adachi, S; Daisaki, H; Kato, Y; Nakayama, H; Okada, M; Okumura, S; Uehara, H; Yoshimura, M | 1 |
| Assenat, E; Aufort, S; Bacigalupo, L; Eberlé, MC; Gallix, B; Ychou, M | 1 |
| de Keyzer, F; Deroose, C; Haustermans, K; Lambrecht, M; Penninckx, F; Roels, S; Sagaert, X; van Cutsem, E; Vandecaveye, V | 1 |
| Ceulemans, G; De Ridder, M; Engels, B; Everaert, H; Hoorens, A; Sermeus, A; Storme, G; Urbain, D; Vanhove, C; Verellen, D; Vermeersch, M | 1 |
| Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
| Canda, AE; Kaya, GC; Sengoz, T; Sürücü, E; Terzi, C; Tuna, B; Yorukoglu, K | 1 |
| Devic, S; Faria, S; Lehnert, S; Lisbona, R; Menard, S; Tomic, N | 1 |
| August, DA; Gannon, C | 1 |
| Alakus, H; Baldus, S; Bollschweiler, E; Brabender, J; Dietlein, M; Hölscher, AH; Metzger, R; Mönig, SP; Schmidt, M; Schneider, PM; Vallböhmer, D | 1 |
| Sendler, A | 1 |
| Ansquer, C; Frampas, E; Meurette, G; Pery, C; Regenet, N | 1 |
| Carlton, MM; Hall, NC; Hinkle, GH; Johnson, MA; Knopp, MV; Martin, EW; Mojzisik, CM; Povoski, SP; Sun, D; Xu, RX; Zou, P | 1 |
| Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Loft, A; Lundvall, L; Nedergaard, L; Risum, S | 2 |
| Ajani, JA; Bhutani, MS; Hofstetter, WL; Lee, JH; Liao, Z; Macapinlac, HA; Murthy, SB; Patnana, SV; Rohren, E; Swisher, SG; Wang, X; Xiao, L | 1 |
| Aikawa, H; Higashi, K; Machida, Y; Sagawa, M; Sakuma, T; Tanaka, M; Ueda, Y; Ueno, M; Usuda, K; Zhao, XT | 1 |
| Buechel, RR; Husmann, L; Kaufmann, PA; Pazhenkottil, AP; Tatsugami, F | 1 |
| Aklilu, M; Blackstock, AW; Clark, P; Geisinger, KR; Isom, S; Levine, EA; Mishra, G; Monjazeb, AM; Riedlinger, G | 1 |
| Ito, M; Murashima, S; Qiao, S; Suzawa, N; Takao, M; Takeda, K; Uchida, K; Yamada, T | 1 |
| Ahn, JB; Hur, H; Keum, KC; Kim, H; Kim, NK; Lee, KY; Min, BS; Yun, M | 1 |
| Hyun Yoon, J; Jung Moon, H; Kim, EK; Min Jeon, H; Young Kwak, J | 1 |
| Guo, J; Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
| Krause, BJ; Lordick, F; Ott, K | 2 |
| Kumamoto, Y; Nakahara, T; Suzuki, K; Watada, S; Yoko, M | 1 |
| Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Yap, JT | 1 |
| Alekshun, TJ; Rai, M; Rustagi, T | 1 |
| Blauwgeers, H; Boersma, L; Burgers, S; Gilhuijs, K; Klomp, H; Knegjens, J; Rossi, M; Siedschlag, C; Stroom, J; van Baardwijk, A; van Loon, J; van Suylen, RJ; Vogel, W | 1 |
| Jia, C; Lou, G; Lu, P; Tian, M; Wang, W; Wang, X; Yu, L | 1 |
| Komatsu, Y; Maekawa, H; Orita, H; Sakurada, M; Sato, K | 1 |
| Gönen, M; Larson, SM; Schöder, H; Singnurkar, A; Solomon, SB | 1 |
| Duffy, GJ; Gillham, C; Keogan, M; Lucey, JA; Malik, V; McNamara, L; Reynolds, JV; Wilson, L | 1 |
| Chen, YM; Guan, ZW; Liu, B; Liu, CB; Qu, BL; Tian, JH; Wang, H; Wang, RM; Xu, BX; Zhang, JM | 1 |
| Antinolfi, F; Antinolfi, G; Barra, E; Brunese, L; Cappabianca, S; Caputi, M; Catalano, M; De Rimini, ML; De Rosa, I; De Rosa, N; Di Matteo, A; Grassi, R; Greco, B; Muto, P; Muto, R; Petrillo, M; Piccolo, S; Porto, A; Reginelli, A; Ronza, F; Rossi, G; Rotondo, A; Setola, F | 1 |
| Furonaka, O; Miyata, Y; Noriyuki, T; Osaki, N; Shimoda, K; Shioya, S; Takahashi, G; Yonehara, S | 1 |
| Akutsu, Y; Kono, T; Matsubara, H; Natsume, T; Ohira, G; Ota, T; Saito, H; Shuto, K; Toma, T; Uesato, M | 1 |
| Bouchelouche, K; Gerke, O; Holt, P; Jensen, TK; Marcussen, N; Riehmann, M; Svolgaard, B | 1 |
| Bergman, JJ; Boellaard, R; Bonenkamp, HJ; Bossuyt, PM; Busch, OR; Cuesta, MA; Hoekstra, OS; Hulshof, MC; Nieuwenhuijzen, GA; Omloo, JM; Plukker, JT; Pruim, J; Sloof, GW; Ten Kate, FJ; Tilanus, HW; van Berge Henegouwen, MI; van Dekken, H; van der Gaast, A; van Heijl, M; van Lanschot, JJ | 1 |
| Bugaj, JE; Gokhale, PC; Guleryuz, S; Manning, HC; Mantis, C; McKinley, ET; Wild, R; Zhao, P | 1 |
| Chan, Q; Gu, J; Khong, PL; Law, W; Liu, RK; Wang, S; Wu, EX; Zhang, J | 1 |
| Chondrogiannis, S; Conti, G; D'Ambrosio, D; Farace, P; Marzola, P; Merigo, F; Nanni, C; Quarta, C; Rubello, D; Sbarbati, A; Tambalo, S | 1 |
| Cavallaro, A; Kuwert, T; Manger, B; Schett, G; Schmidt, D; Wacker, J | 1 |
| Aschoff, P; Pfannenberg, C; Reimold, M; Werner, MK | 1 |
| Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
| Allen, AM; Aristophanous, M; Berbeco, RI; Chen, AB; Killoran, JH; Larson, E; Sher, DJ; Yap, JT | 1 |
| Gokce, M; Kilicgun, A; Saydam, O; Tanriverdi, O | 1 |
| Bartsch, DK; Fendrich, V; Jacobsen, ID; Maitra, A; Opfermann, T; Schneider, R | 1 |
| Huh, JW; Kim, HR; Kim, YJ; Lee, JH; Min, JJ | 1 |
| Chang, DT; Chennupati, SK; Graves, E; Kamaya, A; Koong, AC; Krakow, TE; La, T; Pai, RK; Quon, A | 1 |
| Adachi, S; Daisaki, H; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
| Kong, FM; Ma, L; Meng, X; Mu, D; Sun, X; Xing, L; Yang, G; Yu, J; Zhang, B; Zhao, S | 1 |
| De Palma, GD; Iodice, D; Magliulo, M; Mainenti, PP; Pace, L; Salvatore, M; Segreto, S; Storto, G | 1 |
| Akhurst, TJ; Chessin, DB; Guillem, JG; Larson, SM; Leibold, T; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Riedel, E; Saltz, LB; Shia, J; Weiser, MR; Wong, WD; Yeung, HW | 1 |
| Bockisch, A; Freudenberg, LS; Jentzen, W; Rosenbaum-Krumme, SJ; Stahl, A | 1 |
| Fournet, S; Giacalone, PL; Rathat, G; Rouleau, C | 1 |
| Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Saint-Blancard, P; Salles, Y; Staub, E; Vaylet, F | 1 |
| Hasegawa, C; Ito, H; Kameda, Y; Kondo, T; Murakami, S; Nakayama, H; Oshita, F; Saito, H; Sakuma, Y; Tsuboi, M; Yamada, K; Yokose, T | 1 |
| Fockens, P; Groen, H; Janssens, AC; Plukker, JT; Pruim, J; Schreurs, LM; Sloof, GW; Steyerberg, EW; van Berge Henegouwen, MI; van Dullemen, HM; van Lanschot, JJ | 1 |
| Dang, CJ; Li, W; Li, YJ | 1 |
| Au, DH; Ghaus, SJ; Gould, MK; Provenzale, D; Schultz, EM; Wagner, TH; Wallace, RB; Xu, X | 1 |
| Cline, KJ; Darling, GE; Driedger, AA; Evans, WK; Gu, CS; Gulenchyn, KY; Inculet, RI; Julian, JA; Kuruvilla, MS; Levine, MN; Maziak, DE; Ung, YC | 1 |
| Hihara, J; Ikeda, T; Mimura, T; Misumi, K; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Choi, IS; Choi, WJ; Kang, YH; Lee, SE; Min, HS; Moon, JI; Oh, HH; Ra, YM; Yoon, DS | 1 |
| Matsumoto, I; Oda, M; Shimizu, Y; Tamura, M; Waseda, R; Watanabe, G | 1 |
| Ishibashi, T; Ishikawa, K; Kadoya, M; Kaji, M; Kato, T; Tamaki, N | 1 |
| Brennan, C; Campos, C; Graeber, TG; Heguy, A; Huse, JT; Kastenhuber, ER; Komisopoulou, E; Larson, SM; Linkov, I; Mellinghoff, IK; Osborne, JR; Palaskas, N; Phelps, ME; Plaisier, SB; Port, E; Rohle, D; Sander, C; Schultz, N; Taschereau, R; Tran, C; Wong, J; Wu, H; Yannuzzi, N | 1 |
| Calcagni, ML; Dambra, DP; De Gaetano, AM; Giordano, A; Leccisotti, L; Meduri, GM; Rufini, V; Spitilli, MG; Treglia, G | 1 |
| Abel, U; Debus, J; Haag, GM; Haberkorn, U; Jäger, D; Lordick, F; Lorenzen, S; Münter, MW; Stange, A; von Gall, C; Weichert, W; Weitz, J | 1 |
| Abe, T; Hayashi, Y; Ito, Y; Koyama, K; Sato, M | 1 |
| Neuman, A; Ouvrier, MJ; Pop, G; Soussan, M; Weinmann, P | 1 |
| Citak, N; Gurses, A; Kök, A; Melek, H; Metin, M; Pekcolaklar, A; Sayar, A | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Vliegen, RF | 1 |
| Barth, T; Muehling, B; Oberhuber, A; Orend, KH; Schelzig, H; Wehrmann, C | 1 |
| Becker, K; Ebert, M; Friess, H; Geinitz, H; Herrmann, K; Krause, BJ; Langer, R; Lordick, F; Ott, K; Peschel, C; Schuster, T; Schwaiger, M; Zimmermann, F; zum Büschenfelde, CM | 1 |
| Bazan, J; Diehn, M; Donington, JS; Graves, EE; Hara, WY; Hoang, CD; Kozak, MM; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Schipper, ML; Shrager, JB; Wakelee, HA; Whyte, RI; Zhou, L | 1 |
| Abdul-Karim, FW; Faulhaber, P; Kunos, C; Radivoyevitch, T | 1 |
| Ciarallo, A; Laufer, J; Makis, W; Rush, C; Xu, B | 1 |
| Cai, S; He, Y; Peng, J; Sheng, J; Xu, J; Zhang, Z | 1 |
| Amin, SN; Chopra, A; De Noronha, R; Farquharson, AL; Ford, A; Matthews, S | 1 |
| Ahmed, K; Hanna, GB; Kayani, B; Zacharakis, E | 1 |
| Aboagye, EO; Al-Nahhas, A; Challapalli, A; Contractor, KB; Coombes, RC; De Nguyen, Q; Hogben, K; Kenny, LM; Lewis, JS; Palmieri, C; Shousha, S; Stebbing, J | 1 |
| Chiu, CH; Chou, TY; Lee, YC; Lin, KH; Tsai, CM; Wu, YC; Yeh, YC | 1 |
| de Koning, HJ; Groen, HJ; Lammers, JW; Mali, W; Nackaerts, K; Oudkerk, M; Thunnissen, FB; van Klaveren, RJ; van't Westeinde, SC; Vernhout, R; Weenink, C | 1 |
| Fukuda, I; Hatanaka, R; Kimura, D; Sakai, T; Tsushima, T; Yamada, Y | 1 |
| Chen, T; Chen, YM; Pan, XF; Shi, YP; Tong, LJ | 1 |
| Lam, S; Subramaniam, RM; Surasi, DS | 1 |
| Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yen, KY | 1 |
| Bergman, JJ; Bossuyt, PM; Hulshof, MC; Mearadji, BM; Omloo, JM; Phoa, SS; Richel, DJ; Sloof, GW; Stoker, J; Ten Kate, FJ; van Berge Henegouwen, MI; van Heijl, M; van Lanschot, JJ | 1 |
| Bomanji, J; Hashemi, M; Iordanidou, L; Markar, SR; Mitchell, I; Read, S; Stoker, D; Vyas, S; Winslet, M | 1 |
| Endo, M; Kaira, K; Kondo, H; Murakami, H; Naito, T; Nakagawa, K; Nakajima, T; Ohde, Y; Okumura, T; Takahashi, T; Yamamoto, N | 1 |
| Dehdashti, F; Grigsby, PW; Schwarz, JK; Siegel, BA | 1 |
| Goya, S; Hatazawa, J; Hirata, H; Inoue, A; Kawase, I; Kida, H; Kijima, T; Kumagai, T; Kumanogoh, A; Nagatomo, I; Okumura, M; Shimosegawa, E; Tachibana, I; Takahashi, R; Takeda, Y; Yoshida, M | 1 |
| Akiyama, K; Ishihara, K; Iwano, M; Kobayashi, Y; Kumita, S; Satoh, H; Shiiba, M; Yoshihara, H | 1 |
| Kong, FM; Wang, J; Wang, L; Welch, K | 1 |
| Dong, MJ; Ouyang, XB; Pan, JH | 1 |
| Ishihara, K; Kimura, G; Kondo, Y; Kumita, S; Kuwako, T; Sato, H; Shiiba, M; Tsuchiya, S; Yoshihara, H; Yoshihara, N | 1 |
| Nguyen, BD; Nguyen, CC; Nguyen, VX | 1 |
| Archambault, M; Bénard, F; Croteau, É; Lecomte, R; Ouellet, R; Paquette, M | 1 |
| Aubard, Y; Fermeaux, V; Genet, D; Leobon, S; Marin, B; Maubon, A; Monteil, J; Renaudie, J; Roux, S; Tubiana-Mathieu, N | 1 |
| Fukushima, Y; Kawai, K; Mukasa, A; Ota, T; Saito, N; Uozaki, H | 1 |
| Chaiwatanarat, T; Kingpetch, K; Pipatrattana, R; Sirisalipoch, S; Tepmongkol, S | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Stohr, I; Vliegen, RF | 1 |
| Fineberg, NS; Kim, H; Rana, S; Rigell, CJ; Samuel, SL; Stockard, CR; Umphrey, HR; Zhai, G; Zinn, KR | 1 |
| Hirami, Y; Maeda, A; Nakata, M; Saisho, S; Shimizu, K; Yasuda, K; Yukawa, T | 1 |
| Helin, H; Karhumäki, L; Kauppi, JT; Kemppainen, J; Oksala, N; Räsänen, JV; Salo, JA; Sihvo, EI | 1 |
| Ascui, R; Caro, R; Díaz, RE; Utreras, C; Véliz, J; Wohllk, N | 1 |
| Hong, R; Lim, SC | 1 |
| Donington, JS | 1 |
| Hoh, CK; Jensen, LG; Lau, SK; Liang, Y; Mell, LK; Rose, BS; Yashar, CM | 1 |
| Au-Yeung, AW; Lo, AX; Luk, WH | 1 |
| Abele, JT; Bédard, EL; Gill, RS; Perry, T; Schiller, D | 1 |
| Arguis, P; Boada, M; Cabañas, M; Gómez-Caro, A; Lomeña, F; Molins, L; Ramirez, J; Sanchez, M | 1 |
| Fujibayashi, Y; Fujieda, S; Kimura, Y; Kiyono, Y; Kositwattanarerk, A; Kudo, T; Maruyama, R; Mori, T; Oh, M; Okazawa, H | 1 |
| Gao, S; Li, YJ; Xing, XL | 1 |
| Kim, CK; Kim, KS; Lee, J; Lee, JD; Yun, M | 1 |
| Bradley, KM; Gillies, RS; Gleeson, FV; Han, C; Marshall, RE; Maynard, ND; Middleton, MR | 1 |
| Chang, DT; Graves, E; Jayachandran, P; Koong, AC; Krakow, TE; La, T; Loo, BW; Pai, RK; Quon, A | 1 |
| Choi, YJ; Huh, CY; Ki, KD; Kim, GY; Lee, JM; Lee, SK; Lim, SJ; Seol, HJ; Tong, SY | 1 |
| Ishida, T; Kunimasa, K; Masuda, G; Watanabe, N | 1 |
| Cheng, J; Hu, S; Pan, L; Xu, J; Yang, Z; Ye, D; Zhang, Y | 1 |
| Mirtcheva, R; Wosnitzer, B | 1 |
| Bjartell, A; Evans-Axelsson, S; Hagman, Z; Lilja, H; Nilsson, O; Olsson, T; Örbom, A; Peterson, P; Strand, J; Strand, SE; Tolmachev, V; Ulmert, D; Wennerberg, J; Wingårdh, K | 1 |
| Alakus, H; Berthold, F; Dietlein, M; Drebber, U; Hero, B; Holinski-Feder, E; Schmidt, MC; Schneider, C; Simon, T; Uphoff, US | 1 |
| Ding, XP; Li, BS; Li, HS; Sun, HF; Wang, DQ; Wang, ZT; Yi, Y; Zhang, J | 1 |
| Farlow, D; Gan, G; Hollands, M; Lam, VW; Laurence, JM; Pleass, HC; Richardson, A; Yao, J | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA; Thomas, M | 1 |
| Bolton, WD; Geraldson, CT; Greene, RA; Lagrew, JP; Schammel, CM; Schammel, DP; Stephenson, JE | 1 |
| Cheoi, K; Chung, H; Lee, H; Lee, JH; Lee, SK; Lee, YC; Park, JC; Shin, SK; Yun, MJ | 1 |
| Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V | 1 |
| Buchpiguel, CA; Campos, FG; Gama-Rodrigues, J; Habr-Gama, A; Imperiale, AR; Lynn, PB; Nahas, SC; Ono, CR; Perez, RO; Proscurshim, I; São Julião, GP; Sousa, AH | 1 |
| Alavi, A; Codreanu, I; Torigian, DA; Zhuang, H | 1 |
| Burger, R; Held, P; Rohlfs, AK; Römer, FW; Strutz, J; Viebahn, C; Woenckhaus, M | 1 |
| Adusumilli, PS; Colovos, C; Dunphy, MP; Kadota, K; Rizk, NP; Rusch, VW; Sima, CS; Suzuki, K; Travis, WD; Yoshizawa, A; Zabor, EC | 1 |
| Cincibuch, J; Formanek, R; Koranda, P; Myslivecek, M; Neoral, C; Vomackova, K; Vrba, R; Zapletalova, J | 1 |
| Carlson, KE; Chan, SR; Dence, CS; Fettig, NM; Fowler, AM; Jeyakumar, M; Katzenellenbogen, JA; Schreiber, RD; Sharp, TL; Welch, MJ; Zhou, D | 1 |
| Bal, C; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, P; Singh, H | 1 |
| Chen, TY; Chiu, JS; Hung, CC; Hung, GU; Kao, CH | 1 |
| Bal, C; Kumar, R; Malhotra, A; Reddy, RM; Sharma, A; Sharma, P; Singh, H; Suman, SK; Thulkar, S | 1 |
| Asada, T; Chijiiwa, K; Haruyama, Y; Hotokezaka, M; Nagamachi, S; Uchiyama, S | 1 |
| Jeon, HM; Kim, SH; O, JH; Oh, SI; Park, CH; Shim, JH; Song, KY; Yoo, HM | 1 |
| Kamata, H; Machida, T; Ohizumi, Y; Okada, K; Sadahiro, S; Suzuki, T; Tanaka, A; Yasuda, S | 1 |
| Axelrod, R; Champ, C; Fogh, SE; Intenzo, C; Keane, WM; Kubicek, GJ; Machtay, MM | 1 |
| Cheng, J; Cohen, SJ; Keller, L; Klayton, T; Konski, A; Li, T; Meropol, NJ; Scott, W; Xu-Welliver, M; Yu, JQ | 1 |
| Scappaticci, AA; Yoo, DC | 1 |
| Frumovitz, M; Jhingran, A; Klopp, AH; Macapinlac, HA; Nick, AM; Ramirez, PT; Ramondetta, LM | 1 |
| Chin, HM; Chung, WC; Jeon, HS; Jun, KH; Kim, JH; Lee, H; Lee, KM; Paik, CN | 1 |
| Hamamoto, Y; Kataoka, M; Kozuki, T; Nakajima, N; Nogami, N; Sawada, S; Shinkai, T; Shinohara, S; Suehisa, H; Sugawara, Y; Yamashita, M | 1 |
| Cheng, J; Dai, D; Ma, WC; Song, XY; Xu, WG; Xu, XX; Zhu, L; Zhu, X | 1 |
| Chan, DS; Ellis-Owen, R; Fielding, P; Lewis, WG; Reid, TD; Roberts, SA | 1 |
| Abelson, JA; Bazan, JG; Diehn, M; Graves, EE; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Quon, A; Trakul, N | 1 |
| Arens, AI; de Geus-Oei, LF; Hutchings, M; Oyen, WJ; Vriens, D | 1 |
| Allende-Riera, A; Cabello-García, D; Cárdenas-Negro, JC; De Sequera-Rahola, M; Martínez-Gimeno, E; Muñoz-Iglesias, J; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
| Claver Valderas, MA; Frutos Esteban, L; Frutos, MD; Luján, J; Mohamed Salem, L; Murcia Duréndez, MJ; Navarro Fernández, JL; Ruiz Merino, G; Valero, G | 1 |
| Endozo, R; Engledow, A; Goh, V; Groves, AM; Halligan, S; Kozarski, R; Peck, J; Rodriguez-Justo, M; Shastry, M; Taylor, SA | 1 |
| Li, M; Liu, Q; Peng, Z; Sun, J; Yao, S | 1 |
| Lordick, F | 1 |
| Hakucho, T; Higashiyama, M; Hosoki, T; Miyake, C; Morimoto, D; Nakanishi, K; Takahashi, Y; Takashima, S; Tomita, Y; Watanabe, S | 1 |
| Choi, WH; Han, EJ; Lee, KY; Yoo, IeR | 1 |
| Chowdhury, FU; Godfrey, EM; Radhakrishna, G | 1 |
| Akhurst, TJ; Ginsberg, MS; Gollub, MJ; Guillem, JG; Larson, SM; Leibold, T; Mazumdar, M; Minsky, BD; Nash, GM; Paty, PB; Riedel, ER; Ruby, JA; Saltz, LB; Shia, J; Suriawinata, AA; Temple, LK; Weiser, MR; Yeung, HW | 1 |
| Chen, W; D'Souza, WD; Feigenberg, S; Kim, G; Kligerman, S; Lu, M; Lu, W; Suntharalingam, M; Tan, S | 1 |
| Knox, JJ; Zhu, AX | 1 |
| Choi, H; Chung, JK; Kang, KW; Kim, DW; Lee, DS; Lee, JK; Paeng, JC; Park, CM | 1 |
| Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D | 1 |
| Goto, H; Hata, Y; Isobe, K; Mitsuda, A; Otsuka, H; Sato, F; Shibuya, K; Takagi, K; Wakayama, M; Watanabe, Y; Yuasa, R | 1 |
| Ansquer, C; Bodere, F; Bouchot, O; Branchereau, J; Hitier-Berthault, M; Renaudin, K; Rigaud, J | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Zöphel, K | 1 |
| Dong, L; Eifel, PJ; Fontanilla, HP; Iyer, RB; Jhingran, A; Kelly, P; Klopp, A; Levenback, CF; Takiar, V; Zhang, Y | 1 |
| Ajiki, T; Asari, S; Fukumoto, T; Goto, T; Kitajima, K; Ku, Y; Matsumoto, I; Shinzeki, M; Shirakawa, S | 1 |
| Hashizume, Y; Shimizu, Y | 1 |
| Bailão Aguilar, P; Buchpiguel, CA; Gama-Rodrigues, J; Habr-Gama, A; Lynn, P; Nahas, SC; Ono, CR; Perez, RO; Proscurshim, I; São Julião, GP | 1 |
| Andersen, ES; Antonsen, SL; Asmussen, J; Berthelsen, AK; Christensen, IJ; Fagö-Olsen, CL; Fisker, R; Høgdall, C; Høgdall, E; Jochumsen, K; Loft, A; Nielsen, AL; Tabor, A | 1 |
| Hu, W; Shen, W; Sun, W; Xu, J; Zhang, Z | 1 |
| Bianco, A; Brunese, L; De Rimini, M; De Rosa, N; Grassi, R; Greco, B; Guarracino, MR; Lassandro, F; Muto, P; Muto, R; Piccolo, S; Rotondo, A; Setola, FR | 1 |
| Akhurst, T; Etchebehere, EC; Gonen, M; Humm, K; Larson, SM; Macapinlac, HA; Scher, HI; Yeung, HW | 1 |
| De Cobelli, F; Fazio, F; Gianolli, L; Landoni, C; Maschio, AD; Matarrese, M; Messa, C; Picchio, M | 1 |
| Aldighieri, F; Alonso, G; Duarte, PS; Machado, C; Martins, LR; Zhuang, H | 1 |
| Brouwer, J; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR; Pruim, J; Regelink, G; Roodenburg, JL; Vaalburg, W; van der Laan, BF; Vissink, A | 1 |
| Asaka, M; Kato, T; Katoh, C; Kondo, S; Kuge, Y; Nambu, T; Nobuta, A; Tamaki, N; Tsukamoto, E | 1 |
| Alavi, A; Chacko, TK; Duarte, PS; Feng, Q; Hickeson, M; Nakhoda, KZ; Zhuang, H | 1 |
| Abbruzzese, JL; Baker, C; Bucana, C; Charnsangavej, C; Davis, DW; Ellis, LM; Herbst, RS; Hess, KR; Kim, HW; Madden, TL; McConkey, DJ; Mullani, NA; O'Reilly, MS; Pluda, J; Rashid, A; Roach, J; Tran, HT | 1 |
| Decker, M; Eckel, F; Frank, R; Helmberger, H; Lersch, C; Lippl, F; Neverve, J; Schulte-Frohlinde, E; Schusdziarra, V; Schwaiger, M; Weber, W | 1 |
| Beckers, C; Foidart, J; Malaise, MG; Thiry, A | 1 |
| Buck, A; Dankerl, A; Glatting, G; Kalker, T; Kotzerke, J; Kühn, T; Mattfeldt, T; Reske, S; Schirrmeister, H; Shen, C | 1 |
| Beggs, AD; Hain, SF | 1 |
| Clark, LA; Clary, BM; Coleman, RE; Gottfried, M; Kalady, MF; Pappas, TN; Rohren, EM; Tyler, DS | 1 |
| Grünwald, F; Junginger, T; Kneist, W; Menzel, C | 1 |
| Binns, D; Frydenberg, M; Hicks, R; Hogg, A; Salminen, E | 1 |
| Di Martino, E; Gagel, B; Hausmann, R; Krombach, GA; Nowak, B; Tietze, L; Westhofen, M; Zimny, M | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W | 1 |
| Deichen, JT; Gack, M; Kuwert, T; Prante, O; Schmiedehausen, K | 1 |
| Biesma, B; Hoekstra, CJ; Hoekstra, OS; Schramel, FJ; Smit, EF; Stroobants, SG; van Tinteren, H; van Zandwijk, N; Vansteenkiste, J | 1 |
| Frick, MP; Karabulut, N; Martin, DR; Yang, M | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Conti, PS; Garcia, AA; Jadvar, H; Tatlidil, R | 1 |
| Buell, U; Cremerius, U; Hochstenbag, M; Lamers, R; Reinartz, P; ten Velde, G; Zimny, M | 1 |
| Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H | 1 |
| Andriole, GL; Dehdashti, F; Fischer, KC; Kibel, AS; Michalski, JM; Miller, TR; Oyama, N; Picus, J; Siegel, BA; Welch, MJ | 1 |
| Fink, U; Ott, K; Siewert, JR; Weber, W | 1 |
| Bartenstein, P; Böttcher, HD; Döbert, N; Grünwald, F; Junginger, T; Kneist, W; Menzel, Ch; Mose, S; Rieker, O; Teising, A | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Boland, GW; Fischman, AJ; Kalra, MK; Maher, MM; Saini, S | 1 |
| Hicks, RJ; Mackay, JR; Patrikeos, AP | 1 |
| Becker, K; Fink, U; Helmberger, H; Müller, J; Ott, K; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA | 1 |
| Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H; Yamaguchi, A | 1 |
| Groen, H; Heeren, PA; Jager, PL; Plukker, JT; van Dullemen, HM; van Westreenen, HL | 1 |
| Bartenstein, P; Grünwald, F; Junginger, T; Kneist, W; Oberholzer, K; Schreckenberger, M | 1 |
| Forsthuber, EP; Gallowitsch, HJ; Gasser, J; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Umschaden, HW | 1 |
| Chierichetti, F; Decet, G; Ferronato, A; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Berlangieri, SU; Ollenberger, GP | 1 |
| Begent, RH; Boden, R; Boxer, GM; Dearling, JL; Flynn, AA; Green, AJ; Pedley, RB; Petrie, IA; Sutcliffe-Goulden, J | 1 |
| Dong, JC; Guan, YH; He, SL | 1 |
| Koumanis, DJ; Meterissian, S; Tzimas, GN | 1 |
| Boom, RP; Buter, J; Comans, EF; Hoekstra, OS; Krak, NC; Lammertsma, AA; Meijer, S; Pinedo, HM; Teule, GJ; van der Hoeven, JJ; van der Wall, E; van Geldere, D | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 2 |
| Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Neumaier, B; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L; Wurziger, I | 1 |
| Kawahara, M | 1 |
| Chen, YK; Kao, CH; Shen, YY | 1 |
| Aksoy, E; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Mühling, B; Neumaier, B; Nüssle-Kügele, K; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L | 1 |
| Chao, D; Gregson, NA; Leff, A; Mak, I; McCabe, DJ; Perkin, GD; Schapira, AH; Turner, NC; Womersley, HJ | 1 |
| Bley, TA; Brink, I; Hentschel, M; Imdahl, A; Kleimaier, M; Mix, M; Moser, E; Walch, A | 1 |
| Constable, CJ; Fulham, MJ; Gradinscak, DJ; Mohamed, A | 1 |
| Bongaerts, F; Heeren, PA; Jager, PL; Plukker, JT; Sluiter, W; van Dullemen, H | 1 |
| Flamen, P | 2 |
| Akhurst, T; Weng, LJ | 1 |
| Chen, L; Ding, Y; Shao, M; Tian, J; Wei, B; Yao, S; Yin, D | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Guo, J; Higashi, K; Kodama, Y; Nagao, Y; Oguchi, M; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Chen, B; Kou, QL; Li, R; Liu, XB; Lu, yL; Wei, B; Yao, sL | 1 |
| Blackstone, EH; Lauer, MS | 1 |
| Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Hayashi, S; Hisada, K; Kamisaki, Y; Kato, H; Kishida, M; Matsunari, I; Noguchi, K; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Antoine, JC; Cinotti, L; Cottin, V; Honnorat, J; Janier, MF; Ternamian, PJ; Tronc, F; Trouillas, P; Younes-Mhenni, S | 1 |
| Liu, XB; Sun, YE; Tian, JH; Wang, K; Wang, T; Yao, SL | 1 |
| Ball, DL; Binns, D; Hicks, RJ; Hogg, A; Mac Manus, MP; Matthews, JP; Peters, LJ; Rischin, D | 1 |
| Ajani, JA; Correa, AM; Cox, JD; Erasmus, J; Hong, D; Komaki, RR; Lee, HK; Macapinlac, H; Maish, M; Putnam, JB; Rice, DC; Roth, JA; Smythe, WR; Swisher, SG; Thai, L; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Zimny, M | 1 |
| Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT | 1 |
| Capirci, C; Carpi, A; Chierichetti, F; Crepaldi, G; Mandoliti, G; Nicolini, A; Polico, C; Rubello, D | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Uno, K; Watanabe, K | 1 |
| Liu, FY; Shang, JB; Wang, QS; Zhang, XL | 1 |
| Haglund, U; Långström, B; Rasmussen, I; Sörensen, J | 1 |
| Binns, D; Hicks, R; Jong, I; Lau, E; Ramdave, S | 1 |
| Abe, T; Fukuda, H; Ishioka, C; Iwata, R; Kanamaru, R; Kitagawa, Y; Kubota, K; Yamaguchi, K; Yamaura, G; Yoshioka, T | 1 |
| Georg, T; Graeter, TP; Hellwig, D; Kirsch, CM; Schäfers, HJ; Ukena, D | 1 |
| Färkkilä, MA; Knuuti, MJ; Luostarinen, ME; Minn, HR; Räsänen, JV; Salo, JA; Sihvo, EI; Viljanen, T | 1 |
| Groen, H; Heeren, PA; Jager, PL; Plukker, JT; van der Jagt, EJ; van Dullemen, HM; van Westreenen, HL | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Mutch, DG; Rader, J; Siegel, BA; Zoberi, I | 1 |
| Baker, JA; Coleman, RE; Rosen, EL; Soo, MS; Turkington, TG | 1 |
| Hellwig, D; Kirsch, CM; Menger, MD; Menges, M; Moellers, MO; Romeike, BF; Samnick, S; Schneider, G | 1 |
| Fulham, MJ; McCaughan, BC; Modi, D; Mohamed, A | 1 |
| Antoch, G; Bier, U; Freudenberg, L; Frings, M; Knorn, P; Maschke, M; Timmann, D | 1 |
| Delbeke, D; Pinson, CW | 1 |
| Adler, L; Doss, M; Freedman, G; Haluszka, O; Hanlon, A; Konski, A; Milestone, B | 1 |
| Hsieh, TC; Kao, CH; Liang, JA; Shiau, AC; Sun, SS; Yen, KY | 1 |
| Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
| Amthauer, H; Denecke, T; Felix, R; Gutberlet, M; Hildebrandt, B; Hoffmann, KT; Hünerbein, M; Rau, B; Ruf, J; Wust, P | 1 |
| Brunken, R; Bybel, B; Lin, H; Neumann, D; Wu, G | 1 |
| Chen, J; Cheong, JH; Hyung, WJ; Kim, J; Lim, JS; Noh, SH; Yun, MJ | 1 |
| Fukunaga, H; Hatazawa, J; Higuchi, I; Ikeda, M; Ikenaga, M; Monden, M; Nishimura, T; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Tatsumi, M; Yamamoto, H; Yasui, M | 1 |
| Chen, YK; Kao, CH | 1 |
| Bong, JK; Choi, HS; Lee, JD; Ryu, YH; Yoo, E; Yun, M | 1 |
| Lidner, TK; Nguyen, BD | 1 |
| Hirashima, T; Iwasaki, T; Kawahara, K; Kawase, I; Kobayashi, M; Matsui, K; Sasada, S; Takimoto, T; Yamadori, T | 1 |
| Higashi, T; Ishimori, T; Ishizu, K; Kitaichi, M; Li, M; Mamede, M; Manabe, T; Nakamoto, Y; Saga, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
| Changchien, CR; Chen, JS; Ho, KC; Liu, FY; Liu, SH; Yeh, CY; Yen, TC | 1 |
| Butori, C; Italiano, A; Mouroux, J; Thyss, A; Verge, M | 1 |
| Bauerfeind, P; Clavien, PA; Goerres, GW; Hany, TF; Heinrich, S; Pestalozzi, BC; Sagmeister, M; Schäfer, M; von Schulthess, GK | 1 |
| Fischman, AJ; Hahn, PF; Kalva, SP; Mueller, P; Ryan, D; Sahani, DV; Saini, S | 1 |
| Asakura, H; Haba, R; Mitani, M; Ohkawa, M; Seo, R; Takashima, H; Toyama, Y; Yokoe, K | 1 |
| Basu, S; Nair, N | 2 |
| Bonardel, G; Foehrenbach, H; Gontier, E; Guigay, J; L'Her, P; Mantzarides, M; Salles, Y; Vaylet, F | 1 |
| Carpentier, P; Kirova, J; Kolesnikov-Gauthier, H; Levy, E; Meignan, M; Merlet, P; Piedbois, P; Syrota, A | 1 |
| Castillo, E; Lawler, LP | 1 |
| Grigsby, PW; Hope, AJ; Saha, P | 1 |
| Kobayashi, T; Kosaka, N; Naruke, T; Nomori, H; Ohtsuka, T; Uno, K; Watanabe, K | 1 |
| Hoksch, B; Jüngling, F; Körner, M; Schmid, RA; Weber, T | 1 |
| Beer, AJ; Fischer, M; Lordick, F; Ott, K; Rummeny, EJ; Schwaiger, M; Siewer, JR; Weber, WA; Wieder, HA; Ziegler, S | 1 |
| Gupta, C; Gupta, V; Malani, AK; Rangineni, S | 1 |
| Liao, SQ; Liu, RS; Su, HY; Wang, SJ | 1 |
| Cheng, JD; Cohen, SJ; Eisenberg, D; Engstrom, P; Freedman, G; Haluszka, O; Hoffman, J; Konski, A; McGarrity, E; Meropol, NJ; Sigurdson, E; Watson, JC | 1 |
| Fink, U; Ott, K; Schwaiger, M; Stahl, A; Stollfuss, J; Weber, WA; Wieder, H | 1 |
| Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; McArthur, GA; McCarthy, TJ; Roselt, P | 1 |
| Feuerbach, S; Hamer, OW | 1 |
| Piehler, JM | 1 |
| Akhurst, T; Bains, MS; Downey, RJ; Gonen, M; Larson, S; Rizk, N; Rusch, V | 1 |
| Higashi, K; Maeda, S; Sagawa, M; Sakuma, T; Sugita, M; Toga, H; Ueda, Y | 1 |
| Guo, J; Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Takegami, T; Toga, H; Tonami, H; Ueda, Y; Yamamoto, I; Yokota, H | 1 |
| Drenth, JP; Laverman, P; Nagengast, FM; Oyen, WJ; van Kouwen, MC; van Krieken, JH | 1 |
| Adebonojo, SA; Katz, N; Little, AG; Moezzi, J; Paull, DE | 1 |
| Blackstock, AW; Clark, P; Farmer, MR; Geisinger, KR; Ho, C; Levine, EA; Lovato, J; Melin, SA; Mishra, G; Oaks, T | 1 |
| Cho, SY; Engles, JM; Ishimori, T; Mambo, E; Quarless, SA; Wahl, RL | 1 |
| Civelek, AC; Khayyat, N; Memisoglu, E; Naunheim, KS; Osman, MM; Piotrowski, B; Reimers, HJ | 1 |
| Ishido, Y; Kamano, T; Matsuoka, T; Sakamoto, K; Sakamoto, S; Takahashi, M; Tomiki, Y; Yaginuma, Y | 1 |
| Dou, Y; Raja, S; Roscoe, KJ; Tronic, B | 1 |
| Backhaus, B; Biersack, HJ; Jaeger, U; Matthies, A; Müller, SC; Palmedo, H; Reinhardt, M; von Mallek, D | 1 |
| Ell, PJ; Groves, AM; Pakzad, F | 1 |
| Plukker, JT; Sloof, GW; Van Lanschot, JJ; Van Westreenen, HL; Westerterp, M | 1 |
| Ebihara, A; Goya, T; Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Orikasa, H; Uno, K; Watanabe, K; Yamazaki, K | 1 |
| Heldmann, MG; Lilien, DL; Reddy, MP; Sangster, G | 1 |
| Boni, G; Capirci, C; Chierichetti, F; Crepaldi, G; Fanti, S; Mandoliti, G; Mariani, G; Polico, C; Rampin, L; Rubello, D; Salviato, S | 1 |
| Ak, I; Ozalp, S; Stokkel, MP; Vardareli, E; Yalçin, OT; Zor, E | 1 |
| Aloj, L; Avallone, A; Cascini, GL; Comella, P; De Martinis, F; Delrio, P; Guida, C; Lastoria, S; Marone, P; Parisi, V; Tatangelo, F | 1 |
| Alberini, JL; Gontier, E; Guinebretiere, JM; Wartski, M | 1 |
| Ishida, Y; Isozaki, H; Morimoto, T; Mukai, K; Nishiyama, S; Okajima, K | 1 |
| Becker, K; Busch, R; Fink, U; Herrmann, K; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Weber, WA; Wieder, H | 1 |
| Devaux, JY; Duron, F; Grahek, D; Gutman, F; Kerrou, K; Maurel, G; Montravers, F; Périé, S; Saint Guily, JL; Talbot, JN; Younsi, N; Zanotti, P; Zanotti-Fregonara, P | 1 |
| Fukuda, H; Iwasaki, T; Katsura, H; Kawahara, K; Nakagawa, K; Nakane, S | 1 |
| Lau, WF; Lourie, R; Taranto, AJ | 1 |
| Blake, MA; Blaszkowsky, LS; Fischman, A; Holalkere, NS; Setty, B | 1 |
| Goto, M; Higashi, T; Mizumatsu, S; Nishimura, T; Sakai, K; Sugatani, H | 1 |
| Plukker, JT; van Westreenen, HL | 1 |
| Sloof, GW | 1 |
| Choi, JY; Kim, BT; Lee, KS; Shim, YM; Sung, YM; Yi, CA | 1 |
| Dam, HQ; Manzone, TM; Sagar, VV | 1 |
| Kaji, M; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 2 |
| Herts, BR; Remer, EM; Yoon, JK | 1 |
| Danno, K; Fukunaga, H; Gu, J; Hatazawa, J; Ikeda, M; Monden, M; Nishimura, T; Sekimoto, M; Takemasa, I; Tatsumi, M; Yamamoto, H | 1 |
| Amthauer, H; Böhmig, M; Denecke, T; Felix, R; Koch, I; Langrehr, J; Lopez Hänninen, E; Plotkin, M; Ruf, J; Wiedenmann, B | 1 |
| Hicks, RJ; Lau, EW; Ware, RE | 1 |
| Corstens, FH; de Geus-Oei, LF; Leer, JW; Oyen, WJ; Punt, CJ; Ruers, TJ | 1 |
| Collins, CD; Fennelly, D; Heffernan, E | 1 |
| Awasare, S; Malhotra, G; Nair, N | 1 |
| Fujibayashi, Y; Kotsuji, F; Kurokawa, T; Okazawa, H; Sawamura, Y; Shinagawa, A; Yoshida, Y | 1 |
| Allen, PJ; Brennan, MF; D'Angelica, M; Fong, Y; Larson, SM; Mansour, JC; Pandit-Taskar, N; Schwartz, L | 1 |
| Krüger, S; Mottaghy, FM; Pauls, S | 1 |
| Chen, X; Dai, JZ; Dong, MJ; Guan, YH; Jiang, BD; Lin, XT; Zhao, J; Zuo, CT | 1 |
| Fukushima, M; Imai, Y; Kadoya, M; Oguchi, K; Yamada, A | 1 |
| Chang, CC; Chen, YW; Hou, MF | 1 |
| Blackstone, EH; Bybel, B; Falk, GW; Little, SG; Mason, DP; Murthy, SC; Rice, TW; Rybicki, LA | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Hortling, N; Joe, AY; Palmedo, H | 1 |
| Bourbouloux, E; Bridji, B; Graveleau, J; Kraeber-Bodéré, F; Lanctin-Garcia, C; Marchand, V; Resche, I; Rousseau, C | 1 |
| Bartholomeusz, D; Kirkwood, ID; Liau, N; Ooi, C; Reid, C | 1 |
| Armbruster, C; Feichtinger, H; Gschwantler, M; Kriwanek, S; Kroiss, A; Moeschl, P; Plattner, D; Roka, R; Schueller, J; Singer, E; Weiss, W | 1 |
| Arii, S; Ishiwata, K; Kawamura, K; Liu, HY; Oda, K; Teramoto, K | 1 |
| Bong, JS; Cheng, V; Chundru, S; Fink-Bennett, D; Gaskill, M; Grills, I; Kestin, L; Martinez, AA; Schmidt, J; Wong, CY; Yan, D | 1 |
| Cheng, JD; Cohen, SJ; Freedman, G; Goldberg, M; Haluszka, O; Konski, AA; Li, T; Maurer, A; Meropol, NJ; Scott, W; Weiner, LM; Yu, JQ | 1 |
| Adachi, S; Iwanaga, K; Kitamura, Y; Mimura, T; Ohbayashi, C; Okada, M; Sakuma, T; Tauchi, S; Watanabe, H | 1 |
| Choti, MA; Gearhart, SL; Jacene, HA; Lavely, WC; Melton, GB; Schulick, RD; Wahl, RL | 1 |
| Becker, K; Essler, M; Hartung, R; Krause, BJ; Maurer, T; Schwaiger, M; Souvatzoglu, M; Stollfuss, J; Treiber, U | 1 |
| Chen, XX; Fu, Z; Mu, DB; Sun, XR; Wang, SP; Yang, WF; Yu, JM | 1 |
| Ahmed, S; Ghesani, N; Liu, Y; Maldjian, PD | 1 |
| Abenhardt, W | 1 |
| Chen, DW; Cheng, YL; Huang, TW; Lee, SC; Tsai, WC; Tzao, C | 1 |
| Chen, Y; Cui, NJ; Ma, J; Sun, Y; Tang, LL; Wang, Y; Wu, HB; Zong, JF | 1 |
| Chambers, J; Damani, N; Katsoulis, IE; Livingstone, JI; Mattheou, AK; Wong, WL | 1 |
| Fu, Z; Guo, HB; Li, WW; Liu, TH; Yang, GR; Yang, XH; Yu, JM; Yu, YH; Yuan, SH | 1 |
| Boellaard, R; Hoekstra, OS; Meijer, GA; Molthoff, CF; Reitsma, JB; Sloof, GW; Ten Kate, FJ; van Lanschot, JJ; Westerterp, M | 1 |
| Mittra, E; Niederkohr, R; Rodriguez, C; Segall, G; Vasanawala, M | 1 |
| Becker, K; Fink, U; Herrmann, K; Lordick, F; Ott, K; Schwaiger, M; Siewert, JR; Stahl, A; Weber, WA; Wieder, HA | 1 |
| Becker, K; Bredenkamp, R; Fink, U; Herrmann, K; Höfler, H; Krause, BJ; Lordick, F; Lorenzen, S; Ott, K; Peschel, C; Schuster, T; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA; Wieder, H | 1 |
| Abreu-E-Lima, P; Gerbaudo, VH; Mamede, M; Mamon, H; Nosé, V; Oliva, MR | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA | 1 |
| Arbuckle, S; Holland, AJ; Howman-Giles, R; Kellie, S; Mihm, D; Montfort, JM | 1 |
| Park, KG; Smith, TA; Suttie, SA | 1 |
| Gerbaudo, VH; Julius, B | 1 |
| Branstetter, BF; Shah, VN | 1 |
| Becker, K; Fink, U; Lordick, F; Ott, K; Peschel, C; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA | 1 |
| Galysh, RL; Hernandez, A; Jones, DR; Kahaleh, M; McDonough, PB; Northup, PG; Shami, VM; Shen, KR; White, GE | 1 |
| Conejo-Mir, JS; Congregado-Loscertales, M; Holgado, C; Loscertales, J; Moya, F; Muñoz, MA | 1 |
| DeLellis, RA; Mayo-Smith, WW; Prince, EA; Yoo, DC | 1 |
| Guan, YS; Sun, L; Wu, H; Ye, HY; Zhang, YH | 1 |
| Castellucci, P; Di Fabio, F; Fanti, S; Funaioli, C; Giaquinta, S; Longobardi, C; Martoni, AA; Mutri, V; Pinto, C; Rojas Llimpe, FL; Sperandi, F | 1 |
| Isowa, N; Maeda, R; Miura, H; Onuma, H | 1 |
| Burmeister, BH; Couper, GC; Gotley, DC; Harvey, JA; Martin, I; Smithers, BM; Thomas, JM; Thomson, DB; Walpole, ET; Watts, N; Wong, D | 1 |
| Davis, D; Dockery, KF; Puri, S; Qazi, R | 1 |
| Ahn, MI; Choi, JJ; Jeon, JS; Park, MY; Park, YH | 1 |
| Aizawa, T; Arakura, N; Hamano, H; Kadoya, M; Kawa, S; Kiyosawa, K; Miyata, K; Momose, M; Muraki, T; Oguchi, K; Ozaki, Y | 1 |
| Bonomo, G; Chiappa, A; Della Vigna, P; Ferrari, M; Mallia, A; Monfardini, L; Orsi, F; Paganelli, G; Ravasi, L; Travaini, LL; Trifirò, G | 1 |
| Ikeda, K; Katahira, K; Kawanaka, K; Mori, T; Nomori, H; Shiraishi, S; Yamashita, Y | 1 |
| Fukaya, T; Kohsaki, S; Maeda, N; Oguri, H; Yamada, R; Yamamoto, Y | 1 |
| Davey, K; Drummond, E; Heriot, AG; Hicks, RJ; Hogg, A; Mackay, J; Milner, AD; Ngan, S | 1 |
| Boughanim, M; Duvillard, P; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Pham, CT; Rey, A; Schlumberger, M; Zafrani, Y | 1 |
| Adler, AC; Haddad, R; Keidar, Z; Lachter, J | 1 |
| Benua, RS; Brill, AB; Christman, DR; Fowler, JS; Kemeny, NE; MacGregor, RR; Som, P; Stamm, R; Wolf, AP; Yeh, SD; Yonekura, Y | 1 |
| Benyounes, H; Bruce, D; Campbell, C; Eremin, O; Evans, NT; Heys, SD; Mikecz, P; Norton, MY; Sharp, PF; Smith, FW | 1 |
| Anderson, CJ; Connett, JM; Cutler, PD; Dehdashti, F; Meares, CF; Philpott, GW; Schwarz, SW; Siegel, BA; Welch, MJ; Zinn, KR | 1 |
| Coleman, RE; Duhaylongsod, FG; Lowe, VJ; Patz, EF; Vaughn, AL; Wolfe, WG | 1 |
| Bishop, J; Frank, A; Gobar, L; Gupta, N; Jaeger, S; Lefkowitz, D; Lynch, H; Mailliard, J; Scott, W; Sunderland, J | 1 |
| Fukatsu, H; Ikeda, M; Ishigaki, T; Isomura, T; Ito, K; Ito, S; Kato, T; Nishino, M; Ota, T; Tadokoro, M | 1 |
| Hawkins, RA | 1 |
| Berger, HG; Friess, H; Glatting, G; Kocher, F; Reske, SN; Stollfuss, JC | 1 |
| Fujii, M; Imamura, M; Inokuma, T; Kajiyama, T; Konishi, J; Magata, Y; Ohshio, G; Tamaki, N; Torizuka, T; Yonekura, Y | 1 |
| Aoki, S; Fujii, H; Kosuda, S; Nakamura, O; Shitara, N; Suzuki, K; Tanaka, Y | 1 |
| Altmann, A; Bellemann, ME; Blatter, J; Haberkorn, U; Kahn, B; Morr, I; Oberdorfer, F; van Kaick, G | 1 |
| Kanamaru, R; Oikawa, H; Takahashi, H; Yoshioka, T | 1 |
| Bares, R; Büll, U; Cremerius, U; Fass, J; Hauptmann, S; Hellwig, D; Klever, P; Mittermayer, C; Schumpelick, V | 1 |
| Frank, A; Gupta, N | 1 |
| Couson, F; Donath, A; Junod, AF; Lemoine, R; Louis, O; Nicod, L; Slosman, DO; Spiliopoulos, A | 1 |
| Bares, R; Buell, U; Fass, J; Hambuechen, U; Hauptmann, S; Hellwig, D; Klever, P; Mueller, B; Schumpelick, V; Zopp, L | 1 |
| Dalbohm, NM; Glaspy, JA; Hawkins, RA; Hoh, CK; Moser, EA; Nitzsche, EU; Phelps, ME | 1 |
| Broussard, WF; Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Tilbury, RS; Wong, WH | 1 |
| Aberle, DR; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Phelps, ME; Razavi, MK; Rege, SD | 1 |
| Clavo, AC; Higashi, K; Wahl, RL | 2 |
| Blahd, W; Brown, C; Khonsary, A; Mandelkern, M; Santiago, SM; Sazon, DA; Soo Hoo, GW; Williams, AJ | 1 |
| Feine, U; Hanke, JP; Held, J; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Kawashima, A; Kuwabara, Y; Masuda, K; Omagari, J; Sasaki, M; Yoshida, T | 1 |
| Delbeke, D; Mazer, MJ; Meranze, SG; Pinson, CW; Vitola, JV | 1 |
| Blount, CL; Dworkin, HJ | 1 |
| Cooper, JD; Dehdashti, F; Flanagan, FL; Patterson, GA; Siegel, BA; Sundaresan, SR; Trask, DD | 1 |
| Chung, YS; Kawabe, J; Nakata, B; Nishihara, T; Nishimura, S; Ochi, H; Okamura, T; Sakurai, Y; Sawada, T; Sowa, M | 1 |
| Clavo, AC; Torizuka, T; Wahl, RL | 1 |
| Bazzicalupo, L; Fiore, F; Gravina, A; Mainolfi, C; Maurea, S; Panico, MR; Salvatore, M; Wang, H | 1 |
| Adam, G; Bares, R; Buell, U; Cremerius, U; Dohmen, B; Fass, J; Klever, P; Sabri, O; Schumpelick, V; Zimny, M | 1 |
| Akaizawa, T; Fukuda, H; Ido, T; Kanamaru, R; Maeda, S; Oikawa, H; Takahashi, H; Yoshioka, T | 1 |
| Borson-Chazot, F; Houzard, C; Sassolas, G; Sigartau, C | 1 |
| Arildsen, RC; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
| Altmann, A; Bellemann, ME; Blatter, J; Brix, G; Doll, J; Gerlach, L; Haberkorn, U; Morr, I; Oberdorfer, F; van Kaick, G | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Bailey, MS; Block, MI; Cooper, JD; Dehdashti, F; Flanagan, FL; Patterson, GA; Siegel, BA; Sundaresan, RS | 1 |
| Belani, CP; Cidis Meltzer, C; Ferson, PF; Keenan, RJ; Luketich, JD; Schauer, P; Townsend, DW; Urso, K | 1 |
| Higashi, K; Nambu, Y; Nishikawa, T; Oguchi, M; Okimura, T; Seki, H; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Abdel-Nabi, H; Carbone, GM; Cronin, VR; Doerr, RJ; Galantowicz, PJ; Lamonica, DM; Spaulding, MB | 1 |
| Cheon, EM; Han, J; Kim, BT; Kim, Y; Kwon, OJ; Lee, KS; Rhee, CH; Shin, MH; Yoon, SB | 1 |
| Abdel-Dayem, HM; Abujudeh, H; Atay, S; El-Zeftawy, HM; Luo, JQ; Marans, HY; Mithilesh, K; Naddaf, SY; Omar, WS; Radin, AI; Wong, S | 1 |
| Deters, EC; Gross, MD; Kison, PV; Shreve, PD; Steventon, RS; Wahl, RL | 1 |
| Hara, T; Kishi, H; Kosaka, N | 1 |
| Higashi, K; Noguchi, T; Oguchi, M; Okimura, T; Seki, H; Taniguchi, M; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Bruchhaus, H; Hillinger, S; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Higashi, T; Honda, T; Imamura, M; Inokuma, T; Katsushima, S; Kimura, T; Konishi, J; Nakamoto, Y; Ohshio, G; Sakahara, H; Tamaki, N; Torizuka, T | 1 |
| Faulhaber, PF; Miraldi, F; Rajput, A; Stellato, TA; Vesselle, HJ | 1 |
| Couper, GW; McAteer, D; Nicolson, M; Norton, M; Park, KG; Wallis, F; Welch, A | 1 |
| Bishop, H; Gill, H; Graeber, G; Gupta, N; Hurst, J; Stephens, T | 1 |
| Präuer, HW; Römer, W; Schwaiger, M; Treumann, T; Weber, WA; Ziegler, SI | 1 |
| Branch, MS; Clark, L; Coleman, RE; DeLong, DM; Keogan, MT; McDermott, VG; Tyler, D | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 1 |
| Endo, K; Inoue, T; Masuda, H; Oriuchi, N; Shimizu, N; Yamanaka, H | 1 |
| Avril, N; Roder, JD; Schwaiger, M; Sendler, A; Siewert, JR | 1 |
| Johkoh, T; Kusuoka, H; Miyoshi, S; Nakamura, H; Nishimura, T; Tatsumi, M; Tomiyama, N; Watanabe, Y; Yutani, K | 1 |
| Higashi, T; Imamura, M; Kogire, M; Konishi, J; Nakamoto, Y; Sakahara, H; Tamaki, N | 1 |
| Bangard, M; Bangard, N; Bender, H; Biersack, HJ; Metten, N; Mezger, J; Schomburg, A | 1 |
| Beauchamp, RD; Chapman, WC; Delbeke, D; Frexes, ME; Leach, SD; Pinson, CW; Richards, WO; Rose, DM; Sandler, MP; Sharp, KW; Wright, JK | 1 |
| Block, T; Breul, J; Hartung, R; Hofer, C; Laubenbacher, C; Schwaiger, M | 1 |
| Beger, HG; Berberat, P; Büchler, MW; Friess, H; Kashiwagi, M | 1 |
| Fujiwara, T; Fukuda, H; Gamo, M; Ido, T; Ishioka, C; Iwata, R; Kanamaru, R; Murakawa, Y; Yoshioka, T | 1 |
| Higashi, T; Hiraoka, M; Imamura, M; Kanamori, S; Konishi, J; Nakamoto, Y; Nishimura, Y; Sakahara, H; Tamaki, N; Torizuka, T | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
| Friedman, DM; Keenan, RJ; Luketich, JD; Meehan, MA; Meltzer, CC; Townsend, DW; Weigel, TL | 1 |
| Beauchamp, RD; Chapman, WC; Delbeke, D; Leach, SD; Pinson, CW; Rose, DM; Shyr, Y; Wright, JK | 1 |
| Arocena, J; Berián, JM; Giménez, M; Richter, JA; Robles, JE; Rodriguez-Rubio, F; Rosell, D; Sánchez, D; Sanz, G | 1 |
| Belhocine, T; Daenen, F; Focan, C; Honoré, P; Hustinx, R; Rigo, P | 1 |
| Hansen, SB; Keiding, S; Munk, OL; Schiøtt, KM | 1 |
| Birnbaum, EH; Dehdashti, F; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Read, TE; Siegel, BA; Whiteford, HM; Whiteford, MH; Yee, LF | 1 |
| Fernandez, O; Galbis, J; Garcia-Velloso, MJ; Richter, J; Torre, W | 1 |
| Damm, M; Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H; Stennert, E | 1 |
| Delbeke, D; Leach, SD; Mertz, HR; Sechopoulos, P | 1 |
| Adams, S; Hör, G; Nickel, E | 1 |
| Bormans, G; Coosemans, W; De Leyn, P; De Wever, W; Dupont, P; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, A; Mortelmans, L; Peeters, M; Stroobants, S; Van Cutsem, E; Van Raemdonck, D | 1 |
| Bares, R; Buechin, P; Buell, U; Cremerius, U; Fass, J; Sabri, O; Schumpelick, V; Zimny, M | 1 |
| Enomoto, K; Fujii, H; Hojo, T; Ide, M; Ikeda, T; Kameyama, K; Kubo, A; Shohtsu, A; Yasuda, S | 1 |
| Avril, N; Bengel, F; Helmberger, H; Roder, JD; Schwaiger, M; Sendler, A; Siewert, JR; Stollfuss, J; Weber, W | 1 |
| Ayabe, K; Higashi, K; Katsuda, S; Nambu, Y; Oguchi, M; Sakurai, A; Seki, H; Shikata, H; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Agress, H | 1 |
| Charron, M; Dachille, MA; Friedman, D; Luketich, JD; Meehan, M; Meltzer, CC; Strollo, D; Townsend, DW; Urso, GK | 1 |
| Kim, S; Pai, M; Park, CH; Whang, KH; Yoon, SN | 1 |
| Futatsubashi, M; Kanno, T; Kasamatsu, N; Momiki, S; Nobezawa, S; Okada, H; Ouchi, Y; Torizuka, T; Yoshikawa, E | 1 |
| Cambier, JP; De Leyn, P; De Wever, W; Flamen, P; Lerut, A; Maes, A; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
| Fujibayashi, Y; Itoh, H; Sadato, N; Sugimoto, K; Takahashi, N; Tsuchida, T; Waki, A; Welch, MJ; Yonekura, Y | 1 |
| Chisin, R; Larson, SM; Macapinlac, HA; Ramos, CD; Yeung, HW | 1 |
| Lear, J; Lin, EC; Quaife, RA | 1 |
| Birk, D; Buchmann, I; Buck, AC; Diederichs, CG; Guhlmann, CA; Kotzerke, J; Mattfeldt, T; Reske, SN; Schirrmeister, HH; Shen, C | 1 |
| Barthel, H; Berr, F; Caca, K; Georgi, P; Hesse, S; Huster, D; Kluge, R; Schmidt, F; Seese, A | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Buchheimer, N; Ehrenkaufer, RL; Huang, Y; Kuhner, R; Mach, RH; Morton, TE; Wallen, CA; Wang, L; Wheeler, KT; Wu, L | 1 |
| Avril, NE; Becker, K; Busch, R; Dittler, HJ; Fink, U; Helmberger, H; Meisetschläger, G; Ott, K; Schwaiger, M; Siewert, JR; Weber, WA | 1 |
| Hirakawa, K; Ishikawa, T; Kawabe, J; Nakata, B; Nishimura, S; Nishino, H; Ochi, H; Ohira, M | 1 |
| Brink, I; Hasse, J; Imdahl, A; Jenkner, S; Moser, E; Nitzsche, E; Stoelben, E | 1 |
| Akino, H; Ishida, H; Kanamaru, H; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Tanase, K; Yonekura, Y | 1 |
| Koizumi, M; Maekawa, K; Miyazaki, C; Osawa, H; Tanaka, A; Tanaka, T; Watanabe, N | 1 |
| Higashi, K; Katsuda, S; Oguchi, M; Sakuma, T; Seki, H; Taki, S; Taniguchi, M; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Gerber, E; Knoll, P; Köhn, H; Kumpan, W; Mirzaei, S; Raderer, M; Schiessel, R; Schratter-Sehn, AU | 1 |
| Balon, H; Bohdiewicz, P; Chmielewski, GW; Dickinson, C; Dworkin, HJ; Fink-Bennett, D; Hill, JC; Nuñez, R; Pursel, SE; Ravikrishnan, KP; Welsh, RJ; Wong, CY | 1 |
| Fukunaga, H; Furukawa, J; Ikenaga, M; Katsumoto, Y; Maruyama, K; Maruyama, N; Nakaguchi, K; Nakamura, M; Okajima, S; Sekimoto, K; Shingai, T; Sue, F | 1 |
| Alonso, JD; Candel, I; De La Cueva, L; López, D; Martínez, C; Milio, A; Sopena, R | 1 |
| Hung, GU; Kao, CH; Tsai, SC | 1 |
| Alavi, A; Ghesani, N; Neto, CA; Zhuang, H | 1 |
| Canuel, C; De Gramont, A; Godeberge, P; Grahek, D; Kerrou, K; Montravers, F; Perniceni, T; Talbot, JN; Younsi, N | 1 |
| Angelberger, P; Dudczak, R; Füger, B; Kletter, K; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Patri, P; Raderer, M; Traub, T; Virgolini, I; Wogritsch, S | 1 |
| Akhurst, T; Cai, S; Gonen, M; Larson, SM; Macapinlac, HA; Nuñez, R; Osman, I; Riedel, E; Scher, HI; Yeung, HW | 1 |
| Doi, R; Higashi, T; Hosotani, R; Imamura, M; Ishimori, T; Konishi, J; Mamede, MH; Nakamoto, Y; Saga, T; Wada, M | 1 |
| Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y | 1 |
| Hanbidge, AE | 1 |
| Del Frate, C; Mortele, K; Ros, PR; Zanardi, R | 1 |
| Aitken, CL; Kramer, EL; Maguire, GQ; Mahmoud, F; McGuinness, G; Noz, ME | 1 |
| Bormans, G; De Potter, T; Filez, L; Flamen, P; Maes, A; Mortelmans, L; Penninckx, F; Van Cutsem, E | 1 |
| Boerner, AR; Fricke, H; Hofmann, M; Knapp, WH; Langen, KJ; Otto, D; Petrich, T; Weckesser, E; Weckesser, M | 1 |
| Cabrera Villegas, A; Ciria Santos, JP; Martín Urreta, JC | 1 |
| Kartheuser, A; Lonneux, M; Van Beers, BE | 1 |
| Bormans, G; Cambier, JP; De Leyn, P; De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Lerut, A; Maes, A; Mortelmans, L; Van Cutsem, E; Van Raemdonck, D | 1 |
| Grigsby, PW; Miller, TR | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nobezawa, S; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Alavi, A; Cuchiara, A; Hickeson, M; Matthies, A | 1 |
| Eremin, O; Evans, NT; Gvozdanovic, D; Heys, SD; Mallard, JR; Roeda, D; Smith, FW | 1 |
| Grossman, HB; Harney, J; Hutchins, G; Wahl, RL | 1 |
| Fukuda, H; Ido, T; Ito, M; Maeda, S; Matsuzawa, T; Takahashi, H; Wakui, A; Yamaguchi, K; Yang, PK | 1 |
| Ahonen, A; Joensuu, H | 1 |
64 review(s) available for fluorodeoxyglucose f18 and Adenocarcinoma
| Article | Year |
|---|---|
Focal Thyroid Incidentalomas on
Topics: Adenocarcinoma; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prevalence; Risk Factors; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2021 |
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2022 |
The impact of baseline
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2022 |
Role of PET/Computed Tomography in Elderly Thyroid Cancer: Tumor Biology and Clinical Management.
Topics: Adenocarcinoma; Aged; Biology; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Ligands; Male; Molecular Imaging; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Somatostatin | 2023 |
The Role of PET/CT in the Imaging of Pancreatic Neoplasms.
Topics: Adenocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Rectal Neoplasms | 2020 |
The value of 18F-FDG-PET testing in the management of esophageal and gastroesophageal junction adenocarcinoma - review.
Topics: Adenocarcinoma; Chemoradiotherapy; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2021 |
The first report of co-existence of pulmonary tuberculosis and lung malignancy in a kidney transplant recipient: a case report and literature review.
Topics: Adenocarcinoma; China; Ethambutol; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Isoniazid; Kidney Transplantation; Lung; Lung Neoplasms; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Thoracic Surgery, Video-Assisted; Treatment Outcome; Tuberculosis, Pulmonary | 2021 |
PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals | 2017 |
The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Patient Care Planning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (
Topics: Adenocarcinoma; Aged; Cell Transformation, Neoplastic; Clinical Decision-Making; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioactive Tracers; Treatment Outcome | 2019 |
Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities.
Topics: Adenocarcinoma; Algorithms; Calcinosis; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2013 |
Use of high-resolution computed tomography and positron emission tomography/computed tomography in the management of stage IA adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Imaging appearance of sarcomas of the prostate.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
[Importance of PET in surgery of esophageal cancer].
Topics: Adenocarcinoma; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Response Evaluation Criteria in Solid Tumors | 2014 |
Incidentally detected increased FDG uptake in bowel and its correlation with hystopathological data: our experience in a case series study.
Topics: Adenocarcinoma; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2014 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy | 2014 |
Is there a role for PET/CT with esophagogastric junction adenocarcinoma?
Topics: Adenocarcinoma; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Observer Variation; Patient Selection; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2015 |
Lung cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Tumor Burden | 2015 |
FDG PET/CT Can Assess the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy: Evidence From Meta-analysis and Systematic Review.
Topics: Adenocarcinoma; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2016 |
[Case of antiamphiphysin antibody-positive stiff-person syndrome with breast cancer diagnosed by FDG-PET].
Topics: Adenocarcinoma; Autoantibodies; Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Tissue Proteins; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Stiff-Person Syndrome | 2008 |
Recent advances in imaging of pancreatic neoplasms.
Topics: Adenocarcinoma; Diagnostic Imaging; Endoscopy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Medical Oncology; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2008 |
[PET and PET-CT of malignant tumors of the exocrine pancreas].
Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Positron emission tomography in the management of cervix cancer patients].
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms; Uterine Neoplasms | 2009 |
[Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett's cancer].
Topics: Adenocarcinoma; Barrett Esophagus; Blood Glucose; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis | 2009 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Granulocyte Colony-Stimulating Factor; Humans; Leukocytosis; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2010 |
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
Topics: Adenocarcinoma; Cystadenocarcinoma; Cystadenoma; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2010 |
New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.
Topics: Adenocarcinoma; Algorithms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Stomach Neoplasms; Treatment Outcome | 2010 |
[A case of long-term survival after resection for postoperative solitary adrenal metastasis from esophageal adenocarcinoma].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Male; Organoplatinum Compounds; Positron-Emission Tomography | 2010 |
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
[Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
Topics: Adenocarcinoma; Combined Modality Therapy; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Diverticulitis, Colonic; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Leiomyosarcoma; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
Topics: Adenocarcinoma; Area Under Curve; Confidence Intervals; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Odds Ratio; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2011 |
Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
¹⁸F-FDG PET/CT imaging of the pancreas: spectrum of diseases.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT based response-adapted treatment.
Topics: Adenocarcinoma; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography.
Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Positron emission tomography and colorectal carcinoma: an update.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mass Screening; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Screening for lung cancer.
Topics: Adenocarcinoma; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mass Screening; Radiography, Thoracic; Smoking; Solitary Pulmonary Nodule; Sputum; Tomography, Emission-Computed; Tomography, Spiral Computed | 2004 |
Positron emission tomography in gastric and esophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Diagnostic imaging of pancreatic cancer--the role of PET.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Tomography, Emission-Computed | 2004 |
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.
Topics: Adenocarcinoma; Biopsy, Fine-Needle; Cholangiopancreatography, Magnetic Resonance; Diagnostic Imaging; Endosonography; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Diagnostic radiology and nuclear medicine.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Spiral Computed | 2005 |
The role of positron emission tomography in the management of pancreatic cancer.
Topics: Adenocarcinoma; Adult; Case Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[PET in thyroid cancers].
Topics: Adenocarcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2006 |
Staging in oesophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Evolving role of (18)F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2006 |
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Diagnosis and staging of pancreatic cancer by positron emission tomography.
Topics: Adenocarcinoma; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US?
Topics: Adenocarcinoma; Diagnostic Imaging; Endosonography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Advances in imaging for pancreatic disease.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Cystadenoma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Cyst; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
74 trial(s) available for fluorodeoxyglucose f18 and Adenocarcinoma
| Article | Year |
|---|---|
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
Topics: Adenocarcinoma; Adult; Carcinoma, Pancreatic Ductal; Clinical Trials, Phase II as Topic; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multicenter Studies as Topic; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma.
Topics: Adenocarcinoma; Chemoradiotherapy; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies | 2020 |
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Oxaliplatin; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Young Adult | 2021 |
Intraoperative Molecular Imaging Combined With Positron Emission Tomography Improves Surgical Management of Peripheral Malignant Pulmonary Nodules.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Pilot Projects; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spectroscopy, Near-Infrared | 2017 |
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Fluorodeoxyglucose F18; Glycolysis; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2018 |
[
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Treatment Outcome | 2018 |
Prospective comparison of (4S)-4-(3-
Topics: Adenocarcinoma; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glutamates; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Safety | 2019 |
Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2019 |
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2013 |
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Interventional | 2014 |
Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Diagnostic value of preoperative SUVmax on FDG-PET/CT for the detection of ovarian cancer.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiography; Radiopharmaceuticals; Rectal Neoplasms | 2014 |
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.
Topics: Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Epigenesis, Genetic; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Patient Selection; Phenylurea Compounds; Positron-Emission Tomography; Prospective Studies; Pyridines; Research Design; Retreatment; Survival Rate; Tomography, X-Ray | 2015 |
Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Therapeutic implication of HER2 in advanced biliary tract cancer.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Gene Amplification; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Signal Transduction; Treatment Outcome; Xenograft Model Antitumor Assays | 2016 |
Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Fiber Optic Technology; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Patient Selection; Positron-Emission Tomography; Radiation Dosage; Research Design; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Astrocytoma; Carcinoma, Adenoid Cystic; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Hemangioma, Cavernous, Central Nervous System; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Melanoma; Middle Aged; Neurilemmoma; Optic Nerve Neoplasms; Orbital Neoplasms; Orbital Pseudotumor; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2008 |
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Monitoring; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Neoadjuvant Therapy; Neutrons; Pancreatectomy; Pancreatic Neoplasms; Photons; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Treatment Outcome | 2010 |
Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Regression Analysis; Thiosemicarbazones | 2009 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2010 |
Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study.
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Phantoms, Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Perioperative Period; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Rectal Neoplasms; Remission Induction; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2011 |
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gastrectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms | 2010 |
Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; ROC Curve; Treatment Outcome | 2011 |
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thoracotomy; Tomography, X-Ray Computed | 2011 |
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Treatment Outcome | 2011 |
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Biopsy; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Tomography, X-Ray Computed; Young Adult | 2011 |
Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Contrast Media; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Sample Size; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?
Topics: Adenocarcinoma; Adult; Algorithms; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Regression Analysis; Remission Induction; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Rectum; ROC Curve; Tomography, Spiral Computed; Treatment Outcome | 2013 |
18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cystectomy; Fluorodeoxyglucose F18; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Inguinal Canal; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinosarcoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Linear Models; Lymph Node Excision; Middle Aged; Multimodal Imaging; Ovariectomy; Pelvis; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Assessment; ROC Curve; Salpingectomy; Tomography, X-Ray Computed | 2013 |
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Cervical Vertebrae; Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Lumbar Vertebrae; Male; Pelvis; Phantoms, Imaging; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Ribs; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin.
Topics: Adenocarcinoma; Adult; Aged; Angiogenesis Inhibitors; Apoptosis; Biomarkers; CD3 Complex; Collagen; Dose-Response Relationship, Drug; Endostatins; Endothelium; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Lasers; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Prospective Studies; Recombinant Proteins; Tomography, Emission-Computed | 2002 |
Monitoring of tumour glucose metabolism by PET in a phase I study evaluating hormonal therapy in advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Glucose; Hormone Antagonists; Humans; Indoleacetic Acids; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Cholecystokinin; Thiazoles; Tomography, Emission-Computed | 2002 |
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Topics: Acetates; Adenocarcinoma; Aged; Carbon; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Irritants; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms | 2004 |
Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2004 |
Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage | 2006 |
18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; ROC Curve; Treatment Outcome | 2006 |
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Survival Rate | 2007 |
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Colorectal Neoplasms; Copper Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radiation Dosage; Radioimmunodetection; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kidney Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate; Teratoma; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Tomography, Emission-Computed | 1996 |
Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchoscopy; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.
Topics: Adenocarcinoma; Aged; Animals; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1999 |
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Cicatrix; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[18FDG-PET imaging of pancreatic adenocarcinoma].
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Pancreatic Neoplasms; Probability; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Tomography, Emission-Computed | 2000 |
FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2000 |
11C-acetate PET imaging of prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; CA-125 Antigen; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Postoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
974 other study(ies) available for fluorodeoxyglucose f18 and Adenocarcinoma
| Article | Year |
|---|---|
The usefulness of [18F]FDG-PET/CT in detecting and managing cancers with unknown primary site depends on histological subtype.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Young Adult | 2021 |
Peripheral pulmonary mucous gland adenoma with a cavity mimicking lung cancer.
Topics: Adenocarcinoma; Adenoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2022 |
Different adenocarcinomas subtypes present different 18-FDG PET/TC and 68Ga-DOTATOC uptake: An unique case.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Octreotide; Organometallic Compounds | 2022 |
Predictive value of metabolic activity detected by pre-operative 18F FDG PET/CT in ampullary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphocytes; Male; Middle Aged; Neoplasm Staging; Neutrophils; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2021 |
[(18)F-FDG PET-CT imaging of small intestinal adenocarcinoma with ovarian metastasis: two cases report].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Accuracy of
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Retrospective Studies; United States | 2022 |
Total neoadjuvant chemotherapy: a silver lining during the COVID pandemic for a patient with locally advanced diffuse distal gastric adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; COVID-19; Fluorodeoxyglucose F18; Gastrectomy; Humans; Neoadjuvant Therapy; Pandemics; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2022 |
Discordant Metabolic Response on 18F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma.
Topics: Adenocarcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
FDG PET/CT in a Case of Diffuse Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Quality of Life; Retrospective Studies; Thyroid Neoplasms | 2022 |
High SUVmax on routine pre-operative FDG-PET predicts early recurrence in pancreatic and peri-ampullary cancer.
Topics: Adenocarcinoma; Ampulla of Vater; Common Bile Duct Neoplasms; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms | 2022 |
Application of PET/CT in Preoperative Evaluation and Diagnosis of Gastric Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2022 |
68 Ga-PSMA-11 and 18 F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate.
Topics: Adenocarcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms | 2022 |
FDG PET/CT Imaging Findings of Renal Infarction in a Patient With Gastric Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Infarction; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2022 |
Evaluation of the 18F-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Caspase 3; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Double Trap Escape: Omental Nodular Hyperplasia Misdiagnosed as Metastasis by 18F-FDG PET/CT and 68Ga-FAPI PET/MRI in a Patient With Gastric Adenocarcinoma.
Topics: Adenocarcinoma; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Omentum; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms | 2022 |
Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcopenia; Stomach Neoplasms | 2022 |
Contribution of Metabolic Tumor Volume and Total Lesion Glycolysis to Predict Prognosis in Early-Stage Lung Cancer at Preoperative Staging.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2022 |
68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Epiglottic Polymorphous Adenocarcinoma With Multiple Bone Metastases Detected by 68 Ga-FAPI PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancer.
Topics: Adenocarcinoma; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prostate.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Prostatic Neoplasms | 2022 |
Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway.
Topics: Adenocarcinoma; ADP Ribose Transferases; Animals; Arginine; Cell Line, Tumor; Colonic Neoplasms; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Phosphatidylinositol 3-Kinases; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins c-akt | 2022 |
Routine contrast-enhanced CT is insufficient for TNM-staging of duodenal adenocarcinoma.
Topics: Adenocarcinoma; Cohort Studies; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2022 |
An uncommon and aggressive presentation of ceruminous adenocarcinoma of external auditory canal detected with
Topics: Adenocarcinoma; Bone Neoplasms; Ear Canal; Ear Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2022 |
The long noncoding RNA HOXA11-AS promotes lung adenocarcinoma proliferation and glycolysis via the microRNA-148b-3p/PKM2 axis.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Glycolysis; Homeodomain Proteins; Humans; Lung; Lung Neoplasms; MicroRNAs; Positron Emission Tomography Computed Tomography; RNA, Long Noncoding; Transcription Factors | 2023 |
Value of diffusion MRI versus [18F]FDG PET/CT in detection of cervical nodal metastases in differentiated thyroid cancer patients.
Topics: Adenocarcinoma; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2022 |
The Significance of FDG PET/CT-Derived Parameters in Determining Prognosis of Cases with Pancreatic Adenocarcinoma: A Prospective Study.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Matrix Metalloproteinase 2; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies | 2022 |
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Prognosis; Retrospective Studies | 2022 |
Mesenteric Mesonephric Adenocarcinoma on 68 Ga-FAPI PET/CT.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Mesentery; Positron Emission Tomography Computed Tomography | 2023 |
PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK).
Topics: Adenocarcinoma; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2022 |
Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Topics: Adenocarcinoma; Biomarkers, Tumor; Cicatrix; Fluorodeoxyglucose F18; Gallbladder; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection.
Topics: Adenocarcinoma; CA-19-9 Antigen; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Complete Metabolic Response in Adenocarcinoma Lung With Lymphangitic Carcinomatosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Contribution of F-18 fluorodeoxyglucose PET/CT and contrast-enhanced thoracic CT texture analyses to the differentiation of benign and malignant mediastinal lymph nodes.
Topics: Adenocarcinoma; Bayes Theorem; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2023 |
Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colonic Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Rectal Neoplasms; Retrospective Studies | 2022 |
18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Fluorides; Fluorodeoxyglucose F18; Humans; Medicare; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; United States | 2023 |
Do fine needle aspirate cytomorphological features correlate with positron emission tomography findings of metastatic non-small cell lung carcinoma in lymph nodes?
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2023 |
Can 99 Tc m -3PRGD 2 (α ν β 3 ) and 18 F-FDG dual-tracer molecular imaging change the therapeutic strategy for progressive refractory differentiated thyroid cancer: Case report.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2023 |
Predicting the pathological invasiveness of early lung adenocarcinoma prior to surgery using Deauville criteria: reliability and validity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies | 2023 |
The value of preoperative positron emission tomography/computed tomography in differentiating the invasive degree of hypometabolic lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
SUVmax-to-HU ratio in diagnosis of hepatic metastases of colon cancer on FDG PET/CT. A new semiquantitative parameter.
Topics: Adenocarcinoma; Adult; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphocytes; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Thyroid Neoplasms | 2023 |
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Cohort Studies; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2023 |
FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Multivariate analysis based on the maximum standard unit value of
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Incidental Detection of Second Primary in Bladder on PET scan of a Patient with Colon Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Transitional Cell; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies | 2023 |
Utility of non-contrast Dual Energy Computed Tomography in diagnosis of differentiated thyroid cancer - two case study.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2023 |
Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI study.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnets; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
68 Ga-FAPI PET/CT Detection of Non-FDG-Avid Poorly Differentiated Adenocarcinoma of the Trachea.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Trachea | 2023 |
Subcutaneous and Muscle Metastases From Rectal Adenocarcinoma on 18 F-FDG PET/CT Imaging.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Subcutaneous Tissue | 2023 |
FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biomarkers; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mutation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Predicting
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neural Networks, Computer; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
Early Detection of Gastric Intramucosal Adenocarcinoma on 68 Ga-FAPI PET/CT.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2023 |
Differential diagnosis of lung cancer and tuberculosis based on 18 F-fluorodeoxyglucose PET/CT multi-time points imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis | 2023 |
Clinical role of 18F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
[Primary α-fetoprotein positive hepatoid adenocarcinoma of the lung: a case report].
Topics: Adenocarcinoma; Aged, 80 and over; alpha-Fetoproteins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung; Male; Positron Emission Tomography Computed Tomography | 2023 |
Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Comparison of early and late
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cholestasis; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2020 |
A case report of rectal adenocarcinoma with intrahepatic cholangiocarcinoma of the liver.
Topics: Adenocarcinoma; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Rectal Neoplasms | 2019 |
[Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features in
Topics: Adenocarcinoma; Algorithms; Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography; Support Vector Machine | 2019 |
Added value of para-aortic surgical staging compared to
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Complications; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2020 |
Esophageal Adenocarcinoma With Subscalp Metastasis as the First Manifestation Detected by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Rare Esophageal Leptomeningeal Metastases Detected on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Meningeal Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Isolated Pancreatic Metastasis From Squamous Cell Lung Cancer Mimicking Primary Pancreatic Ductal Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Sub-centimeter adenocarcinoma arising from mature mediastinal teratoma during 11 years of follow-up.
Topics: Adenocarcinoma; Cell Transformation, Neoplastic; Chest Tubes; Drainage; Dyspnea; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mediastinal Neoplasms; Middle Aged; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Thoracotomy | 2020 |
Early recurrence detected by 18F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; China; Female; Fluorodeoxyglucose F18; Humans; Male; Margins of Excision; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2020 |
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Clostridium Infections; Clostridium septicum; Colonic Neoplasms; Endophthalmitis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography | 2020 |
A case of COVID-19 lung infection first detected by [18F]FDG PET-CT.
Topics: Adenocarcinoma; Aged, 80 and over; Betacoronavirus; Carcinoembryonic Antigen; Clinical Laboratory Techniques; Colonic Neoplasms; Coronavirus Infections; COVID-19; COVID-19 Testing; Fluorodeoxyglucose F18; Humans; Male; Myalgia; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; SARS-CoV-2; Whole Body Imaging | 2020 |
Is It Time to Introduce PET/CT in Colon Cancer Guidelines?
Topics: Adenocarcinoma; Aged; Biopsy; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic | 2020 |
Topics: Adenocarcinoma; Back Pain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningioma; Middle Aged; Multiple Pulmonary Nodules; Neoplasm Grading; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Thoracic Vertebrae | 2021 |
Metastasectomy for Isolated Right-Sided Thoracic Lymph Node Metastasis From Tubal Carcinoma.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Contrast Media; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Node Excision; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Robotic Surgical Procedures; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2020 |
Simultaneous use of FDG-18 and
Topics: Adenocarcinoma; Aged; Anthracosis; Biopsy; Bronchoscopy; Citrates; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium; Humans; Lung; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2020 |
Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunotherapy; Male; Middle Aged; Positron-Emission Tomography | 2020 |
FDG PET/CT of Hepatoid Adenocarcinoma of the Gallbladder.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Ultrasonography | 2020 |
Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Patient Selection; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2021 |
18F-FDG PET/CT Findings of an Isolated Splenic Metastasis From Endometrial Adenocarcinoma.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Splenic Neoplasms | 2020 |
Machine learning based on clinico-biological features integrated
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Machine Learning; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Preoperative carbohydrate antigen 19-9 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Incidental Finding of Endobronchial Metastasis by 18F-FDG PET/CT Leads to Change in Management in a Patient With Rectal Adenocarcinoma.
Topics: Adenocarcinoma; Biopsy; Bronchial Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Rectal Neoplasms | 2020 |
Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Watchful Waiting | 2020 |
Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer.
Topics: Adenocarcinoma; Brachytherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Risk Assessment; Survival Rate; Uterine Cervical Neoplasms | 2021 |
Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Prognostic role of early 18-FDG PET/CT during neoadjuvant chemotherapy for resectable adenocarcinoma of the esophagus and esophagogastric junction.
Topics: Adenocarcinoma; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Apoptosis Regulatory Proteins; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Pancreatic Neoplasms; Phosphoric Monoester Hydrolases; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
False negative rate at
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2021 |
Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Malignant priapism in metastatic adenocarcinoma of gastrointestinal origin: A
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Penis; Positron Emission Tomography Computed Tomography; Priapism | 2021 |
Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Atypical presentation of colorectal carcinoma with sole multiple osteolytic bone metastases: a case report.
Topics: Adenocarcinoma; Bone Neoplasms; Colorectal Neoplasms; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged | 2021 |
FDG PET/CT in a Case of Lynch Syndrome With Synchronous Inverted Urothelial Papilloma of the Bladder, Urothelial Carcinoma of the Ureter, and Jejunal Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Transitional Cell; Colorectal Neoplasms, Hereditary Nonpolyposis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Papilloma; Positron Emission Tomography Computed Tomography; Ureter; Ureteral Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms | 2022 |
The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre.
Topics: Adenocarcinoma; Aged; Australia; Biopsy; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Bone Marrow Metastases From Gastric Adenocarcinoma on 68Ga-FAPI-04 PET/CT.
Topics: Adenocarcinoma; Adult; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2022 |
PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome.
Topics: Adenocarcinoma; Adult; Antigens, Surface; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glutamate Carboxypeptidase II; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thyroid Neoplasms | 2021 |
Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ROC Curve; Transcription Initiation, Genetic | 2017 |
Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Republic of Korea; Retrospective Studies; Stomach Neoplasms | 2017 |
A 33-Year-Old Woman With a Fluorodeoxyglucose-Avid Left Lower Lobe Mass.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Pulmonary Sclerosing Hemangioma; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2017 |
SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Pharmacological; Biomarkers, Tumor; CA-19-9 Antigen; Drug Resistance, Neoplasm; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Humans; Inhibitor of Apoptosis Proteins; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Receptor, ErbB-2; Stomach Neoplasms; Survivin; Tumor Suppressor Protein p53 | 2017 |
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Middle Aged; Positron-Emission Tomography; Propensity Score; Prospective Studies; Radiopharmaceuticals; Survival Analysis | 2017 |
Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Correlation analysis of [
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma | 2017 |
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cohort Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hydroxybenzoates; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Gastrointestinal: Multiparametric hybrid 18-FDG PET/MRI evaluation of gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2017 |
Supraclavicular schwannoma mimicking a lymphadenopathy in a lung cancer patient: PET/CT findings.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Clavicle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphadenopathy; Male; Neurilemmoma; Positron Emission Tomography Computed Tomography | 2017 |
Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colitis, Ischemic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Solitary Choroidal Metastasis From Lung Adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2017 |
High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, CD; Biomarkers, Tumor; Cadherins; Cell Adhesion Molecules; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Tumor Burden | 2017 |
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2017 |
Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biopsy; Colon, Descending; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Jejunum; Laparotomy; Male; Mesentery; Neoplasm Recurrence, Local; Neoplasm Staging; Panniculitis, Peritoneal; Peritoneal Neoplasms; Peritoneum; Prognosis; Tomography, X-Ray Computed | 2017 |
Misleading
Topics: Adenocarcinoma; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Emtricitabine; Fluorodeoxyglucose F18; Gastrectomy; HIV Infections; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tenofovir; Treatment Outcome | 2018 |
Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2017 |
Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Hypoxia | 2017 |
Thyroid Metastasis as First Manifestation of a Colon Adenocarcinoma With KRAS Mutation: Usefulness of 18F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mutation; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Thyroid Neoplasms | 2017 |
Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2018 |
An Unusual Presentation of Cervical Carcinoma Metastasis as Mediastinal Adenopathy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Mediastinal Diseases; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Treatment Outcome; Uterine Cervical Neoplasms | 2017 |
CT and PET/CT fusion for lung cancer biopsy planning.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Uncommon Metastasis to the Pancreas From Adenocarcinoma of the Cervix Detected on Surveillance 18F-FDG PET/CT Imaging.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2017 |
Uterine Metastasis From Gastric Adenocarcinoma Masquerading as Physiologic Endometrial Uptake in FDG PET/CT.
Topics: Adenocarcinoma; Adult; Biological Transport; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Uterine Neoplasms | 2017 |
Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.
Topics: Adenocarcinoma; Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Injuries; Retrospective Studies | 2018 |
Spontaneous regression of FDG/PET positive lung adenocarcinoma in an elderly man.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Regression, Spontaneous; Neoplasm Staging | 2017 |
Evolving role of FDG-PET/CT in prognostic evaluation of resectable gastric cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Stomach Neoplasms | 2017 |
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2018 |
Quantitating whole lesion tumor biology in rectal cancer MRI: taking a lesson from FDG-PET tumor metrics.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Retrospective Studies; Tumor Burden | 2018 |
Optimal Interval for
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Rectal Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome | 2018 |
Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report.
Topics: Adenocarcinoma; Adult; Bone Marrow Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Renal Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT.
Topics: Adaptation, Physiological; Adenocarcinoma; Adenocarcinoma of Lung; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Nivolumab; Positron Emission Tomography Computed Tomography | 2018 |
A SUV
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Propensity Score; Radiopharmaceuticals; Radiosurgery; Survival Rate | 2018 |
Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
Topics: Adenocarcinoma; Aged; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2018 |
Comparison of different automated lesion delineation methods for metabolic tumor volume of 18F-FDG PET/CT in patients with stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Tumor Burden | 2017 |
CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Chemotherapy, Adjuvant; Colonic Neoplasms; Colonoscopy; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Keratin-20; Keratin-7; Lung; Lung Neoplasms; Male; Pneumonectomy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
PET-SUV Max and Upstaging of Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Retrospective Studies | 2019 |
Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Topics: Adenocarcinoma; Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neuroendocrine Tumors; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2018 |
Tumour metabolic activity measured by fluorodeoxyglucose positron emission tomography for radiotherapy planning as a prognostic factor for locally advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Treatment Outcome | 2018 |
FDG-Avid Focal Liver Reaction From Proton Therapy in a Patient With Primary Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Proton Therapy; Radiopharmaceuticals | 2018 |
Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Immunohistochemistry; Ki-67 Antigen; Linear Models; Liver Neoplasms; Mice, Nude; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Vascular Endothelial Growth Factor A | 2018 |
18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis | 2018 |
FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?
Topics: Adenocarcinoma; Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2018 |
(
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Rate; Uterine Cervical Neoplasms | 2018 |
Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Prognosis; Retrospective Studies | 2018 |
Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer.
Topics: Adenocarcinoma; Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
[Multiple primary malignant neoplasms detected by PET/CT in cancer patients].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Cross-Sectional Studies; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2017 |
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Hexokinase; Humans; Japan; Linear Models; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Predictive value of dual-time
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2018 |
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies | 2018 |
Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in Seven Patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Combined Modality Therapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Tumor Burden; Young Adult | 2018 |
Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Uterine Corpus Metastasis From Rectal Adenocarcinoma Detected Using 18F-FDG PET/CT.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Uterine Neoplasms | 2018 |
[Prognostic value of PET/CT in pancreatic cancer].
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Time Factors; Tumor Burden | 2018 |
Diagnosis of Multiple Primary Intestinal-Type Adenocarcinoma in the Lung by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
[Fetal Adenocarcinoma of the Lung].
Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2018 |
Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes.
Topics: Adenocarcinoma; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Color; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Support Vector Machine | 2018 |
Prognostic value of CT attenuation and FDG uptake of adipose tissue in patients with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adipose Tissue; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2018 |
Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Gastrointestinal: Caval tumor thrombus and duodenal metastasis from endometrial carcinoma.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed; Vena Cava, Inferior | 2019 |
68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Signet Ring Cell; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
Texture analysis of computed tomography data using morphologic and metabolic delineation of esophageal cancer-relation to tumor type and neoadjuvant therapy response.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2019 |
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Gene Ontology; Glycolysis; Humans; Male; Middle Aged; Organic Cation Transport Proteins; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras) | 2018 |
FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Chemoradiotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proctectomy; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; ROC Curve; Sacrum; Soft Tissue Neoplasms | 2019 |
Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2019 |
Routinely staging gastric cancer with
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; United Kingdom | 2019 |
Rectal adenocarcinoma presenting with thigh muscle metastasis as the only metastatic site.
Topics: Adenocarcinoma; Chemoradiotherapy, Adjuvant; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Metastasectomy; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Thigh; Treatment Outcome | 2019 |
Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings.
Topics: Adenocarcinoma; Aged; Densitometry; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Solitary Pulmonary Nodule | 2019 |
Correlation between EGFR mutation status and F
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Non-Smokers; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Regression Analysis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathology.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oxaliplatin; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2019 |
[A Case of Pulmonary Enteric Adenocarcinoma with Soleus Muscle Metastasis].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron Emission Tomography Computed Tomography | 2019 |
Cyclo-oxygenase-2 expression is associated with mean standardised uptake value on 18F-Fluorodeoxyglucose positron emission tomography in oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers; Cyclooxygenase 2; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Isolated Vaginal Recurrence of Early-Stage Rectal Cancer Detected by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Vaginal Neoplasms | 2019 |
Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Chemoradiotherapy; Disease Progression; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Esophageal Mucosa; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Primary Cell Culture; Progression-Free Survival; Signal Transduction; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Sister Mary Joseph Nodule in Advanced Pancreatic Adenocarcinoma Identified on
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Sister Mary Joseph's Nodule | 2019 |
Utility of Metabolic Parameters on FDG PET/CT in the Classification of Early-Stage Lung Adenocarcinoma: Prediction of Pathological Invasive Size.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Retroperitoneal Fibrosis | 2019 |
Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas.
Topics: Adenocarcinoma; Adenomatous Polyps; Aged; Aged, 80 and over; Biomarkers; Cell Line, Tumor; Colorectal Neoplasms; DNA, Mitochondrial; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Male; Middle Aged; Mitochondria; Monocarboxylic Acid Transporters; Muscle Proteins; Mutation; Neoplasm Staging; Oxidative Phosphorylation; Oxygen Consumption; Positron Emission Tomography Computed Tomography; Tumor Burden | 2019 |
Incidental Detection of Adenocarcinoma in the Neck of the Pancreas by FDG PET Imaging When a Cystic Lesion in the Body of Pancreas Was Evaluated.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pancreas; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
[18F]fluorodeoxyglucose-positron emission tomography and glucose-transporter type 1 expression in untreated primary small bowel adenocarcinoma.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Assessing radiomic feature robustness to interpolation in
Topics: Adenocarcinoma; Algorithms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Adenocarcinoma of the Stomach Leading to Recurrent Regurgitation and Muscular Hypermetabolism on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Fluorodeoxyglucose F18; Humans; Laryngopharyngeal Reflux; Male; Muscles; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2019 |
Alveolar Sarcoidosis With Intense FDG Uptake, Mimicking Multi-focal Pneumonia and Infiltrative Lung Malignancy.
Topics: Adenocarcinoma; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary | 2019 |
Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2019 |
Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2019 |
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Decision Making; Diagnostic Imaging; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2013 |
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma.
Topics: Adenocarcinoma; Case-Control Studies; Cell Proliferation; ErbB Receptors; Fluorodeoxyglucose F18; Genotype; Humans; Lung Neoplasms; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Survival Rate | 2013 |
Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Choline; Fluorodeoxyglucose F18; Humans; Lumbosacral Plexus; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Sciatic Nerve; Tomography, X-Ray Computed; Vascular Neoplasms | 2013 |
Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Drug Monitoring; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
In vitro chemoresponse to cisplatin and outcomes in cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Screening Assays, Antitumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2014 |
The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Synchronous quadruple primary tumors of thyroid, breast, pancreas, and stomach: a case report.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2013 |
[Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2013 |
Perineural spread of cervical cancer to the sciatic nerve.
Topics: Adenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Rare Diseases; Sciatic Neuropathy; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Investigation of incidental bowel FDG uptake.
Topics: Adenocarcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2013 |
Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Chemoradiotherapy, Adjuvant; Cyclooxygenase 2; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
[Is it useful to perform additional colonoscopy to detect unmatched lesion between positron emission tomography/computed tomography and colonoscopy?].
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
A rare case of synchronous fetal type adenocarcinoma and mucinous adenocarcinoma of the lung evaluated by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenocarcinoma, Mucinous; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Multiple Pulmonary Nodules; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2013 |
A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinoscopy; Middle Aged; Models, Statistical; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Scotland; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2014 |
Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography | 2014 |
Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Benzylidene Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Inflammation Mediators; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Nude; Multimodal Imaging; Phosphorylation; Piperidones; Positron-Emission Tomography; Signal Transduction; Time Factors; Tomography, X-Ray Computed; Transcription Factor RelA; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
PET/CT findings for bone marrow carcinosis because of lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Bone Marrow Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Ability of FDG-PET/CT in the detection of gallbladder cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dihydrouracil Dehydrogenase (NADP); Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Microvessels; Middle Aged; Neovascularization, Pathologic; Neuroendocrine Tumors; Orotate Phosphoribosyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymidylate Synthase; Thymus Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Statistics as Topic; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Outcome analysis of (18)F-fluorodeoxyglucose positron-emission tomography in patients with lung cancer after partial volume correction.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2013 |
[Determination of prognostic factors].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
(18)F-FDG PET/CT scan in malignant priapism with diffuse pulmonary adenocarcinoma metastatic invasion of both corpus spongiosum and cavernosum.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Penile Neoplasms; Positron-Emission Tomography; Priapism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma in Situ; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Decision Making; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
[Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Pleural metastases from papillary thyroid carcinoma mimicking mesothelioma.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Diagnosis, Differential; Fatal Outcome; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
Detection of skeletal muscle metastases on initial staging of lung cancer: a retrospective case series.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Ultrasonography, Doppler, Duplex | 2014 |
(18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2014 |
Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Endpoint Determination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Risk Factors; Survival Analysis | 2014 |
Ectopic hypercellular parathyroid tissue of the mediastinum masquerading as metastatic adenocarcinoma on positron emission tomography-computed tomography scan.
Topics: Adenocarcinoma; Biopsy, Fine-Needle; Choristoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Parathyroid Glands; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT superscan in prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
18FDG PET/CT findings in the unusual urachal adenocarcinoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Cisplatin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Irinotecan; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Mediastinal sarcoid-like reaction after colon adenocarcinoma resection.
Topics: Adenocarcinoma; Aged; Biopsy; Colectomy; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Mediastinal Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Time Factors; Tomography, X-Ray Computed | 2015 |
Positron emission tomography imaging of pancreatic cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis | 2014 |
Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2014 |
[Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis].
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pneumoconiosis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
A "dose on demand" Biomarker Generator for automated production of [(18)F]F(-) and [(18)F]FDG.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cyclotrons; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heterografts; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2014 |
IMRT with ¹⁸FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
Prognostic importance of volumetric measurements in stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Software; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Decision Making; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
Topics: Adenocarcinoma; Aged; Cough; Deglutition Disorders; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Respiratory Sounds; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Vascular Neoplasms; Vena Cava, Superior | 2015 |
(18)F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer.
Topics: Adenocarcinoma; Biopsy; Bronchioles; Bronchoscopy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies | 2014 |
How should synchronous multiple primary adenocarcinomas of the lung be resected?
Topics: Adenocarcinoma; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Multiple Primary; Pneumonectomy; Positron-Emission Tomography; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Renal mucinous tubular and spindle cell carcinoma and 18F-fluorodeoxyglucose-PET/CT findings.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Metastasis to the thyroid from non-small cell carcinoma of the lung: findings in (18)F-FDG PET/CT study.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Neoplasms; Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; False Positive Reactions; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2014 |
Utility of FDG-PET in clinical neuroendocrine prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prevalence; Prostatic Neoplasms; Retrospective Studies; Soft Tissue Neoplasms | 2014 |
Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/CT on survival in lung cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Pulmonary Atelectasis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2014 |
Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2015 |
Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2014 |
Use of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography to aid in diagnosing intestinal adenocarcinoma in 2 rhesus macaques (Macaca mulatta).
Topics: Adenocarcinoma; Animals; Female; Fluorodeoxyglucose F18; Intestinal Neoplasms; Macaca mulatta; Monkey Diseases; Positron-Emission Tomography | 2014 |
Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Fine-Needle; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2014 |
Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
A case of tracheal metastasis in colon cancer: detection with 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tracheal Neoplasms | 2015 |
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Comparison of intratumoral FDG and Cu-ATSM distributions in cancer tissue originated spheroid (CTOS) xenografts, a tumor model retaining the original tumor properties.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Coordination Complexes; Fluorodeoxyglucose F18; Mice; Organometallic Compounds; Spheroids, Cellular; Thiosemicarbazones | 2014 |
[Gene-targeted radiation therapy mediated by radiation-sensitive promoter in lung adenocarcinoma and the feasibility of micro-PET/CT in evaluation of therapeutic effectiveness in small animals].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Baculoviridae; Cell Line, Tumor; Combined Modality Therapy; Early Growth Response Protein 1; Fluorodeoxyglucose F18; Genetic Therapy; Genetic Vectors; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Peptide Fragments; Plasminogen; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Promoter Regions, Genetic; Random Allocation; Recombinant Proteins; Tomography, X-Ray Computed; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
Invited commentary.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Constriction, Pathologic; Cytological Techniques; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Small lesion, severe consequences. An intriguing ventilation-perfusion scintigraphy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Perfusion Imaging; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Topics: Adenocarcinoma; Aged; Biopsy; Esophageal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2014 |
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Symporters; Tumor Microenvironment | 2014 |
Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; ROC Curve; Survival Analysis | 2015 |
Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ear Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2015 |
Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid.
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome; Zoledronic Acid | 2015 |
Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Anaplastic Lymphoma Kinase; Biomarkers, Tumor; Case-Control Studies; Female; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Tomography, X-Ray Computed | 2015 |
Heterogeneity in [18F]fluorodeoxyglucose positron emission tomography/computed tomography of non-small cell lung carcinoma and its relationship to metabolic parameters and pathologic staging.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Validity of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pretreatment evaluation of patients with cervical carcinoma: a retrospective pathology-matched study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Topics: Adenocarcinoma; Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2014 |
Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Signal Transduction; Tomography, X-Ray Computed | 2014 |
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Hysterectomy; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction; Retreatment; Treatment Outcome | 2014 |
[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Relative low glycometabolism may also occur in invasive lung adenocarcinoma with visceral pleural invasion: case report and comments.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Penile metastasis from rectal cancer by PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2015 |
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT findings of a recurrent adenocarcinoma arising from malignant transformation of abdominal wall endometriosis.
Topics: Abdominal Wall; Adenocarcinoma; Adult; Cell Transformation, Neoplastic; Endometrial Neoplasms; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Differences in the prognostic significance of the SUVmax between patients with resected pulmonary Adenocarcinoma and squamous cell carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2014 |
Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Staging; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Parathyroid adenoma upstaging the lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Neoplasm Staging; Parathyroid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Extensive invasive extramammary Paget disease evaluated by F-18 FDG PET/CT: a case report.
Topics: Adenocarcinoma; Fatal Outcome; Fluorodeoxyglucose F18; Groin; Hip; Humans; Male; Middle Aged; Neoplasm Metastasis; Paget Disease, Extramammary; Penis; Positron-Emission Tomography; Radiotherapy; Scrotum; Skin Neoplasms; Thigh; Tomography, X-Ray Computed | 2015 |
What are the radiologic findings predictive of indolent lung adenocarcinoma?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2015 |
Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Chondrosarcoma; Coordination Complexes; Dog Diseases; Dogs; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Male; Molecular Imaging; Multimodal Imaging; Nose Neoplasms; Organometallic Compounds; Osteosarcoma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Prognosis; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Thiosemicarbazones; Thymidine; Tomography, X-Ray Computed; Tumor Burden | 2015 |
An FDG-PET/CT-positive lesion mimicking local recurrence of colon cancer 5 years after radical colectomy.
Topics: Adenocarcinoma; Aged; Cicatrix; Colectomy; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Time Factors; Tomography, X-Ray Computed | 2015 |
Case of the season: management of the subsolid pulmonary nodule.
Topics: Adenocarcinoma; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies | 2015 |
Unexpectedly fludeoxyglucose (18F) avid well-differentiated adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
[Positron emission tomography/computed tomography for lung cancer staging].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate.
Topics: Adenocarcinoma; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Organ Specificity; Positron-Emission Tomography; Prevalence; Prostate; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Tissue Distribution | 2015 |
Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2015 |
Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.
Topics: Adenocarcinoma; Aged; Bronchoscopy; Carcinoma, Squamous Cell; Databases, Factual; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma | 2015 |
Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; ROC Curve; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy.
Topics: Adenocarcinoma; Aged; Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tomography, X-Ray Computed | 2015 |
Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Indications and Limitations in the Management Algorithm of Patients With Esophageal Adenocarcinoma: Positron Emission Tomography Computed Tomography.
Topics: Adenocarcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Organs at Risk; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report.
Topics: Adenocarcinoma; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Cytoreduction Surgical Procedures; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Unnecessary Procedures | 2015 |
Diaphragm and Laryngeal FDG Uptake With Hiccups.
Topics: Adenocarcinoma; Diaphragm; Fluorodeoxyglucose F18; Hiccup; Humans; Larynx; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2015 |
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2016 |
The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2015 |
Adenocarcinoma of the Cervix Uteri and Endometrium Combined With the Kartagener Syndrome on FDG PET/CT.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Kartagener Syndrome; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms | 2015 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Regression Analysis; Retrospective Studies; ROC Curve; Survival Analysis; Tumor Burden | 2015 |
Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Progressing Sclerosing Mesenteritis (Mesenteric Panniculitis) Mimics Progression of Malignancy After Neoadjuvant Chemotherapy for Gastric Adenocarcinoma on Serial 18F-FDG PET/CT.
Topics: Adenocarcinoma; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Panniculitis, Peritoneal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Rate; Tissue Distribution | 2015 |
Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nomograms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Tomography, X-Ray Computed; Tumor Burden | 2016 |
In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, ErbB-3; Time Factors; Tumor Burden; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2015 |
Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oncogene Proteins, Fusion; Phenotype; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Collision of lymphoepithelioma-like carcinoma and adenocarcinoma of the lung: a case report.
Topics: Adenocarcinoma; Biomarkers, Tumor; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Squamous Cell; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Dyspnoea in a 72-year-old woman.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Dyspnea; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Positron-Emission Tomography | 2015 |
A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2016 |
The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Carcinoma, Squamous Cell; Cohort Studies; Dyrk Kinases; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nuclear Proteins; Primary Cell Culture; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA, Messenger; Ubiquitin-Protein Ligases | 2015 |
Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
Topics: Adenocarcinoma; Biomarkers; Blood Proteins; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Cost-Benefit Analysis; Diagnostic Imaging; DNA Methylation; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; MicroRNAs; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
A 79-Year-Old Man With Interstitial Lung Disease and Cryptic Area of High 18 Fluorodeoxyglucose Uptake in Left Upper Lobe.
Topics: Adenocarcinoma; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasms, Second Primary; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Evaluation of 18F-FDG uptake for detecting lymph node metastasis of gastric cancer: a prospective pilot study for one-to-one comparison of radiation dose and pathological findings.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; RNA, Messenger; Survival Analysis | 2016 |
Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[Prognostic value of the metabolically active tumour volume].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2016 |
The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.
Topics: Adenocarcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Preoperative Period; Retrospective Studies | 2016 |
[(18) F]-Fluorodeoxy-d-glucose uptake-positive seborrhoeic keratosis on positron emission tomography may result from high expression of glucose transporter.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Keratosis, Seborrheic; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 2016 |
FDG PET/CT in Sarcomatoid Carcinoma of the Gallbladder With Chondroid Differentiation.
Topics: Adenocarcinoma; Carcinosarcoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Mucin-1; Neprilysin; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vimentin | 2016 |
Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.
Topics: Adenocarcinoma; Aged; C-Reactive Protein; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients.
Topics: Adenocarcinoma; Aged; Chemoradiotherapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2016 |
Clinicopathological Parameters Influence Assessment of FDG SPECT in Gastric Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon; Tumor Burden | 2015 |
18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Young Adult | 2016 |
Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Bronchoscopy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Thoracotomy | 2016 |
18F-FDG PET/CT and Contrast-Enhanced CT of Primary Malignant Tracheal Tumor.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tracheal Neoplasms | 2016 |
Contribution of ¹⁸Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Base Sequence; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Mutation; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sequence Analysis, DNA; Thyroid Nuclear Factor 1; Transcription Factors | 2016 |
[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sex Factors; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Surgical Resection for Solitary Myocardial Metastasis of Gastric Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Oxonic Acid; Positron Emission Tomography Computed Tomography; Pyridines; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tegafur | 2016 |
The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Observer Variation; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
FDG PET/CT in Hepatoid Adenocarcinoma of the Lung.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Data Accuracy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2016 |
FDG PET/CT in Peritoneal Metastasis From Prostate Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
Topics: Adenocarcinoma; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vulvar Neoplasms | 2016 |
Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Agents; Biomarkers; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Treatment Outcome | 2016 |
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms | 2017 |
Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
Topics: Adenocarcinoma; Antigens, Surface; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2016 |
Uterine Cervical Metastasis From Primary Rectal Adenocarcinoma on PET/CT and MRI.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Uterine Cervical Neoplasms | 2016 |
Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radioisotopes; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2016 |
Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Comorbidity; Disease Management; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; United States | 2018 |
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve | 2016 |
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Grading; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2016 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
The value of
Topics: Adenocarcinoma; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Early Detection of Cancer; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Texas; Treatment Outcome | 2017 |
Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
Topics: Adenocarcinoma; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Utility of
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Survival Rate | 2017 |
FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophil Infiltration; Nivolumab; Pemetrexed; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Thyroid Neoplasms | 2016 |
Diagnosis of Primary Intestinal-Type Adenocarcinoma in the Nasal Cavity by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2016 |
Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings.
Topics: Adenocarcinoma; Adenoma; Colon; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Dual-Tracer PET/CT Using 18F-FDG and 11C-Acetate in Gastric Adenocarcinoma With Liver Metastasis.
Topics: Acetates; Adenocarcinoma; Aged; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2016 |
Correlation of HIF-1α/HIF-2α expression with FDG uptake in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Basic Helix-Loop-Helix Transcription Factors; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged | 2016 |
Topics: Adenocarcinoma; Contrast Media; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Utility of 18 fludeoxyglucose in preoperative positon-emission tomography-computed tomography (PET-CT) in the early diagnosis of exocrine pancreatic cancer: A study of 139 resected cases.
Topics: Adenocarcinoma; Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreas, Exocrine; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals | 2016 |
Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcino
Topics: Abdominal Fat; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Subcutaneous Fat; Survival Rate | 2017 |
PET-CT Post-Hepatic Radiation Changes in Gastroesophageal Adenocarcinoma.
Topics: Adenocarcinoma; Diagnosis, Differential; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Hepatitis; Humans; Image-Guided Biopsy; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Conformal; Stomach Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Hepatic radiation injury mimicking metastasis in distal esophageal cancer
Topics: Adenocarcinoma; Adult; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Hepatitis; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiopharmaceuticals | 2017 |
Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2017 |
Occult breast primary malignancy presenting as isolated axillary lymph node metastasis - early detection of primary site by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Axilla; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging | 2016 |
18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2016 |
A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
Topics: Adenocarcinoma; Aged; Bile Ducts, Extrahepatic; Biomarkers, Tumor; Biopsy; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cholangiopancreatography, Magnetic Resonance; Cholecystectomy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endoscopy, Gastrointestinal; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Jejunostomy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2016 |
Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2017 |
Incidental 18F-FDG PET/CT bilateral breast uptake due to carcinoma.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Carcinoma, Papillary; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
18F-FDG PET/CT of Seminal Vesicle Metastasis From Ascending Colon Adenocarcinoma.
Topics: Adenocarcinoma; Colon, Ascending; Colonic Neoplasms; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminal Vesicles | 2017 |
18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
The predictive value of
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Pancreatic Neoplasms; Pancreatitis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Costal chondrosarcoma requiring differential diagnosis from metastatic tumor.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biopsy; Bone Neoplasms; Chondrosarcoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteotomy; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Ribs; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Mucosa-associated lymphoid tissue lymphoma with unusual
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Colectomy; Colon, Sigmoid; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sigmoid Neoplasms; Vincristine | 2017 |
Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Carbonic Anhydrase IX; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
Topics: Adenocarcinoma; Adult; Aged; Disease-Free Survival; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastric Mucosa; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms | 2017 |
AEG I and II: is it one tumor entity?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome | 2008 |
Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjuvant chemoradiation.
Topics: Adenocarcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2008 |
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction.
Topics: Adenocarcinoma; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; ROC Curve; Time Factors | 2008 |
Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
Topics: Adenocarcinoma; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Clinical case report and literature review: metachronous colorectal splenic metastases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Splenectomy; Splenic Neoplasms | 2008 |
Whipple's procedure in a renal transplant recipient with polycystic liver disease.
Topics: Adenocarcinoma; Aged; Cholangiopancreatography, Endoscopic Retrograde; Cysts; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Liver Diseases; Pancreatic Neoplasms; Pancreaticoduodenectomy; Polycystic Kidney Diseases; Positron-Emission Tomography | 2008 |
Eosinophilic pneumonia and thoracic metastases as an initial manifestation of prostatic carcinoma.
Topics: Adenocarcinoma; Aged, 80 and over; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Pulmonary Eosinophilia; Thoracic Neoplasms | 2008 |
[Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Topics: Adenocarcinoma; Age Distribution; Age Factors; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sex Distribution; Sex Factors; Smoking; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2008 |
Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2008 |
(18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.
Topics: Adenocarcinoma; Aged; Bone Marrow; Carcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The value of F-18 FDG-PET/CT in diagnosis of chronic empyema-associated malignancy.
Topics: Adenocarcinoma; Chronic Disease; Empyema, Pleural; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Diagnosis of poorly differentiated thyroid cancer with radioiodine scanning after thyrotropin alfa stimulation.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Glycoprotein Hormones, alpha Subunit; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed | 2008 |
Metastasis to psoas muscle detected by F-18 FDG PET-CT imaging.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Psoas Muscles; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology.
Topics: Adenocarcinoma; Adult; Aged; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Dosage; Humans; Image Interpretation, Computer-Assisted; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[Recurrent infective endocarditis. A case report].
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bioprosthesis; Cecal Neoplasms; Colonoscopy; Endocarditis, Bacterial; Enterococcus faecalis; Fluorodeoxyglucose F18; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Opportunistic Infections; Positron-Emission Tomography; Recurrence; Streptococcal Infections; Streptococcus bovis; Streptococcus oralis | 2010 |
Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2009 |
A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography.
Topics: Adenocarcinoma; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urinary Bladder Neoplasms; Whole Body Imaging | 2008 |
Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction.
Topics: Adenocarcinoma; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Treatment Outcome | 2009 |
Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2009 |
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Statistics, Nonparametric | 2009 |
Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Cross-Sectional Studies; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2009 |
Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopy, Digestive System; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Skip metastasis to abdominal lymph nodes from lung adenocarcinoma.
Topics: Abdomen; Adenocarcinoma; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; ROC Curve; Treatment Outcome | 2009 |
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; DNA, Neoplasm; ErbB Receptors; Female; Fluorodeoxyglucose F18; Genetic Testing; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2010 |
Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Survival Rate; Treatment Outcome | 2009 |
Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Array Analysis | 2009 |
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Antigens, CD34; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Male; Microvessels; Middle Aged; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Positron-Emission Tomography; Radiopharmaceuticals; Thoracotomy; Vascular Endothelial Growth Factor A | 2009 |
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Physical Examination; Positron-Emission Tomography | 2009 |
[Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antigens, CD34; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Microvessels; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
[(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[The role of (18)F-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.
Topics: Adenocarcinoma; Animals; Cell Growth Processes; Cell Hypoxia; Connective Tissue Growth Factor; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Nude; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Small Interfering; Transfection; Transplantation, Heterologous | 2009 |
Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancer
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Young Adult | 2009 |
Prognostic value of maximum standardized uptake values from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Survival Analysis | 2009 |
Invited commentary.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3 cm in size.
Topics: Adenocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution | 2009 |
The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma.
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2009 |
Osteoblastic bone flare on F18-FDG PET in non-small cell lung cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapy.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Osteoblasts; Positron-Emission Tomography; Risk Assessment; Treatment Outcome | 2009 |
Detection of prostatic glandular adenocarcinoma during staging of non-small-cell lung carcinoma with F-18 FDG PET.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2009 |
Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2009 |
The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Body Weight; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2009 |
Dual primary subclavicular angiosarcoma and lung cancer imaging with C-11 acetate PET and FDG PET.
Topics: Acetates; Adenocarcinoma; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
[Case of a sigmoid colon cancer with metachronous metastases of the stomach and the abdominal wall].
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed | 2009 |
Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2009 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma.
Topics: Adenocarcinoma; Chi-Square Distribution; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Whole Body Imaging | 2009 |
Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Protein Isoforms; Radiopharmaceuticals; Radiotherapy, Adjuvant | 2009 |
Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Dextrans; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2010 |
11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness.
Topics: Acetates; Adenocarcinoma; Carbon; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis, Pulmonary | 2009 |
Biological correlates of the maximum 18-fluoro-2-deoxy-glucose uptake on positron emission tomography in non-small cell lung carcinoma after induction chemotherapy.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Remission Induction | 2009 |
Hypertrophic pulmonary osteoarthropathy diagnosed by FDG PET-CT in a patient with lung adenocarcinoma.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Osteoarthropathy, Secondary Hypertrophic; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG.
Topics: Acetates; Adenocarcinoma; Animals; Carbon; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Isotope Labeling; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals | 2009 |
A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphography; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2009 |
Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
[Lung cancer detected by fluorodeoxyglucose-positron emission tomography/computed tomography in the course of Mycobacterium avium infection; report of a case].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Rate | 2009 |
Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2009 |
Chylothorax due to metastatic prostate carcinoma: an unusual complication.
Topics: Adenocarcinoma; Biopsy; Chylothorax; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Usefulness of fluoro-2-deoxyglucose positron emission tomography for investigating unexplained rising carcinoembryonic antigen levels that occur during the postoperative surveillance of lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals | 2009 |
Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
Interesting image. Incidental diagnosis of prostate cancer by F-18 FDG PET/CT.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Interesting image. Utility of FDG metabolism to differentiate synchronous metastatic liver lesions from synchronous colon cancer: nonmucinous versus mucinous adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Sensitivity and Specificity | 2010 |
(18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Carcinoma, Adenosquamous; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2010 |
FDG uptake in cutaneous and subcutaneous metastases from colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Skin Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2010 |
Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
PET and PET/CT for pancreatic malignancies.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
FDG PET-CT evaluation of granular cell tumor of the soft tissue.
Topics: Adenocarcinoma; Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
Using 18F-FDG positron emission tomography/computed tomography to judge benign or malignant colorectal hypermetabolic lesions.
Topics: Adenocarcinoma; Adenomatous Polyps; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
The diagnostic challenge of mediastinal sarcoidosis accompanying esophageal cancer.
Topics: Adenocarcinoma; Aged; Decision Making; Diagnosis, Differential; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Mediastinal Diseases; Middle Aged; Neoplasms, Squamous Cell; Palliative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2010 |
Prognostic implication of dual-phase PET in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Regression Analysis; Retrospective Studies; Tumor Burden | 2010 |
Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Appendiceal Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Subcutaneous metastases of colorectal cancer detected with PET/CT.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Incidental early stage endometrial adenocarcinoma diagnosed by F-18 FDG PET-CT, which was negative on ultrasound and nonspecific on MRI.
Topics: Adenocarcinoma; Aged; Endometrial Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Demonstration of a tubercular fistula-in-ano on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Colonic Neoplasms; Cutaneous Fistula; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Fistula; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis, Cutaneous | 2010 |
High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Positron-Emission Tomography; Proportional Hazards Models; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Comparison of the biodistribution and PET imaging with (11)C-PDT and (18)F-FDG in the mouse model of lung adenocarcinoma].
Topics: Adenocarcinoma; Animals; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Kidney; Liver; Lung Neoplasms; Mice; Myocardium; Podophyllotoxin; Positron-Emission Tomography; Tissue Distribution | 2010 |
The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Blood Glucose; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies | 2010 |
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Antineoplastic Agents; Base Sequence; DNA Primers; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Polymorphism, Genetic; Vascular Endothelial Growth Factor A | 2011 |
F-18 FDG PET/CT imaging in small cell prostate cancer.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2010 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2011 |
[Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Cystadenocarcinoma, Serous; DNA-Binding Proteins; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Transcription Factors | 2010 |
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases | 2010 |
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA, Neoplasm; Female; Fluorodeoxyglucose F18; Genotype; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2010 |
Limitation of F-18 fluorodeoxyglucose positron emission tomography in the detection of metastatic adenocarcinoma of brain combining intratumoral hemorrhage.
Topics: Adenocarcinoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intracranial Hemorrhages; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography | 2010 |
Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Contrast Media; Dermatitis, Contact; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Prognosis; Recurrence; Retrospective Studies; Risk; Vascular Endothelial Growth Factor D | 2010 |
F-18 fluorodeoxyglucose PET in Fournier gangrene.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Fournier Gangrene; Humans; Male; Middle Aged; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed | 2010 |
Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Guest editorial: Neoadjuvant therapy, predictors of response, and patient outcomes.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2010 |
124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Colonic Neoplasms; Fluorodeoxyglucose F18; Glycoproteins; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Algorithms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Prognosis; Survival Analysis | 2011 |
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Stomach Neoplasms | 2010 |
Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Japan; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Incidental detection of a pulmonary adenocarcinoma on low-dose computed tomography used for attenuation correction in myocardial perfusion imaging with SPECT.
Topics: Adenocarcinoma; Aged; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Myocardial Reperfusion; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Contrast Media; Deoxycytidine; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Platinum Compounds; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Treatment Outcome | 2010 |
Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Excitatory Amino Acid Transporter 2; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 3; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2011 |
18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Camptothecin; Colectomy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Treatment Outcome | 2011 |
Metastatic colon carcinoma in a preexisting thyroid nodule.
Topics: Adenocarcinoma; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroid Nodule | 2010 |
VEGF-A and its isoform VEGF₁₂₁ mRNA expression measured by quantitative real-time RT-PCR: correlation with F-18 FDG uptake and aggressiveness of lung adenocarcinoma: preliminary study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2011 |
Successful diagnosis of gallbladder carcinoma coexisting with adenomyomatosis by 18F-FDG-PET--report of a case.
Topics: Adenocarcinoma; Adenomyoma; Adult; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Four-dimensional positron emission tomography: implications for dose painting of high-uptake regions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Gastric adenocarcinoma? Looks similar but behaves differently!
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Biological; Neoplasm Invasiveness; Netherlands; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Regression Analysis; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Jejunal cancer detected after a resection of bilateral ovarian metastasis: report of a case.
Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Double-Balloon Enteroscopy; Female; Fluorodeoxyglucose F18; Humans; Jejunal Neoplasms; Laparotomy; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk; Tomography, Emission-Computed; Treatment Outcome; Young Adult | 2010 |
Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus.
Topics: Adenocarcinoma; Adult; Aged; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Survival Analysis; Whole Body Imaging | 2010 |
Monitoring early responses to irradiation with dual-tracer micro-PET in dual-tumor bearing mice.
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Monitoring, Physiologic; Positron-Emission Tomography; Radiotherapy; Transplantation, Heterologous | 2010 |
Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
[18F-fluorodeoxyglucose positron emission tomography (FDG-PET) negative poorly differentiated adenocarcinoma of lung with mediastinal lymph node metastases].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium | 2011 |
18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Lung Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Pyrazines; Receptor, IGF Type 1; Receptor, Insulin; Xenograft Model Antitumor Assays | 2011 |
Dynamic contrast-enhanced MRI of primary rectal cancer: quantitative correlation with positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Potential role of combined FDG PET/CT & contrast enhancement MRI in a rectal carcinoma model with nodal metastases characterized by a poor FDG-avidity.
Topics: Adenocarcinoma; Animals; Contrast Media; Fluorodeoxyglucose F18; HT29 Cells; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Mice; Mice, Nude; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Clinical Images: Hippokrates confirmed by positron emission tomography.
Topics: Adenocarcinoma; Comorbidity; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Osteoarthropathy, Primary Hypertrophic; Periostitis; Positron-Emission Tomography | 2011 |
FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies.
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Spinal Neoplasms; Spine; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2011 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Movement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Respiration; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Topics: Adenocarcinoma; Aged; Anthracosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Coal; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Carcinoma in Situ; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Genetic Engineering; Glucose; Glucose Transporter Type 2; Humans; Mice; Mice, Transgenic; Pancreatic Neoplasms; Positron-Emission Tomography; Precancerous Conditions | 2011 |
The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Tomography, X-Ray Computed | 2012 |
Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Topics: Adenocarcinoma; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Rectal Neoplasms | 2012 |
Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Risk Assessment; Risk Factors; ROC Curve; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Tumor Microenvironment | 2012 |
Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2011 |
False positive lymph node activity on positron emission tomography (PET/CT) due to hemostatic compresses.
Topics: Adenocarcinoma; Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Surgical Sponges; Tomography, X-Ray Computed | 2011 |
[Bifocal lung cancer: the same histology?].
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Preoperative Period; Prospective Studies; Radiopharmaceuticals | 2016 |
PET/CT appearance of appendiceal adenocarcinoma.
Topics: Adenocarcinoma; Appendiceal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Survival Rate; Treatment Outcome | 2011 |
Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2011 |
The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2011 |
Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; ROC Curve; Survival Analysis; Tomography, X-Ray Computed | 2011 |
18F-FDG uptake in primary lung cancer as a predictor of intratumoral vessel invasion.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies | 2011 |
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
Topics: Adenocarcinoma; Astrocytoma; Breast Neoplasms; Cell Line, Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, myc; Glucose; Glycolysis; Humans; Male; Melanoma; Neoplasm Proteins; Positron-Emission Tomography; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Radiopharmaceuticals; RNA, Messenger; RNA, Neoplasm | 2011 |
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Germany; Humans; Multicenter Studies as Topic; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Taxoids; Treatment Outcome | 2011 |
Collision lung cancer on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Diagnosis of synchronous isolated splenic metastasis from lung adenocarcinoma: complementary role of FDG PET/CT and diffusion-weighted MRI.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Diffusion; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed | 2011 |
The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomogr
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2011 |
Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2011 |
Cholecystocolic fistula of Crohn disease mimics colon adenocarcinoma invasion of gallbladder on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Crohn Disease; Diagnosis, Differential; Digestive System Fistula; Female; Fluorodeoxyglucose F18; Gallbladder; Humans; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Incidental focal colonic lesions found on (18)Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Algorithms; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Survival Rate | 2011 |
A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutrophils; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
F-18 FDG PET/CT imaging of a hidradenocarcinoma of head and neck.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sweat Gland Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Simultaneous rectal schwannoma and prostatic adenocarcinoma detected on FDG PET/CT.
Topics: Adenocarcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Prostatic Neoplasms; Rectal Neoplasms; Tomography, X-Ray Computed | 2011 |
The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Colonic Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity | 2011 |
MUC1 expression in pulmonary metastatic tumors: a comparison of primary lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Metastasectomy; Middle Aged; Mucin-1; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Young Adult | 2012 |
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms; Uterus; Young Adult | 2012 |
Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Prognosis; Quinazolines; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
Topics: Adenocarcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
A hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma detected by F-18 FDG PET/CT imaging.
Topics: Adenocarcinoma; Aged; Carcinoma, Hepatocellular; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2012 |
Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2011 |
Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to vestibular schwannoma suspected on preoperative [18F]-fluorodeoxyglucose positron emission tomography imaging.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Neuroma, Acoustic; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2012 |
Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
Topics: Adenocarcinoma; Adult; Autoantibodies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Basigin; Carbocyanines; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, SCID; Microscopy, Fluorescence; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, TNF-Related Apoptosis-Inducing Ligand; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2012 |
Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Cyclooxygenase 2; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Proteins; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Taxoids; Tomography, X-Ray Computed | 2012 |
[Addisonian crisis caused by metastatic lung cancer. Report of one case].
Topics: Addison Disease; Adenocarcinoma; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Invited commentary.
Topics: Adenocarcinoma; Biomarkers, Tumor; Cyclooxygenase 2; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Bone Marrow; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Hematologic Diseases; Humans; Leukocyte Count; Linear Models; Middle Aged; Neutrophils; Platelet Count; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Different distribution of (62) Cu ATSM and (18)F-FDG in head and neck cancers.
Topics: Adenocarcinoma; Aged; Analysis of Variance; Biopsy; Carcinoma, Squamous Cell; Coordination Complexes; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Thiosemicarbazones; Tomography, X-Ray Computed | 2012 |
FDG PET/CT in diagnosing and staging cutaneous eccrine adenocarcinoma.
Topics: Adenocarcinoma; Aged, 80 and over; Back; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sweat Gland Neoplasms; Tomography, X-Ray Computed | 2012 |
Risk stratification of gallbladder polyps (1-2 cm) for surgical intervention with 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Cell Transformation, Neoplastic; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Gallbladder Neoplasms; Gallstones; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Polyps; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Tomography, Emission-Computed | 2012 |
Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Tumor Burden | 2012 |
Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Diffuse metastases of lung adenocarcinoma with EGFR mutation.
Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; ErbB Receptors; Exons; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, erbB-1; Humans; Lung Neoplasms; Middle Aged; Mutation; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiography; Sequence Deletion; Spinal Neoplasms | 2012 |
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2012 |
Extraperitoneal urinary bladder perforation detected by FDG PET/CT.
Topics: Adenocarcinoma; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2011 |
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Choline; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunodetection; Radiopharmaceuticals | 2012 |
[18F]Fluorodeoxyglucose positron emission tomography/computed tomography-positive gastric adenocarcinoma in a 12-year-old girl with Peutz-Jeghers syndrome.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastroscopy; Humans; Immunohistochemistry; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Peutz-Jeghers Syndrome; Positron-Emission Tomography; Risk Assessment; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cystadenoma, Serous; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Changes in cervical cancer FDG uptake during chemoradiation and association with response.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CT.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Patella; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Uncommon lesions in the internal auditory canal (IAC): review of the literature and case report.
Topics: Adenocarcinoma; Brain Neoplasms; Cerebellopontine Angle; Craniotomy; Ear Canal; Ear Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Hearing Loss; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Bone; Tinnitus; Tomography, X-Ray Computed; Vomiting | 2012 |
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2012 |
The value of ¹⁸F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Neoplasm Transplantation; Norpregnenes; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Receptors, Steroid; STAT1 Transcription Factor | 2012 |
Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence.
Topics: Adenocarcinoma; Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
Asymptomatic metastasis to the larynx detected by FDG PET/CT in a patient with recurrent rectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2012 |
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Topics: Adenocarcinoma; Adult; Aged; Asia; Asian People; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Reference Standards; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Colon; Colonic Neoplasms; Colonic Polyps; Colonoscopy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2012 |
A case of isolated paraaortic lymph node recurrence from colon cancer successfully treated with chemoradiotherapy.
Topics: Adenocarcinoma; Carcinoembryonic Antigen; Chemoradiotherapy; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2012 |
Recurrence of lung cancer after radiofrequency ablation detected by PET/CT and contrast enhanced CT scan.
Topics: Adenocarcinoma; Aged, 80 and over; Catheter Ablation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.
Topics: Adenocarcinoma; Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Neoplasm Grading; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2012 |
[A case of gastric adenocarcinoma presenting as portal hypertension].
Topics: Adenocarcinoma; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Hypertension, Portal; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Japan; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Salvage Therapy; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colitis; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastritis; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proctitis; Proctocolitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Odds Ratio; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Endosonography; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2012 |
Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Adenocarcinoma arising in Meckel's diverticulum on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Meckel Diverticulum; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2013 |
Commentary on: Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spatio-Temporal Analysis; Tomography, X-Ray Computed | 2013 |
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Biopsy; CA-125 Antigen; Capecitabine; Carcinoembryonic Antigen; Carrier Proteins; CDX2 Transcription Factor; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cytokines; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Glycoproteins; Hepatectomy; Homeodomain Proteins; Humans; Immunohistochemistry; Keratin-20; Keratins; Liver; Liver Neoplasms; Lymph Node Excision; Magnetic Resonance Imaging; Membrane Transport Proteins; Phenotype; Portal Vein; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 2012 |
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Multimodal Imaging; Mutation; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Receptor Protein-Tyrosine Kinases; Tomography, X-Ray Computed; Young Adult | 2013 |
[Esophageal cancer: outcome according to therapeutic strategy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Ciliated muconodular papillary tumor of the lung: a newly defined low-grade malignant tumor with CT findings reminiscent of adenocarcinoma.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vena Cava, Inferior | 2013 |
18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Diagnostic Tests, Routine; Early Diagnosis; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2013 |
[PET/CT for monitoring the therapeutic response in a patient with abdominal lymph node tuberculosis after colon cancer resection].
Topics: Adenocarcinoma; Adenoma; Aged; Antitubercular Agents; Endoscopy; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Lymph Node | 2012 |
The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2013 |
Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Increased FDG uptake in the right cardiac chambers in a patient with pulmonary emphysema.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Heart Diseases; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung Neoplasms; Male; Middle Aged; Pulmonary Emphysema; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules.
Topics: Adenocarcinoma; Adenoma; Biopsy; Colonic Neoplasms; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Radiopharmaceuticals; Retrospective Studies; Sigmoidoscopy; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2002 |
[Synovial metastases from colonic cancer presenting as arthritis of the knee. Characterization by 18FDG PET scan].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Arthritis; Carcinoma; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Knee Joint; Male; Synovial Membrane; Tomography, Emission-Computed | 2002 |
F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis.
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granulomatosis with Polyangiitis; Humans; Lung Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms.
Topics: Adenocarcinoma; Ampulla of Vater; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Barrett-adenocarcinoma of the esophagus: false negative finding in a surgeon using FDG-PET].
Topics: Adenocarcinoma; Adult; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2002 |
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice.
Topics: Adenocarcinoma; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Proteins; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro.
Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Glioblastoma; Humans; Macrophages; Monocytes; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tumor Cells, Cultured | 2003 |
The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Comparison of MR and PET imaging for the evaluation of liver metastases.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Mediastinum; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Neoadjuvant therapeutic principles guided by response prediction and evaluation].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Neoadjuvant Therapy; Nucleoside-Phosphate Kinase; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Biopsy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Detection of synchronous adenocarcinomas and multiple dysplastic polyps with F-18 FDG positron emission tomography in a case of nonfamilial polyposis.
Topics: Adenocarcinoma; Colonic Neoplasms; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.
Topics: Adenocarcinoma; Adult; Aged; Blood Glucose; Cardia; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Survival Rate; Tomography, Emission-Computed | 2003 |
Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Cholecystitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Gallbladder Neoplasms; Humans; Middle Aged; Polyps; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions.
Topics: Adenocarcinoma; Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 2003 |
Splenic infarction mimicking gastric remnant on PET imaging.
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Gastrectomy; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Splenic Infarction; Stomach Neoplasms; Tomography, Emission-Computed | 2004 |
Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.
Topics: Adenocarcinoma; Animals; Carbon Radioisotopes; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Metabolic Clearance Rate; Mice; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous; Whole-Body Counting | 2004 |
[Study on glucose metabolic rate in non-small cell lung cancer patients with blood stasis syndrome and non-blood stasis syndrome].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carcinosarcoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Subtraction Technique; Tomography, Emission-Computed | 2004 |
Lymph node staging in lung cancer using [18F]FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoid Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies.
Topics: Adenocarcinoma; Adult; Carcinoembryonic Antigen; Deglutition Disorders; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Muscle Weakness; Neurons; Palliative Care; Paraneoplastic Syndromes, Nervous System; Radionuclide Imaging; Spinal Cord; Stiff-Person Syndrome; Upper Extremity | 2004 |
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagitis; Esophagus; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Statistics as Topic; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Lepidic spread of primary lung adenocarcinoma on FDG-PET.
Topics: Adenocarcinoma; Aged; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Pulmonary Alveoli; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
Colon cancer metastasis to the adrenal gland demonstrated with FDG PET/CT.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Choline; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lactic Acid; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Protons; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Survival Analysis | 2004 |
[Glut1 expression and its relation with the absorption of 18F-FDG in stomach cancer].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Radionuclide Imaging; Stomach Neoplasms | 2004 |
Caveat emptor: the treachery of work-up bias.
Topics: Adenocarcinoma; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Observer Variation; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
FDG-PET imaging in duodenal cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brain Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Topics: Adenocarcinoma; Aged; Antibodies, Neoplasm; Breast Neoplasms; Carcinoma, Small Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Paraneoplastic Syndromes, Nervous System; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
[Relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung adenocarcinoma].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2004 |
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2004 |
[False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[18F-FDG positron emission tomography for mediastinal staging of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2004 |
Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses?
Topics: Adenocarcinoma; Carbon Radioisotopes; Chronic Disease; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Sensitivity and Specificity | 2004 |
F-18 PET soft tissue uptake in seatbelt injury.
Topics: Adenocarcinoma; Aged; Artifacts; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Seat Belts; Soft Tissue Injuries | 2004 |
FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases.
Topics: Adenocarcinoma; Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Image Enhancement; Jejunal Neoplasms; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2004 |
Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies | 2004 |
Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Proportional Hazards Models; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Registries; Survival Analysis; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Guess the diagnosis: differentiated adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Weight Loss | 2004 |
Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous | 2005 |
Intraluminal FDG uptake in a rectal polyp detected with PET CT: identification of an unsuspected synchronous primary bowel tumor.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Positron-Emission Tomography; Rectal Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Cerebellar Degeneration; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2005 |
The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Ultrasonography | 2005 |
Fusion images of Tl-201 SPECT and FDG PET with CT in detection of cervical carcinoma with bladder invasion.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urinary Bladder; Uterine Cervical Neoplasms | 2005 |
FDG-PET in a case of multiple bone metastases of gastric cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rare Diseases | 2005 |
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2005 |
Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Colectomy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2005 |
Metastatic hepatic lesions are detected better by delayed imaging with prolonged emission time.
Topics: Adenocarcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2005 |
The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrectomy; Gastric Stump; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Whole-Body Counting | 2005 |
Intraductal papilloma of the breast: F-18 FDG PET demonstration.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Neoplasms; Papilloma, Intraductal; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[A case of adenocarcinoma of lung with idiopathic pulmonary fibrosis, showing 1 8-fluorodeoxyglucose uptake in positron emission tomograhy].
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Fibrosis | 2005 |
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Topics: Adenocarcinoma; Adult; Aged; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Linear Models; Lung; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Necrosis; Neoplasm Metastasis; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Time Factors; Tuberculosis | 2005 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies | 2005 |
[Fortuitous diagnosis of Castleman's disease by FDG-PET Scan during the follow-up of a renal cancer patient].
Topics: Adenocarcinoma; Castleman Disease; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2005 |
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, Emission-Computed; Trastuzumab; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
Selected cases demonstrating the value of furosemide-primed 18F-FDG PET in identifying adrenal involvement.
Topics: Adenocarcinoma; Adolescent; Adrenal Gland Neoplasms; Child, Preschool; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Infant; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[18-FDG positon emission tomography and distal metastasis from lung cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Femur; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tibia; Whole Body Imaging | 2005 |
FDG PET in patients with cancer of an unknown primary.
Topics: Adenocarcinoma; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2005 |
FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cervix Uteri; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 3. Hoarseness caused by cancer metastasis to the vagus nerve.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Cranial Nerve Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hoarseness; Humans; Melanoma; Tomography, X-Ray Computed; Vagus Nerve Diseases | 2005 |
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2005 |
Thyroid metastasis from colorectal cancer: role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Rectal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2005 |
F-18 FDG PET superscan.
Topics: Adenocarcinoma; Adult; Back Pain; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2006 |
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Radiotherapy; Rectal Neoplasms | 2005 |
FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding.
Topics: Adenocarcinoma; Biopsy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Survival Analysis; Time Factors; Tissue Distribution; Tomography, X-Ray Computed | 2005 |
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dideoxynucleosides; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Mice; Morpholines; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tumor Cells, Cultured | 2006 |
How useful is integrated PET and CT for the management of pancreatic cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Invited commentary.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Survival Analysis | 2006 |
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.
Topics: Adenocarcinoma; Biological Transport; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2006 |
Fluorodeoxyglucose uptake correlates with the growth pattern of small peripheral pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2006 |
Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model.
Topics: Adenocarcinoma; Animals; Azoxymethane; Colonic Neoplasms; Disease Models, Animal; Feasibility Studies; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2006 |
Positron emission tomography in well differentiated fetal adenocarcinoma of the lung.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Glucose Transporter Type 1; Hexokinase; Humans; Radiopharmaceuticals; RNA, Messenger; Tritium | 2006 |
Cutaneous metastatic lung cancer detected with 18F-FDG PET.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2006 |
Early colon cancer detected by 18F-FDG PET.
Topics: Adenocarcinoma; Colonic Neoplasms; Colonic Polyps; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2006 |
[Technical limits of PET/CT with 18FDG in prostate cancer].
Topics: Adenocarcinoma; Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Cyclin D1; Female; Fluorodeoxyglucose F18; Genes, Tumor Suppressor; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2006 |
"Cold" vertebrae on F-18 FDG PET: Causes and characteristics.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioma; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spine | 2006 |
Fat necrosis in the abdomen after surgery close to the pancreas: Potential false-positive on positron emission tomography.
Topics: Adenocarcinoma; Diagnosis, Differential; Duodenal Neoplasms; False Positive Reactions; Fat Necrosis; Fluorodeoxyglucose F18; Humans; Pancreas; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Time Factors | 2006 |
F18-FDG coincidence-PET in patients with suspected gynecological malignancy.
Topics: Adenocarcinoma; Adnexal Diseases; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Genital Neoplasms, Female; Humans; Laparotomy; Leiomyoma; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma.
Topics: Adenocarcinoma; Aged; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Usefulness of preoperative FDG-PET for detection of gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neck; Neoplasm Metastasis; Positron-Emission Tomography; Preoperative Care; Stomach Neoplasms; Whole Body Imaging | 2006 |
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Stomach Neoplasms; Survival Analysis | 2006 |
Pulmonary suture abscess with false-positive 18F-fluorodeoxyglucose positron emission scan mimicking lung cancer recurrence.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sutures | 2006 |
Ovarian vascular pedicle sign in ovarian metastasis arising from gall bladder carcinoma.
Topics: Adenocarcinoma; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiographic Image Enhancement; Rare Diseases; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Laparoscopic scar: a mimicker of Sister Mary Joseph's nodule on positron emission tomography/CT.
Topics: Adenocarcinoma; Aged; Cicatrix; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
[A case of brain metastasis from gastric cancer involving bilateral middle cerebellar peduncles].
Topics: Adenocarcinoma; Aged; Brain Neoplasms; Cerebellum; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Stomach Neoplasms | 2006 |
18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Mucoepidermoid; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2006 |
Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2006 |
Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss.
Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Barrett Esophagus; Contrast Media; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Cystadenoma; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2006 |
PET/CT: will it change the way that we use CT in cancer imaging?
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Case Management; Colorectal Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Probability; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Multiple metastases to skeletal muscle from carcinoma of the esophagus detected by FDG PET-CT imaging.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Muscle, Skeletal; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
F-18 FDG PET scan findings in a case of carcinoma of the breast with a rare site of metastases to the gingival region.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2006 |
The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2006 |
11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Aged; Carbon; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography | 2007 |
[18F-FDG PET/CT in paraneoplastic osteoarthropathy].
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Osteoarthropathy, Secondary Hypertrophic; Palliative Care; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
[Malignant tumor with false negative 18F-FDG PET image].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Regression Analysis; Stomach Neoplasms | 2006 |
Incidental diagnosis of endometrial carcinoma in a patient with breast cancer by FDG PET/CT.
Topics: Adenocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Is FDG-PET indicated for superficial esophageal cancer?
Topics: Adenocarcinoma; Diagnosis, Differential; Esophageal Neoplasms; Esophagoscopy; Esophagus; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Incidental Findings; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.
Topics: Adenocarcinoma; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
F-18 FDG PET/CT detection of mediastinal malignancy in a patient with dermatomyositis.
Topics: Adenocarcinoma; Aged; Dermatomyositis; Fluorodeoxyglucose F18; Humans; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis, Chronic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Evaluation of tumor growth in vivo in a rat model of liver metastasis, using a newly devised index obtained by positron emission tomography with [18F] FDG.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Liver Neoplasms, Experimental; Male; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Rats; Rats, Inbred F344 | 2007 |
Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Models, Theoretical; Positron-Emission Tomography; Radiotherapy; Reproducibility of Results; Small Cell Lung Carcinoma; Time Factors; Tomography, X-Ray Computed | 2007 |
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Analysis of Variance; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tomography, Emission-Computed | 2007 |
Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Metastasized urachal carcinoma scanned with 11C-chlorine and 18F-fluorodeoxyglucose PET/CT.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Antineoplastic Agents; Cystectomy; Fluorodeoxyglucose F18; Hematuria; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Paralysis; Positron-Emission Tomography; Spine; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cell Differentiation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed | 2007 |
Adenomyomatosis of the gallbladder: another cause for a "hot" gallbladder on 18F-FDG PET.
Topics: Adenocarcinoma; Aged, 80 and over; Colonic Neoplasms; Colonic Polyps; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
FDG-PET: an important tool in the diagnosis of lung cancer.
Topics: Abdomen; Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Lung cancer with isolated skip metastasis to an abdominal lymph node.
Topics: Abdomen; Adenocarcinoma; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
[The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Pharynx; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2007 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Thoracic Cavity | 2007 |
[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tissue Array Analysis; Tissue Distribution; Treatment Outcome | 2008 |
A case of three synchronous primary tumors demonstrated by F-18 FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms | 2007 |
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2007 |
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2007 |
Somatic malignant transformation in a sacrococcygeal teratoma in a child and the use of F18FDG PET imaging.
Topics: Adenocarcinoma; Cell Transformation, Neoplastic; Child; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sacrococcygeal Region; Teratoma; Treatment Outcome | 2008 |
[18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Flow Cytometry; Fluorodeoxyglucose F18; Fluorouracil; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tumor Cells, Cultured | 2007 |
Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Oncocytoma of the parotid gland: a potential false-positive finding on 18F-FDG PET.
Topics: Adenocarcinoma; Adenoma, Oxyphilic; Aged; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasms, Multiple Primary; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome | 2007 |
Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis.
Topics: Adenocarcinoma; Dermatomyositis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
CT and PET appearance of a pigmented "black" adrenal adenoma in a patient with lung cancer.
Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Endostatins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Recombinant Proteins; Stomach Neoplasms | 2007 |
Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Clinical Trials, Phase II as Topic; ErbB Receptors; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2007 |
Pulmonary intestinal-type adenocarcinoma.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Keratin-20; Keratin-7; Lung Neoplasms; Lymph Node Excision; Male; Nuclear Proteins; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sputum; Thoracic Surgery, Video-Assisted; Thyroid Nuclear Factor 1; Tomography, X-Ray Computed; Transcription Factors | 2008 |
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
FDG-PET on the trail of an unsuspected primary malignancy in the breast.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
F-18 FDG PET/CT demonstration of thymoma followed by development of lung cancer.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed | 2008 |
Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Autoimmune Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
Topics: Ablation Techniques; Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2008 |
Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2008 |
Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results | 2008 |
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Para-Aortic Bodies; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
FDG-PET/CT identifies a curable pancreatic cancer surgical tract metastasis after failure by other imaging modalities.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Seeding; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1982 |
Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
Topics: Adenocarcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Tomography, Emission-Computed | 1995 |
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Carcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; False Positive Reactions; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Recurrence; Reproducibility of Results; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem.
Topics: Adenocarcinoma; Blood Glucose; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Pancreatic tumors: imaging with PET.
Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed | 1995 |
2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Topics: Adenocarcinoma; Adult; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
Topics: Adenocarcinoma; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1995 |
Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Deoxyglucose; Fluorodeoxyglucose F18; Gemcitabine; In Vitro Techniques; Male; Prostatic Neoplasms; Rats; Tomography, Emission-Computed; Tumor Cells, Cultured | 1994 |
[Experimental study on the effectiveness of PET tumor images for cancer diagnosis].
Topics: Adenocarcinoma; Animals; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tomography, Emission-Computed | 1994 |
F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
Topics: Adenocarcinoma; Cholangiocarcinoma; Contrast Media; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Retroperitoneal Fibrosis; ROC Curve; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1994 |
In vitro assessment of FDG, methionine and thymidine uptake.
Topics: Adenocarcinoma; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Methionine; Thymidine; Tumor Cells, Cultured | 1993 |
Satellite PET and lung cancer: a prospective study in surgical patients.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hospitals, Satellite; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
[Whole body positron emission tomography in breast cancer].
Topics: Adenocarcinoma; Adenofibroma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Topics: Adenocarcinoma; Adult; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Thoracic Neoplasms; Tomography, Emission-Computed | 1993 |
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
Topics: Adenocarcinoma; Cell Division; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Ovarian Neoplasms; Thymidine; Tritium; Tumor Cells, Cultured | 1993 |
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Methionine; Ovarian Neoplasms; Thymidine; Time Factors; Tomography, Emission-Computed; Tumor Cells, Cultured | 1993 |
Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Topics: Adenocarcinoma; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Radiography, Thoracic; Tomography, Emission-Computed | 1996 |
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1996 |
Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization.
Topics: Adenocarcinoma; Chemoembolization, Therapeutic; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1996 |
F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
Topics: Adenocarcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity, Morbid; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1996 |
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; Esophagus; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Prognosis; Survival Rate; Tomography, Emission-Computed | 1997 |
Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Leucine; Methionine; Ovarian Neoplasms; Thymidine; Tomography, Emission-Computed; Tumor Cells, Cultured | 1997 |
Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.
Topics: Adenocarcinoma; Blood Glucose; Chronic Disease; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Deoxyglucose; Doxorubicin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Stomach Neoplasms; Time Factors; Tomography, Emission-Computed; Transplantation, Heterologous | 1997 |
[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Topics: Adenocarcinoma; Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thyroid Neoplasms | 1997 |
Staging recurrent metastatic colorectal carcinoma with PET.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Deoxyglucose; DNA, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Male; Neoplasm Transplantation; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Ribonucleotide Reductases; Thymidine; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Improvement in staging of esophageal cancer with the addition of positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Minimally invasive surgical biopsy confirms PET findings in esophageal cancer.
Topics: Adenocarcinoma; Aged; Biopsy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Laparoscopy; Liver Neoplasms; Lumbar Vertebrae; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Sacroiliac Joint; Spinal Neoplasms; Tomography, Emission-Computed | 1997 |
Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Localized form of bronchioloalveolar carcinoma: FDG PET findings.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms | 1998 |
Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Topics: Abdomen; Abdominal Neoplasms; Adenocarcinoma; Axilla; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neck; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
PET imaging of prostate cancer using carbon-11-choline.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Detection of extrathoracic metastases by positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Topics: Adenocarcinoma; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Mediastinal Diseases; Mediastinal Neoplasms; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Diagnosis of pancreatic carcinoma: role of FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Can the extent of pancreatic tumors be evaluated reliably enough by positron emission tomography (PET)].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Chronic Disease; Fluorodeoxyglucose F18; Gastrinoma; Humans; Pancreas; Pancreatic Neoplasms; Pancreatitis; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Contribution of PET in the detection of liver metastases from pancreatic tumours.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Topics: Adenocarcinoma; Blood Glucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
FDG-PET detection of primary lung cancer in a patient with an isolated cerebral metastasis.
Topics: Adenocarcinoma; Biopsy; Brain Neoplasms; Bronchoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Biopsy, Needle; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Problems of differential diagnosis in the diagnosis of mediastinal and pulmonary metastases with F-a8-FDG PET].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Middle Aged; Radiography; Radiopharmaceuticals; Sigmoid Neoplasms; Tomography, Emission-Computed | 2000 |
Lymph node metastasis from breast cancer diagnosed by F-18 FDG whole-body PET (case report).
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Tomography, Emission-Computed | 2000 |
Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
Topics: Adenocarcinoma; Adult; Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Introduction to clinical positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Evaluation of an adrenal mass in a patient with lung cancer by FDG coincidence positron emission tomography using a dual-head gamma camera.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Short dynamic FDG-PET imaging protocol for patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Esophagostomy; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Gastrostomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Free Radical Scavengers; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Thiosemicarbazones; Tissue Distribution; Tomography, Emission-Computed | 2000 |
Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Metastatic peritoneal seeding patterns demonstrated by FDG positron emission tomographic imaging.
Topics: Adenocarcinoma; Aged; Ascitic Fluid; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Seeding; Peritoneal Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Cell Division; Cell Nucleus; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reference Values; ROC Curve; Tomography, Emission-Computed | 2001 |
[[(18)F]N-(4'-fluorobenzyl)-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [(18)F]FDG, and [(125)I]IUDR.
Topics: Acetamides; Adenocarcinoma; Animals; Female; Fluorodeoxyglucose F18; Idoxuridine; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, sigma; Tissue Distribution | 2001 |
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Monitoring; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Male; Middle Aged; Patient Selection; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Tomography, Emission-Computed | 2001 |
Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer.
Topics: Adenocarcinoma; Aged; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pancreatic Neoplasms; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2001 |
Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Fluorodeoxyglucose F18; Glucose; Goserelin; Humans; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, Emission-Computed | 2001 |
[A case of lung cancer in which FDG-PET was useful for preoperative diagnosis].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Middle Aged; Pneumonectomy; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 2001 |
Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
[Determination of therapy management in rectal carcinoma by staging with 18-FDG-PET].
Topics: Adenocarcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2001 |
Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET.
Topics: Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report].
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Postoperative Period; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2001 |
[Endotracheal and endobronchial metastasis of colorectal adenocarcinoma. Diagnosis by 18F-FDG].
Topics: Adenocarcinoma; Aged; Bronchial Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sigmoid Neoplasms; Tomography, Emission-Computed; Tracheal Neoplasms | 2001 |
Two incorrect FDG positron emission tomographic interpretations of a pulmonary mass and mediastinal lymphadenopathy.
Topics: Adenocarcinoma; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Diseases; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Detection of Barrett's esophagus superimposed by esophageal cancer by FDG positron emission tomography.
Topics: Adenocarcinoma; Barrett Esophagus; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[18F]-FDG uptake in soft tissue dermatome prior to herpes zoster eruption: an unusual pitfall.
Topics: Adenocarcinoma; Adult; Carcinoembryonic Antigen; Colonic Neoplasms; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Herpes Zoster; Humans; Lumbosacral Region; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
Topics: Adenocarcinoma; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Intestinal Neoplasms; Ligands; Lung Neoplasms; Lymphoma; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tyrosine | 2001 |
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Tumor localization and image registration of F-18 FDG coincidence detection scans with computed tomographic scans.
Topics: Adenocarcinoma; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Carcinoma, Signet Ring Cell; Databases, Factual; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Stomach Neoplasms; Survival Analysis; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adult; Aged; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[Metastasis in leptomeninges discovered with PET-FDG].
Topics: Adenocarcinoma; Bone Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Middle Aged; Radiopharmaceuticals; Radiosurgery; Rectal Neoplasms; Sigmoid Neoplasms; Spinal Neoplasms; Tomography, Emission-Computed | 2001 |
Positive F-18 FDG positron emission tomography in the perineum after anorectal reconstruction.
Topics: Adenocarcinoma; Adult; Anal Canal; Electric Stimulation Therapy; Female; Fluorodeoxyglucose F18; Humans; Rectal Neoplasms; Rectum; Tomography, Emission-Computed | 2002 |
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2002 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2002 |
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Time Factors; Tomography, Emission-Computed | 2002 |
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colonic Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interleukin-2; Liver Neoplasms; Recombinant Proteins; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies.
Topics: Adenocarcinoma; Aged; Animals; Carcinoma, Transitional Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Pilot Projects; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1991 |
New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).
Topics: Adenocarcinoma; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Stomach Neoplasms; Tomography, Emission-Computed | 1986 |
Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radioisotopes; Radionuclide Imaging; Thyroid Neoplasms | 1987 |